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INTRODUCTION 
 
 
The kidneys have multiple central physiological functions including filtration of metabolic waste 
products from blood. In a healthy human adult approximately 180 liters of ultrafiltrate is formed 
each day, resulting finally in 1.0-1.5 liters of urine (Tisher & Madsen 1991). The primary filtration 
unit of the kidney is the nephron, which consists of the glomerulus and its tubular system. During 
glomerular filtration, plasma fluid traverses the wall of glomerular capillaries which make up the 
complex structure of the glomerular filtration barrier. From inside outward, it consists of fenestrated 
endothelial cells, glomerular basement membrane (GBM), and visceral epithelial cell (podocyte) 
foot processes with intervening slit diaphragms. The integrity of each of these structural elements in 
essential for the maintenance of normal ultrafiltration (Kanwar 1984, Kanwar et al. 1991).  
 
The mechanisms regulating plasma ultrafiltration in glomerulus have been an object of great interest 
and research work during the last decades. The passage of plasma fluid and proteins through the 
glomerular filtration barrier is regulated by a number of factors including the biochemical and 
biophysical properties of the glomerular capillary wall and the size, charge and shape of molecules 
being filtered (Brenner et al. 1978, Kanwar et al. 1991, Remuzzi & Remuzzi 1994). Glomerular 
ultrafiltrate is normally free of large plasma proteins and cellular elements. However, if the integrity 
of the filtration machinery is disrupted, the glomerular permselectivity is reduced allowing increased 
amounts of albumin and other plasma proteins to pass into the urinary space. This leads to 
proteinuria and nephrotic syndrome, which may, when persisting, lead ultimately to scarring and 
end-stage kidney requiring dialysis treatment and renal transplantation. Although a common 
medical finding, the etiology and pathogenesis of proteinuria are still poorly understood.  
 
Nephrotic syndrome represents a series of physiological consequences resulting from the occurence 
of significant urinary loss of protein. Congenital nephrotic syndrome of the Finnish type (CNF) 
forms a distinct entity among congenital nephrotic syndromes with its typical clinical picture and an 
autosomal recessive pattern of inheritance. CNF manifests already at the fetal stage as heavy 
proteinuria in utero and severe nephrotic syndrome develops within the first weeks of life (Hallman 
et al. 1967, Seppälä et al. 1976). The proteinuria in CNF is resistant to any treatment and today, 
renal transplantation preceded with an early nephrectomy and peritoneal dialysis is the only 
therapeutic option (Holmberg et al. 1995).  
 
The pathology of CNF kidneys has been characterized thoroughly (since its discovery in 1956), but 
the basic defect leading to proteinuria remained obscure until very recently, when Kestilä et al. 
(1998) identified a putative CNF gene and its protein product termed nephrin. Extensive 
morphological, histological and biochemical studies on CNF kidneys have been performed by 
several investigators, but none of the findings seemed to be causative for the CNF. The normal 
development of children following kidney transplantation, apparently without any manifestations of 
disease in other organs (Holmberg et al. 1995) implies that CNF is a kidney specific disease and 
thus, an ideal human model disease to study the pathogenesis of proteinuria.  
The aim of this thesis was to study the molecular mechanisms of proteinuria in the kidneys of CNF 
patients. At the time of this research, the basic defect of CNF was still unknown, but it had been 
suggested that it involves a gene essential to establish a functional glomerular filtration barrier, 
either primarily or secondarily. Several different hypotheses have been proposed to explain the  
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mechanisms of proteinuria in CNF, including aspects of the development of functional glomeruli 
and the molecular regulation of filtration. This study was undertaken to examine CNF kidneys in the 
light of these theories and further, to identify any candidate molecules involved in the pathogenesis 
of CNF and proteinuria.  
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REVIEW OF THE LITERATURE 
 
 
1. KIDNEY DEVELOPMENT 
 
1.1. Organogenesis 
 
The permanent mammalian kidney, the metanephros, is created by two tissue components, 
mesenchymal nephric cord (blastema) and epithelial, originally mesoderm-derived Wolffian duct. In 
human embryos, development of the permanent kidney starts during the first trimester of gestation 
with the formation of a Wolffian duct derived ureter bud which invades the metanephric 
mesenchyme (Spitzer 1985, Saxen 1987). The subsequent inductive interaction initiates a sequence 
of morphogenetic changes starting with dichotomous branching of the ureteric bud to form the 
developing collecting duct system, and condensation and polarization of the mesenchymal cells to 
form renal vesicles around the ampullae of collecting ducts. After the comma-shape and S-shape 
stages the early nephrons fuse into the collecting duct tree leading ultimately to the formation of 
mature renal glomeruli with their tubular systems (Figure 1) (Horster et al. 1999). During tubule 
elongation the pretubular cells differentiate to epithelial cell types of proximal and distal tubules and 
loop of Henle. 
 
The growth of the kidney occurs from the center toward the periphery forming a progressive, 
centripetal gradient of developing nephrons: as nephrogenesis in the inner cortex proceeds, new 
nephrons are being formed at the ampullar end of collecting ducts in the subcapsular region of the 
outer cortex (Saxen 1987). Recent reports have shown that while the growth in the kidney volume is 
dramatic during development, it is accompanied by a significant amount of apoptosis or 
programmed cell death (Koseki et al. 1992, Bard et al. 1994, Yasui et al. 1997); there are certain 
secreted molecules that prevent nephrogenic mesenchyme from undergoing apoptosis, and thus 
determine the number of available nephron units. The fact that different nephron populations and 
different nephron segments develop at different times results in a high degree of structural 
heterogeneity that is reflected to the functional complexity of the kidney at various stages of 
development (Spitzer 1985).  
 
1.2. Nephron differentiation 
 
During nephrogenesis different cell types are formed as a result of strictly timed and synchronized 
regulatory mechanisms (Bacallao & Fine 1989, Horster et al. 1999). There are three different cell 
types in the adult glomerular tuft: visceral epithelial cells (podocytes), mesangial cells and 
endothelial cells (Figure 2). The podocytes develop from metanephric mesenchyme. The stimulus 
which initiates epithelial cell formation from the mesenchyme is provided by the reciprocal 
interaction of the epithelium of the branching ureter (Horster et al. 1999). Endothelial cells 
comprise all vasculature and are probably originated from external blood vessels which grow into 
the kidney and migrate to the differentiating glomerulus at the S-shaped body stage (Abrahamson et 
al. 1998, Risau 1998). Although embryonic kidney is known to produce angiogenic factors, the 
precise mechanisms which direct growing capillaries into the primitive glomerulus are still 
unknown. Glomerular basement membrane (GBM) separates the endothelial cells from epithelial 
podocytes and acts as a filtering membrane of the kidney. The GBM forms from the fusion of the 
epithelial and endothelial derived basement membranes during glomerular capillary loop  
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development (Sariola et al. 1984b). An important third cell type of the glomerulus, the mesangial 
cell, is closely associated with the endothelial cell. An obvious question is whether this cell type is 
derived from the metanephric mesenchyme or from the endothelial cell lineage. From the 
morphological and regulatory point of view mesangial cells resemble vascular pericytes (Michael et 
al. 1980, Martinez-Hernandez & Amenta 1983), but mesangial cells also have capacity for 
phagocytosis. The studies of different marker expressions support a common origin of mesangial 
cells and vascular smooth muscle cells of glomerular arterioles (Lindahl et al. 1998), although direct 
evidence of this is still missing. 
 
 
 
 
Figure 1. Stages of nephrogenesis. The mesenchymal cells around the tips of the ureteric bud condense and gradually 
recieve an epithelial character: (a) Induced mesenchymal cells adhere and (b) form condensed aggregates close to the tip 
of ureteric bud. (c) Condensates give rise to the renal vesicle stage and further diversification leads to the formation of 
(d) comma-shaped body and (e) S-shaped body with two crevices. (f) The lower crevice expands to form the glomerular 
cup invaded by capillaries. The middle part develops into the proximal tubulus and the upper part into the distal tubulus, 
which fuses to the extending collecting duct system. The strictly dichotomous branching of collecting duct tree is not 
shown here. m, mesenchyme; u, ureteric bud; rv, renal vesicle; G, glomerular cup with capillary tuft; pt, proximal tubule; 
dt, distal tubule; cd, collecting duct. Adapted from Saxen (1987) and Horster et al. (1999).   
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In addition to the visceral epithelial podocytes, epithelial components of the kidney comprise the 
parietal epithelium of the Bowman’s capsule and the characteristic complex epithelial lining of the 
renal tubules and collecting duct (Sorokin & Ekblom 1992). During nephron differentiation the 
condensed cells acquire their polarity with the formation of distinct apical, basal and lateral borders 
which characterize the epithelial tubular cells. Cell interactions and cell-cell adhesion appear to be 
an important step in the polarization processes (Horster et al. 1999). 
 
 
 
 
 
 
Figure 2. Cross-sectional presentation of the glomerular capillary lobule. The capillary lumens are surrounded by 
the fenestrated endothelial cells, the glomerular basement membrane (GBM) and podocytes with foot processes. In the 
middle of the capillary lobule lie mesangial cells and mesangial matrix. 
 
 
1.3. Molecular expression in the developing kidney 
 
Development is accompanied by characteristic changes in gene expression that precede the 
morphological changes. Over the last few years there has been considerable progress in determining 
the cellular and molecular events at the earliest stages of nephrogenesis (Bard & Woolf 1992, Bard 
et al. 1994, Horster et al. 1999, Kuure et al. 2000). However, looking at the processes of 
nephrogenesis in the context of the regulatory information now available, it is obvious that only a 
small proportion of the regulatory genes involved in kidney development have still been identified 
and the information achieved so far gives only a superficial insight to how nephrogenesis is 
mediated at the genetic level. It is obvious that these processes are autonomous to the developing 
organ as much of this development will take place similarly in vitro. Some of the most important 
developmental factors and their roles in glomerular growth and differentiation are introduced here 
(see also Table 1a-d p.21-23): 
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1.3.1. Transcription factors  
 
Patterns of gene expression in differentiating cells during tissue morphogenesis are largely regulated 
by changes in the pool of DNA-binding transcription factors (Kessel & Gruss 1990). As a cascade 
of sequential transcriptional control has been shown to determine the early Drosophila 
development, mammalian development and organogenesis requires similar cascades of factors with 
strictly timed and spatially limited expressions specifying positional information and the fate of 
differentiating cells (Gruss & Walther 1992). In situ hybridization analyses in mice have revealed 
the expression of many homeobox and paired box containing genes, the Wilms' tumor gene and 
several other control genes in the condensed mesenchyme. Their expression seems to be linked to 
the complex morphogenetic program driving kidney organogenesis (Bard & Woolf 1992, Eccles et 
al. 1995). 
 
Homeobox genes 
The homeobox (Hox) sequence encodes a specific protein domain which has a DNA-binding 
motive. This DNA-binding region allows the homeobox gene products to regulate the transcription 
of other genes. In the mouse, most Hox genes are expressed in the mid-gestation phase (day 9 to 
12), a time when organogenesis prevails (Jackson et al. 1985, Kessel & Gruss 1990). The studies 
with transgenic mice have provided strong direct evidence that homeobox genes constitute critical 
control elements (Kessel et al. 1990, Chisaka & Capecchi 1991). In transgenic mice, in which the 
Hox 1.1 gene (HOXA7, see Scott 1993) was expressed in an abnormally wide range of tissues, the 
embryos developed a malformed face (Kessel et al. 1990). Chisaka and Capecchi (1991) engineered 
mice with abolished expression of Hox 1.5 gene (HOXA3) and these animals lacked both the 
thymys and parathyroid glands, a phenotype which resembled the human DiGeorge syndrome. As 
several of the murine Hox genes are expressed in the developing kidney, the protein products of 
these Hox genes are implicated in the inductive interactions underlying nephrogenesis (Bard & 
Woolf 1992). E.g. Hox 2.3 (HOXB7) transcripts were located on the branching ureter tree of the 
metanephros and a similar pattern was also found in the adult, with transcripts located in the ureter 
and the collecting ducts, both of which are derived from the bud of Wolffian duct (Kress et al. 
1990). The wide expression of homeobox genes in the early kidney may be involved in specifying 
the fate of the mesodermal domain that will become metanephric mesenchyme (Bard et al. 1994). 
 
Paired box genes 
The paired box (Pax) is another DNA-binding domain that is conserved in the evolution of the fly, 
mouse and man (Burri et al. 1989). Pax-containing genes comprise a family of transcription factors 
active in specific tissues during embryonic induction and development and have been associated 
with a variety of known mutations in both the mouse (Balling et al. 1988, Epstain et al. 1991, Hill et 
al. 1991) and man (Ton et al. 1991, Baldwin et al. 1992, Tassabehji et al. 1992). The expression of 
Pax-8 transcripts in the mesenchymal condensations and Pax-2 in the ureteric bud mesenchymo-
epithelial cells as well as their transient expression patterns are suggestive of functions in the 
regulation of early kidney development (Dressler et al. 1990, Poleev et al. 1992, Rothenpieler & 
Dressler 1993, Eccles et al. 1995). Pax-2 is one of the earliest markers of induced mesenchyme and 
is quickly repressed as the mesenchyme derived epithelium matures (Dressler & Douglass 1992, 
Eccles et al. 1992). Thus, Pax-2 is suggested to initiate a genetic cascade controlling a complex 
series of events that results in the conversion of kidney mesenchyme to epithelium. Persistent 
expression of Pax-2 and Pax-8 may be key events during kidney oncogenesis  (Maulbecker & Gruss 
1993, Tagge et al. 1994). Interestingly, deregulated Pax-2 expression in transgenic mice results in 
histologically abnormal and dysfunctional renal epithelium with properties similar to congenital 
   
 
 15 
  
nephrotic syndrome: multifocal microcystic tubular dilation, paucity of podocyte foot processes and 
proteinuria (Dressler et al. 1993).  
 
Wilms´ tumor gene 
The Wilms´ tumor gene WT-1 is a tumor suppressor gene that encodes a transcription factor with 
four DNA-binding zinc finger motifs (Buckler et al. 1991, Madden et al. 1991). The role of WT-1 
appears crucial for the control of metanephric stem cell differentiation as well as for the whole 
kidney development; this is based on the results by Kreidberg et al. (1993) showing that the 
inductive events that lead to formation of metanephric kidney are seriously affected in WT-1 
knockout mice. During normal kidney maturation WT-1 activation turns off the expression of 
molecules involved in embryonal cell proliferation and turns on genes whose expression is required 
for terminal differentiation (Madden et al. 1991, Drummond et al. 1992, Wang et al. 1993). In 
specific types of Wilms´ tumors, the gene retains its responsiveness to its upstream regulators in the 
proliferative response pathway, so that it is transcribed in appropriate cell types, but mutation alters 
the ability of its product to regulate downstream target genes, thus leading to uncontrolled 
proliferation and tumors (Pritchard-Jones et al. 1990).  
 
Early growth response genes 
Other genes that encode for putative DNA-binding proteins and have restricted expression during 
development include early growth response genes, such as EGR-1. EGR-1 gene is induced by a 
variety of mitogenic or differentiation-specific stimulation protocols in every mammalian cell type 
tested including B-lymphocytes, T-lymphocytes, kidney mesangial, glomerular and tubular 
epithelial cells, hepatocytes and endothelial cells (Sukhatme et al. 1988, Cao et al. 1990). EGR-1 
functions as a ubiquitous transcriptional activator, but its interaction with tissue specific factors, e.g. 
WT-1, gives rise to respective tissue specific effects. EGR-1 shares 65 % amino acid sequence 
homology with WT-1 in the zinc finger region. WT-1 protein is able to repress transcription through 
EGR-1 binding site, and also represses transcription of the EGR-1 promoter itself (Rauscher et al. 
1990). Thus, EGR-1 and WT-1 are thought to form a binary on/off element in the condensed 
metanephric mesenchymal cells: EGR-1 is upregulated as a cell receives a mitogenic signal, but as 
differentiation proceeds, WT-1 levels rise, mitogenic molecules are downregulated and growth 
comes to a stop (Sukhatme 1992, Rackley et al. 1995). 
 
Myc oncogenes 
Proto-oncogens are believed to play key roles in the growth and differentiation of embryonic tissues. 
The expression of many proto-oncogenes reaches a peak in early development and ceases before or 
shortly after birth, but failure of repression has a role in preventing the terminal differentiation of 
cells (Forrester et al. 1992). The myc oncogene family of nuclear DNA-binding proteins consists of 
three known members, the c-myc, N-myc and L-myc. All myc genes are expressed at high levels in 
embryonic and fetal tissues with distinct tissue- and stage-specific patterns (Zimmerman et al. 
1986). Northern blotting and in situ hybridization have revealed that N-myc expression is highest in 
brain and kidney (Hirvonen et al. 1989). It has been suggested that N-myc is linked to 
differentiation rather than proliferation, and in the developing kidney, N-myc is not expressed in the 
most rapidly proliferating cell population (cells of the ureteric bud) but rather in the adjacent 
mesenchyme. C-myc on the other hand, is expressed strongly by the urogenital ridge in the mouse 
and is suggested to be linked to the mitogenesis of cells. This is supported by the observation that 
transgenic mice carrying the c-myc gene develop polycystic kidney disease and die of renal failure 
at an early age (Bacallao & Fine 1989). In these animals the kidneys show evidence of tubular 
hyperplasia, microadenomas, and hyperplasia of parietal epithelium of the glomerulus. 
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1.3.2. Growth factors 
 
In addition to transcription factors and other nuclear proteins, various secreted growth factors 
causing a rapid but strictly organized cell division are involved in the developmental control system. 
The importance of growth factors as potential morphogens in the control of development has been 
well documented in lower vertebrates (Green & Smith 1991). In the developing kidney, the 
requirement for specific growth factors is not yet established, but, for example, the importance of 
insulin like growth factor system and neural growth factors are well studied. 
 
Insulin like growth factors 
Insulin-like growth factors (IGFs) have significant effects on renal function and have been 
implicated in renal development and glomerular cell differentiation (Chin & Bondy 1992). Many 
actions of growth hormone on renal size and kidney functions appear to be mediated indirectly 
through stimulation of the synthesis and release of IGF-1 (Mathews et al. 1986, Murphy et al. 1987, 
Hammerman & Miller 1997). All glomerular cell types have also been shown to express IGF-1 
receptors (Conti et al. 1988, Conti et al. 1989) which suggests that the glomerulus is a site for the 
autocrine and paracrine action of IGF-1. Direct actions of IGF-1 include an increase in glomerular 
filtration rate and renal plasma flow in both human and rat when injected into the renal artery, and 
chronically elevated circulating IGF-1 levels are associated with renal enlargement and glomerular 
hypertrophy (Fagin & Melmed 1987). In experimental chronic renal failure of rats, IGF-1 protects 
the glomerulus from injury by restoring autoregulatory control of renal blood flow (Lin et al 1998).  
In addition, IGF-1 induced biochemical changes may have a role in the pathogenesis of the initial 
stages of diabetic nephropathy, perhaps by modulating the metabolism of various glycoproteins of 
the extracellular matrix (Watanabe et al. 1992).  
 
IGF-2 has been shown to be heavily expressed in fetal kidneys and in embryonal renal tumors and 
has been attributed an autocrine and paracrine role in nephrogenesis (Scott et al. 1985). The 
expression of IGF-2 mRNA in fetal kidneys is largely confined to the stromal and blastemal cells 
and proposedly provides a stimulus for the growth and differentiation of epithelial structures; its 
expression in Wilms' tumors reflects a failure of complete differentiation of the tumor cells 
(Hirvonen et al. 1989). In contrast, IGF-2 expression in normal kidney is strictly downregulated at 
the time of birth. 
  
The biological effects of IGFs are mediated through binding to high affinity receptors on the cell 
surface. Two types of IGF receptors have been identified, with different relative affinities for IGF-1, 
IGF-2 and insulin. All known biological actions of IGF-1 and IGF-2 are mediated by type I IGF-
receptor (Czech 1989). In addition to cell surface receptors, the multiple biological functions of 
IGF-1 and IGF-2 are modulated by specific extracellular IGF-binding proteins (IGFBP). IGFBPs 
prolong the half-lives of IGFs, serve as their carriers in the circulation and act as autocrine/paracrine 
regulators of the biological actions of IGFs by regulating their availability to cell surface receptors 
(Hsu & Olefsky 1992). Six different human IGFBPs have been identified so far, differing from each 
other by the sites of synthesis and specific tissue expression patterns. The role of IGFBPs in 
nephrogenesis is undefined, but most probably, together with IGFs, they participate in regulating the 
various cellular events of nephrogenesis (Matsell et al. 1994). Matsell et al. (1994) have 
demontrated a distinct temporal and spatial expression of IGFBP mRNAs in the developing human 
fetal kidney. The expression of some IGFBP mRNAs has been demonstrated also in adult kidneys. 
Suikkari et al. (1992) have studied IGFBP-1, and detected its expression in fetal liver and kidney  
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but not in other fetal tissues. Its transcription in the developing kidney is most remarkable in the 
epithelial cells of the collecting ducts, in developing glomeruli, especially in most immature 
glomeruli, and in the subcapsular zone of undifferentiated nephrogenic mesenchyme. 
 
Vascular endothelial growth factor 
Vascular endothelial growth factor (VEGF), also known as vascular permeability factor (VPF), is 
essential for vasculogenesis and angiogenesis (Breier et al. 1992, Risau 1998). It is also a potent 
agent inducing and enhancing microvascular permeability as demonstrated experimentally in the 
guinea pig skin and peritoneal wall permeability assays (Senger et al. 1983). It is a bioactive product 
of various solid tumors, where VEGF proposedly maintains the basal permeability of microvascular 
endothelia essential for the exchange of nutrients and plasma proteins into the perivascular tissue 
(Senger et al. 1983, Nagy et al. 1988, Brown et al. 1992b). 
 
The expression of VEGF is high in embryonic brain and kidney when angiogenesis occurs, but in 
the kidney, VEGF expression remains high in glomerular podocytes even in the adult (Breier et al. 
1992, Brown et al. 1992a). VEGF receptors 1 and 2 are endothelial specific receptor tyrosine 
kinases (Mustonen & Alitalo 1995). Similar to the ligand, expression of these receptors is high 
during brain and kidney angiogenesis, low in adult brain, but high in adult glomerular endothelium. 
Because VEGF is also a vascular permeability factor, the expression in the adult correlates with the 
low permeability of blood-brain barrier endothelium and the high permeability of fenestrated 
glomerular endothelium, and it has been suggested that VEGF is involved in the regulation of 
glomerular permeability (Brown et al. 1992a, Simon et al. 1995, Shulman et al. 1996). VEGF 
receptor-2 is also known as kinase-insert domain receptor KDR in human. The crucial importance 
of this receptor is underlined by the early lethality resulting from the absence of endothelial cells in 
mice deficient for this molecule (Shalaby et al. 1995). Later during embryonic development, KDR 
becomes restricted to endothelial cells consistent with the function of its ligand VEGF as a vascular 
permeability factor (Kaipainen et al. 1993). It has been speculated that injury to podocytes, the 
cytologic site of VEGF production, may lead to changes in VEGF synthesis and/or secretion and 
thereby to abnormal glomerular permeability and proteinuria (Brown et al. 1992a, Shulman et al. 
1996).  
 
Transforming growth factor β 
The data presented by Lehnert & Akhurst (1988) argue for a major role for transforming growth 
factor β1 (TGF-β1) in a variety of developmental processes, involving tissues of different lineages 
and diverse mechanisms of action. TGF-β1 mRNA has been detected in mouse embryos at 10.5-
15.5 days of gestation and of importance, is present throughout the nephrogenic mesenchyme. Many 
mesenchymal and epithelial cells whose proliferation and differentiation are affected by TGF-β 
demonstrate increased expression of extracellular molecules in response to it.  In developing mouse 
kidney it may act in a paracrine fashion to affect growth and differentiation of the nephron by 
promoting extracellular matrix formation (Bacallao & Fine 1989). Furthermore, there is now 
convincing evidence that the process of matrix deposition in the diseased kidney is regulated by 
TGF-β (Border et al. 1992, Border & Noble 1993). In tissue cultures, TGF-β1 has been implicated 
in the regulation of ureteric bud growth and branching (Santos & Nigam 1993, Ritvos et al. 1995). 
However, mutant mice lacking TGF-β1 (Shull et al. 1992) show no apparent defects in kidney 
morphogenesis suggesting that it is not necessary to kidney development in vivo. 
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Neural growth factors 
Neural elements including neurons, neurotrophic factors and their receptors seem to be crucially 
involved in the induction and development of the nephrogenic mesenchyme (Sariola et al. 1991). 
The effects of neural growth factors are mediated by interaction with specific receptors on target 
cells. Nerve growth factor receptor (NGFR) serves as the binding site for many of the neurotrophic 
factors (Meakin & Shooter 1992). In addition to some neuronal cells and glial cells, NGFR is 
expressed in several embryonic tissues, including metanephric cell condensates and S-shaped 
nephrons (Sariola et al. 1991). Sariola et al. (1991) have shown that inhibition of NGFR expression 
in rat kidney cultures inhibits kidney morphogenesis: no tubules were formed and only rudimentary 
branching of the ureter was seen. In addition, the high affinity neurotrophin receptor, protein 
tyrosine kinase trk-B has been found to be differentially expressed during renal development 
(Durbeej et al. 1993); its expression pattern is mostly restricted to the cortical mesenchyme cells 
that will differentiate into stroma.  
 
Glial cell line-derived neurotrophic factor (GDNF) is a neurotrophic polypeptide distantly related to 
TGF-β. The importance of GDNF in the development of metanephric ureteric epithelium has been 
demonstrated by several investigators (Pichel et al. 1996, Sánchez et al. 1996, Sainio et al. 1997). 
GDNF is expressed in the condensing mesenchyme that surround the developing ureter system of 
kidneys. Sainio et al. (1997) have shown that GDNF can induce primary ureteric bud formation 
from various segments of Wolffian duct. It binds directly to the tips of the ureteric bud and attract 
branches towards the source of GDNF. It functions through increasing cell adhesion rather than cell 
proliferation. One known receptor for GDNF is the cRet receptor tyrosine kinase, which is 
expressed in several tissues adjacent to sites of GDNF synthesis. Transgenic mice deficient for 
GDNF and deficient for cRet show remarkably similiar phenotypes characterized by a severe defect 
in intestinal innervation, and renal aplasia or hypodysplasia (Schuchardt et al. 1996).  
 
Heparin binding growth factors 
Recently, a new family of heparin binding growth and differentiation factors with regulatory 
functions in development have been identified (Muramatsu 1993). The initial members of the new 
family were heparin-binding growth-associated molecule (HB-GAM) and midkine (midgestation 
and kidney, MK), the product of a retinoic acid responsive gene. The occurence of HB-GAM 
correlates with the perinatal developmental phase of neuronal connections during rat brain, heart 
and kidney development (Rauvala 1989, Merenmies & Rauvala 1990). Studies on the neurite 
outgrowth-promoting activity suggest that HB-GAM functions as an extracellular matrix-associated 
protein that enhances axonal growth during perinatal period (Raulo et al. 1992). MK is significantly 
homologous with the HB-GAM (Tsutsui et al. 1991). The mode of temporally and spatially 
controlled localization of MK expression during mouse embryogenesis has been studied extensively 
by several investigators (Kadomatsu et al. 1990, Nakamoto et al. 1992, Mitsiadis et al. 1995). By 
immunohistochemistry, both MK and HB-GAM expression were localized on the surface of 
differentiating cells and in basement membranes of organs undergoing epithelial-mesenchymal 
interactions, including the urogenital system. This observation suggests their signalling roles during 
morphogenesis of epithelio-mesenchymal organs (Mitsiadis et al. 1995). 
 
Wingless genes 
The wingless (Wnt) gene family encodes a group of secreted glycoproteins, which are involved in 
cell-cell communications. Wnt-signalling is thought to play diverse roles in the development of 
embryonic tissues (Wilkinson et al. 1987, Gavin et al. 1990, Roelink & Nusse 1991). In particular, 
the expression of Wnt-4 gene has been documented in mouse kidney mesenchyme: Stark et al. 
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(1994) have detected Wnt-4 mRNA in condensed mesenchymal cells, comma-shaped bodies and 
later in S-shaped bodies in the region where epithelial fusion was occuring with the collecting duct. 
Mice lacking Wnt-4 activity fail to form pretubular aggregates or more developed tubules, but the 
mesenchyme remains morphologically undifferentiated. However, the other aspects of mesenchymal 
and ureteric development are unaffected, suggesting normal induction by the ureter and branching 
of the ureteric epithelium. 
 
1.3.3. Extracellular matrix  
 
Matrix components  
In the course of renal development, both in vivo and in vitro, significant changes in the composition 
of the extracellular matrix occurs. The GBM originates in development from fusion of 
subendothelial and subepithelial matrices. The appearance of certain extracellular matrix proteins 
coincides well with metanephric differentiation and cell polarization (Ekblom 1989, Ekblom et al. 
1990). Undifferentiated kidney mesenchyme expresses fibronectin and types I and III of collagen 
(Ekblom et al. 1981). During epithelialization these extracellular matrix components disappear and 
are replaced by components typical to epithelial cells, such as collagen type IV, laminin and 
heparansulfate proteoglycan (HSPG) (Ekblom 1981a and 1981b). The appearance of type IV 
collagen is entirely dependent on the presence of an inducing stimulus (Ekblom et al. 1981). Type 
IV collagen molecules organize into the basal lamina surrounding the first tubular cell aggregates 
and ultimately form a tridimensional lattice-like network to which the laminin network with other 
basement membrane components are suggested to attach. Collagen molecules are heterotrimers; 
until now six different monomeric chains of type IV collagen have been identified (α1-α6). During 
GBM assembly and maturation, the α1- and α2-chains of type IV collagen are replaced by α3-, α4- 
and α5-chains, whereas the α6-chain is present mostly in the Bowman’s capsule and parts of the 
tubular basement membrane (Kuroda et al. 1998, St John et al. 2001). 
 
Laminin, a major glycoprotein in basement membranes, has been shown to accumulate at early 
developmental stages in the forming basement membranes, and antibodies to certain domains of 
laminin have been the most effective in inhibiting epithelial cell polarization in vitro (Klein et al. 
1988b). Laminins are heterotrimeric proteins which are assembled from a repertoire of five α-, three 
β- and three γ-chains (Miner 1999). The transition of laminin from a monomeric to a polymerized 
state is thought to be a crucial step in the development of basement membranes (Colognato et al. 
1999). In an organ culture model, it was found that the laminin B (β, γ) chains were constitutively 
expressed by the mesenchymal cells already before the onset of morphogenesis, but the laminin α- 
chain could not be detected until the first signs of mesenchymal condensates and epithelial cell 
formation became evident. The appearance of the α-chain is fundamental for induction of early 
polarity of tubular epithelial cells (Sorokin et al. 1990, Sorokin & Ekblom 1992, Dearcangelis et al. 
1996). The glomerular basement membrane contains restricted isoforms of laminin (as well as 
collagen IV). The maturation of GBM is marked by the replacement of laminin 1 (consisting of α5-, 
β2-, and γ1-chains) with laminin 11 (α5β2γ1). GBM is rich in β2-chain of laminin, whereas the 
renal tubular basal laminae bear no detectable β2 but is rich in the more widely distributed laminin 
β1-chain (Noakes et al. 1995). The importance of laminin β2-chain to glomerular ultrafiltration was 
verified, as a null mutation of laminin β2-chain gene in mice leads to nephrotic syndrome 
resembling human congenital nephrotic syndrome and the minimal change nephropathy (Noakes et 
al. 1995).  
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A number of biological activities, especially cell adhesive and cell migratory ones, have been 
attributed to fibronectin expression in embryogenesis. Fibronectin deposition in the developing 
glomerulus seems to be linked to endothelial cell organization within the Bowman´s capsule to form 
the glomerular tuft (Sariola et al. 1984a). The functions of alternatively spliced variants of 
fibronectin are not yet resolved but their temporal and spatial variation during embryogenesis 
suggests a role in differentiation. Nidogen (or entactin) is a glycoprotein found in GBM, mesangial 
matrix and Bowman´s capsule. The ability of nidogen to bind to various other basement membrane 
proteins suggests a potential role for nidogen in complex formation of extracellular matrix 
(Aumailley et al. 1993). Tenascin is an extracellular matrix protein which has been implicated in 
embryonic mesenchymal-epithelial interactions. It is absent in undifferentiated metanephric 
mesenchyme but begins to appear around condensates of epithelial cells and the S-shaped bodies of 
early nephrogenesis, and again disappears when tubules achieve their mature size. These findings 
suggest an important role for tenascin in the process of differentiation, perhaps by mediating the 
interaction of mesenchyme and the budding ureteric epithelium (Aufderheide et al. 1987). 
 
The major proteoglycan of human GBM is HSPG, whereas mesangial proteoglycans contain mainly 
chondroitin sulphate (Kanwar & Farquhar 1979). In human GBM, agrin is a principal HSPG 
component (Groffen et al. 1998). Agrin can stabilize the matrix structure by binding to laminin and 
can be involved also in transmembrane signalling of cells (Groffen et al. 1998 and 1999). Its 
negatively charged structure appears to be of vast importance to glomerular permeability.  
  
Integrins 
In general, the receptors for collagen, fibronectin, and laminin belong to the integrin supergene 
family (but receptors do exists that do not belong to this family (Buck  & Horwitz 1987)). Integrins 
are cell surface transmembrane proteins with two noncovalently linked subunits, α and β, and each 
of the αβ integrins has specific ligands amongst the extracellular molecules (Müller et al. 1997). In 
the developing kidney, different αβ integrins have a distinct spatiotemporal, developmentally 
regulated expression pattern (Korhonen et al. 1990). In the beginning of condensation of the 
pretubular mesenchyme α1 and α4 subunits disappear. During the first stages of epithelial 
polarization α6β1 is expressed in a basally polarized manner and during the distal invagination 
α3β1 is found in podocytes and in Bowman´s capsule, α1β1 in mesangial cells and α2β1 integrin in 
endothelial cells (Kreidberg & Symons 2000). The importance of α3β1 integrin has been addressed 
by the use of the knockout mice (Kreidberg et al. 1996). 
 
Cell adhesion molecules 
In the developing nephron, the induced mesenchyme begins to express molecules at the cell surface, 
which determine cell-cell adhesion, shortly after the elaboration of extracellular matrix proteins. 
The cell surface adhesion molecules include uvomorulin (or liver cell adhesion molecule L-CAM), 
P- and N-cadherin and N-CAM (neural cell adhesion molecule). The initial condensation seems to 
be associated with the production of syndecan, a sulphated proteoglycan, which acts as an adhesion 
molecule between cells in the condensate (Vainio et al. 1989 and 1992). N-CAM is an adhesive 
molecule for determined but yet uninduced mesenchyme and it gradually disappears during 
conversion to an epithelium (Klein et al. 1988a); as the aggregates form, they lose their 
mesenchymal character and form epithelia and at the same time the expression of N-CAM ceases, 
and the production of a new adhesion molecule, uvomorulin (L-CAM), starts. Based on the in vitro 
experiments in mouse embryonic kidney, it can be deduced that production of uvomorulin is related 
to morphological differentiation and appears only in epithelial cells that form a true epithelial 
monolayer but not in the epithelial podocytes of the glomerulus (Vestweber et al. 1985). During 
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development its expression is strongest in cells derived from the ureter and is weaker in 
mesenchymally derived cells, e.g. proximal and distal tubular cells. However, antibodies to both N-
CAM and L-CAM have failed to inhibit tubulogenesis, making their precise contributions to the 
process of nephrogenesis unclear (Vestweber et al. 1985, Klein et al. 1988a, Bacallao & Fine 1989). 
Cadherins are transmembrane adhesion molecules that act as important participants in cell 
recognition and cell sorting during development. Their appearance and disappearance correlate with 
major morphogenetic events during tissue differentiation. Many cadherins, including N-, E-, P-, K- 
and Ksp-cadherins, have been associated with segment-specific morphogenesis of the kidney (Goto 
et al. 1998). Recently, Reiser et al. (2000) localized P-cadherin into the podocyte slit diaphragms 
and speculated that it could have an important structural role in establishing glomerular permeability 
barrier. 
 
 
 
TABLE 1. Gene expression during kidney development. Examples of transcription factor, signalling molecule, 
extracellular matrix, cytoskeleton and cell adhesion molecule expressions in kidney. For references and species 
specifications see Davies & Brandli (2002) and Bard et al. (1994). +, expressed; -, not expressed; ?, unclear or not 
determined; MM, metanephric mesenchyme. Adapted from Davies & Brandli (2002) and Bard et al. (1994). 
 
 
Table 1a. Transcription factors. 
   
GENE ureter bud uniduced MM stem cells renal vesicle glomerulus 
 
Hox genes 
 
 
 
 
 
 
 
 
 
 
Hox A3 + ? ? ? ? 
Hox A4  + ? + ? ? 
Hox A5 + ? + ? ? 
Hox A6  + ? + ? ? 
Hox B3 + ? - + + 
Hox B5 + ? + + ? 
Hox B7 + - - + + 
Hox C6 + ? + ? ? 
Hox C8 + ? + ?  ? 
Hox C9 - - + + - 
 
Pax genes 
     
Pax-2 + - + + ? 
Pax-8 - - - + + 
 
Zinc finger genes 
     
Kid-1 + - - - - 
WT-1 - + + + + 
 
Pou genes 
     
KDN-1 + - - - - 
 
Other nuclear 
proteins 
     
c-myc - ? + + - 
L-myc + ? + - - 
N-myc - ? + + - 
GATA-3 + ? ? ? + 
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Table 1b. Signalling molecules and their receptors. 
 
GENE ureter bud uniduced MM stem cells renal vesicle glomerulus 
 
Growth factors 
     
IGF-1 expressed only in nephric tubules 
IGF-2 - + + + + 
TGF-β1 expressed only in stroma 
GDNF - + + ? ? 
HBGAM + ? ? ? ? 
MK + ? + + ? 
HGF - ? + - - 
PDGF A + - - + + 
PDGF B - ? - - + 
FGF-2 + ? ? + + 
BMP-7 + - + + + 
VEGF ? ? - - + 
 
Wnt genes 
     
Wnt-4 - - ? + - 
Wnt-5b + + + + + 
Wnt 11 + ? ? ? + 
 
Other messenger 
molecules 
     
bcl-2 ? ? - + + 
 
Signal receptors 
     
IGFBP-2 - ? + + + 
IGFBP-3 + - - - - 
IGFBP-4 - ? + - + 
IGFBP-5 ? ? ? - + 
IGFBP-6 ? ? ? + - 
NGFR - ? + + + 
c-ret + - - - - 
trk-B ? ? + ? ? 
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Table 1c. Extracellular matrix (ECM) components and receptors.  
 
GENE ureter bud uniduced MM stem cells renal vesicle glomerulus 
 
ECM 
 
 
 
 
 
 
 
 
 
 
collagen I - + + - - 
collagen III - + + - - 
collagen IV ? - - + + 
fibronectin - + + - - 
laminin β1 + - - + + 
laminin α1 + - - + + 
laminin γ1 + - - + + 
nidogen + + + + + 
 
ECM receptors 
 
 
 
 
 
 
 
 
 
 
α1 dystroglycan ? - - + + 
α1 integrin - + ? + + 
α2 integrin + - - -  + 
α3 integrin - - - - + 
α6 integrin + - - + + 
α8 integrin - - + + - 
β1 integrin + + + + + 
β4 integrin + - - - - 
 
Proteoglycans 
 
 
 
 
 
 
 
 
 
 
syndecan 1 + + + + + 
syndecan 2 - + + - - 
 
 
 
 
 
Table 1d. Cytoskeleton and cell adhesion molecules.  
 
GENE ureter bud uniduced MM stem cells renal vesicle glomerulus 
 
Cytoskeleton 
 
 
 
 
 
 
 
 
 
 
vimentin - + + + + 
cytokeratins + - - + + 
 
Cell adhesion 
molecules 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
N-CAM ? + + + - 
E-cadherin + - - + + 
K-cadherin - ? - + + 
P-cadherin ? ? ? ? + 
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2. GLOMERULAR FILTRATION 
 
2.1. Filtration function 
 
The two kidneys are a pair of bean-shaped organs in the retroperitoneal space. The kidneys have 
multiple central functions including filtration of metabolic waste products from blood and 
regulation of the body fluid and electrolyte balance and blood pressure. The filtration of fluid 
through the glomerular capillary begins in the human fetus between the 9th and 12th weeks of 
intrauterine life (Spitzer 1985). In a healthy human adult approximately 180 liters of glomerular 
ultrafiltrate resulting in 1.0-1.5 liters of urine is formed each day (Kriz & Kaissling 1985, Tisher & 
Madsen 1991). Mechanisms regulating the plasma ultrafiltration in glomerulus have been an object 
of great interest and research work during the last decades. The studies have shown that the 
transcapillary passage of plasma water and proteins is regulated by a number of physical factors 
(Kanwar 1984). These include glomerular plasma flow rate, the hydrostatic and oncotic pressure in 
the capillaries, the size, charge and configuration of molecules being filtered, the biochemical and 
biophysical properties of the glomerular capillary wall, and the hemodynamics within the 
glomerulus. All of these factors are important in maintaining a delicate balance and glomerular 
homeostasis and preventing the leakage of plasma proteins into the urinary space.  
 
The primary functional unit of the kidney is the nephron, which consists of the glomerulus and its 
tubular system. An adult human kidney contains approximately one million nephrons. Each nephron 
microvascular unit consists of an afferent glomerular arteriole, a glomerular capillary tuft, an 
efferent glomerular arteriole, and a peritubular capillary bed (Tisher & Madsen 1991, Abrahamson 
et al. 1998). The glomerulus is composed of 5-7 capillary branches originating from the afferent 
artery and comprising lobule-like structures in which there are numerous anastomoses (Bohle et al. 
1998). The tuft of capillaries is surrounded by the parietal epithelial cells forming Bowman´s 
capsule. The glomerular ultrafiltrate flows from the glomerular capillaries into the Bowman’s space, 
further to the tubular lumen and is then concentrated by reabsorption by the tubular endothelium. 
   
2.2.  Structure of the filtration unit 
 
Mature human glomerulus contains three structural entities: the fenestrated capillary endothelial 
cells, podocyte (visceral epithelial cell) lining between the glomerular space and capillaries, and 
mesangial cells in the middle of the capillary lobule (see Figure 2). A layered GBM is situated 
between podocytes and endothelial cells, and the mesangial matrix surrounds the mesangial cells. 
During glomerular filtration, plasma fluid traverses several cellular and extracellular layers that 
make up the complex structure of the ultrafiltration unit. From inside outward, it consists of 
endothelial fenestrae, GBM, and epithelial foot processes with intervening slit diaphragms (Figure 
3). The integrity of each of these structural elements in essential for the maintenance of normal 
ultrafiltration (Kanwar 1984).  
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Figure 3. Structure of the glomerular filtration barrier. Glomerular filtration barrier between blood and the urinary 
space, forms the sieve through which the primary urine is formed (arrows). The barrier has three elements: the 
fenestrated endothelial cells, the three-layered basement membrane (GBM), and the podocytes. The slit diaphragm is a 
highly specialized structure between adjacent podocyte foot processes, providing the final barrier to the loss of protein. 
LRE = lamina rara externa, LD = lamina densa, LRI = lamina rara interna. For details, see text. 
 
 
2.2.1. Endothelial cells 
 
The glomerular capillary endothelial cells line the GBM on the inner aspect of the capillary wall. 
They have highly attenuated and fenestrated cytoplasm and a negatively charged plasmalemma rich 
in sialic acid and also HSPG (Kanwar 1984, Kanwar et al. 1991). The endothelial fenestrae are 
circular openings with a width of up to 100 nm in cross-section. They are quite large and devoid of 
diaphragms or limiting membranes and allow thus the passage of large volumes of fluid and solute. 
The endothelial cells express vasoactive peptides and their receptors and many contractive and 
relaxant growth factors regulating the hemodynamics of glomerular capillaries (Savage 1994). 
 
2.2.2. Glomerular basement membrane 
 
The GBM is an extracellular matrix interposed between the attenuated endothelium and the 
epithelial foot processes. Studies have shown that GBM is the main filtration barrier of the 
glomerulus which restricts the passage of macromolecules according to their size, charge and shape 
(Bohrer et al. 1978, Brenner et al. 1978, Kanwar 1984, Remuzzi & Remuzzi 1994). In man, it is 
approximately 300 nm wide and consists of a central electron-dense layer, the lamina densa, which 
is flanked on either side by electron lucent regions referred to as lamina rara interna and externa 
(Kanwar 1984, Kanwar et al. 1991). The GBM contains mainly type IV collagen, laminin, 
nidogen/entactin and HSPG. The specialized isoforms of laminin and type IV collagen in GBM are 
critical for its structure and filtration function (Miner 1999). The compact networks of laminin and 
type IV collagen cross-linked and stabilized by nidogen, probably play a vital role in the size 
selective sieving properties of the ultrafiltration unit.  
 
The GBM is a charge selective barrier which filters cationic molecules more easily than anionic 
ones. GBM is rich in HSPG, which are highly negatively charged and by electrostatic repulsion,  
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negatively charged plasma proteins are restricted from penetrating and passing through the 
glomerular capillary wall. The effect of electrical charge is important in small polyanionic 
molecules with an Einstein-Stokes radius less than 4.2 nm but more than 2.0 nm (usually 70-150 
kDa). Molecules of the size of 150 kDa and larger are retained in the circulation on the basis of their 
size (Bohrer et al. 1978, Brenner et al. 1978, Kanwar 1984, Remuzzi & Remuzzi 1994). 
 
2.2.3. Epithelial cells and slit diaphragm 
 
The central body of the epithelial cell lies freely in the urinary space. Cytoplasmic extensions arising 
from these cells anchor to the outside of the GBM as a series of interdigitating foot processes. The 
podocyte is richly coated with podocalyxin, a negatively charged protein, as well as other charged 
molecules thought to provide an additional electrostatic barrier to the movement of proteins across 
the capillary wall (Kerjaschki et al. 1984). The slit diaphragm, which is a modified tight junction 
between foot processes of adjacent podocytes, provides the final size selective barrier to the loss of 
protein. The slit diaphragm has a ladder or zipper like structure with pores of 40x140 Å separated 
by a central filament and cross bridges (Figure 4) (Rodewald & Karnovsky 1974, Abrass 1997). 
According to the hypothesis of Rodewald and Karnovsky (1974), the pore size is slightly smaller 
than the size of albumin. The molecular nature of the slit diaphragm has hitherto been a mystery, but 
during last two years, significant advancement has been made in understanding of its structure and 
function in regulating glomerular permeability (see chapter “5.7. Identification and characterization 
of the CNF gene") (Tryggvason 1999, Kerjaschki 2001, Khoshnoodi & Tryggvason 2001). 
 
 
 
 
 
Figure 4. Slit diaphragm. Schematic model of the podocyte slit diaphragm according to Rodewald & Karnovsky 
(1974). Cross bridges extending from the adjacent foot processes connect to the central filament, leaving filtration pores 
between them. The average cross section dimensions are indicated. 
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2.2.4. Mesangial cells 
 
The mesangial cells are centrally located in the intercapillary region of the glomerulus providing 
structural support for the capillary loops. They are irregular in shape and have number of primary 
processes extending from the body. Mesangial cells contain contractile elements by which they 
modulate glomerular filtration and have capacity to phagocytose, synthesise and degrade matrix 
components and take part in the repair of glomerular injury (Kriz et al. 1990, Latta 1992). 
Mesangial cells are embedded in the mesangial matrix, which is a highly fibrillar, dense network of 
microfibrils. The mesangial matrix contains collagens, fibronectin, laminin, nidogen and 
chondroitin sulfate proteoglycans, and it attaches the mesangial cell to the folding perimesangial 
GBM and counteracts the distending forces during increased glomerular pressure. It is the failure of 
the mechanical integrity of this system that leads to the characterized lesion in tuft architecture, such 
as local expansions of the tuft, seen in human glomerulopathies (Kriz et al. 1990 and 1998). 
 
 
3. PROTEINURIA  
 
3.1. Pathogenesis of proteinuria 
 
Protein excretion in normal adult urine is usually below 150 mg/day, but even as high as 300 
mg/day is considered to be within the normal range. When the integrity of the kidney filtration 
machinery is disrupted, increased amounts of proteins pass into the urinary space leading to 
proteinuria. In proteinuria, urinary proteins are comprised of mostly albumin, plasma 
immunoglobulins, other plasma proteins and different kinds of tissue proteins (Dennis and 
Robinson 1985). On the basis of its pathogenesis, proteinuria is divided into five classes: glomerular 
proteinuria, tubular proteinuria, overflow proteinuria, secretory proteinuria and histuria. Of these 
five types, glomerular proteinuria is the commonest (Dennis & Robinsson 1985); it is an early sign 
of many renal disorders, and it may in turn promote the progression of kidney diseases. Glomerular 
proteinuria can present as selective or non-selective (Dennis & Robinsson 1985). The dominant 
urinary protein is albumin. The dysfunction of tubular reabsorption causes tubular proteinuria. The 
main markers of tubular proteinuria are β2-microglobulin and globulins (Maack et al. 1985). If the 
levels of plasma proteins are increased, they can be filtered in excess of the reabsorption capacity of 
the tubules and then be present in the urine; this is called overflow proteinuria. Proteinuria is 
referred to as secretory proteinuria or histuria when the urinary proteins originate from surrounding 
tissues or other organs via excretion and secretion (Dennis & Robinsson 1985). 
 
3.2. Glomerular changes in proteinuria 
 
The histological findings in clinical entities and experimental models of proteinuria include 
alterations in both the cellular and extracellular components of the glomerular capillary. The same 
basic considerations apply regardless of the nature of the initiating injury and explain the 
remarkable uniformity of the lesion seen in several types of progressive injury of the glomerular tuft 
(Kriz et al. 1998). The available data regarding the mechanisms by which proteinuria is produced 
are mostly consistent with the idea that GBM, podocytes and their slit-junctions, and the 
extracellular glycoproteins are sequential barriers to the filtration of protein, and that each of these 
barriers are essential for normal glomerular function. The common morphologic findings in 
proteinuric conditions are discussed below and summarized in Table 2.  
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Altered podocyte morphology is universal and includes retraction and fusion of foot processes, 
decrease in the total lenght of slit-pore junction, displacement of the junction away from the GBM, 
and vacuolization in podocyte cytoplasm, evidence of podocyte activation. Regional denudation of 
the GBM may occur (Savin 1993). Some investigators have presented evidence for podocyte loss or 
podocyte ”insufficiency” (Fries et al. 1989, Rennke 1994, Pagtalunan et al. 1997). Due to its 
inability to replicate effectively postnatally and its unique susceptibility to specific injury, the 
podocyte is maybe the most vulnerable component of the glomerular tuft and in many cases, it is 
injury to the podocyte that initiates the definitive pathologic sequence of glomerulosclerosis and 
eventual glomerular tuft destruction (Kriz et al. 1998).  
 
The GBM may appear normal or may be thickened with altered distribution or density of anionic 
charges due to abnormal regulation of synthesis or degradation. In some cases, serum proteins, 
antibodies to glomerular components or to other substances, or complement may present within the 
GBM (Savin 1993). Abnormalities of the mesangium may include increased cellularity, protein or 
antibody deposition, and increased matrix. Mesangial or interstitial cell proliferation with 
subsequent matrix deposition, leading to glomerular capillary occlusion and to interstitial expansion 
and tubular atrophy, have been invoked as central mechanisms in glomerular injury (Kashgarian & 
Sterzel 1992, Couser & Johnson 1994). 
 
 
Table 2. Glomerular findings in proteinuria (Adapted from Savin 1993) 
 
 
Podocyte alterations: 
Foot process retraction and fusion 
Slit diaphragm changes 
Cytoplasmic vacuolization 
Cell activation: increased organelles and expanded surface area 
Podocyte loss (and local denudation of GBM) 
Basement membrane alterations: 
Charge density decrease 
Matrix composition changes 
Immune complex and complement deposition 
Mesangial alterations: 
Mesangial hypercellularity 
Mesangial matrix expansion 
Abnormal collagen composition 
Immune complex and complement deposition 
                         
 
 
3.3. Mechanisms of glomerular proteinuria  
 
As would be expected from the variation in morphological expression of human glomerular injuries, 
the underlying mechanisms are also very variable. The ones most often presented are those 
concerning immunological mechanisms, decreased glomerular charge, and detached glomerular 
epithelial cells (Kanwar 1984, Savin 1993). The initial events, such as charge neutralization, 
deposition of antibody-antigen complex, and enzymatic or nonenzymatic biochemical changes may 
affect primarily the extracellular components (Bruijn et al. 1997, Müller & Brändli 1999). 
Proteinuria may be initiated by glomerular reactions to growth factors, cytokines, circulating 
permeability factors, or antibodies to cell membrane antigens, which may lead to enhanced  
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synthesis or degradation of extracellular matrix or to proliferation of glomerular cells (Savin 1993, 
Couser 1998, Gibson & More 1998). Interactions between abnormal matrix and podocyte may affect 
maintenance of the intercellular junctions and matrix homeostasis. If hemodynamic parameters are 
also altered by matrix changes, there may be direct effects on the podocyte resulting from tension or 
stress. In other instances, exogenous toxins, inflammatory mediators, or viruses may initiate 
podocyte injury, altering normal morphology and intercellular junctions (Savin 1993). The 
importance of alteration in basement membrane, of cellular injury, and of cell activation in response 
to mediators undoubtly varies in different clinical syndromes and experimental models. Some of the 
basic theories suggested for the pathogenesis of proteinuria are presented here in more detail. 
 
3.3.1. Charge neutralization  
 
The importance of charged molecules in the glomerular capillary wall for the selective glomerular 
permeability has received a vast amount of research both in experimental animal models of 
glomerular disease and human renal diseases. Key studies include the demonstration that the 
fractional clearance of similar sized dextrans varied dependent upon their charge (Bennett et al. 
1976, Chang et al. 1976, Brenner et al. 1977). Negatively charged structures have been found on the 
surface of podocytes and endothelial cells and throughout the GBM. These sites are provided mostly 
by HSPG as demonstrated by enzyme incubation and immunoelectron microscopy experiments. 
Removal of HSPG by enzyme digestion increased the leakage of ferritin and albumin through the 
GBM and suggests that a decrease in anionic sites could play a role in the pathogenesis of 
proteinuric states (Kanwar et al. 1980, Rosenzweig & Kanwar 1982). Charge neutralization by 
polycations, such as protamine sulphate (Kelley & Cavallo 1978), hexadimethrine (Hunsicker et al. 
1981) and polyethyleneimine (Barnes et al. 1984), resulted in fusion of podocyte foot processes 
similar to the electron microscopic appearance in nephrotic syndrome and increased permeability to 
immunoglobulins and albumin due to alterations in the structural integrity of the capillary wall in 
charge selective barrier (Goode et al. 1996). 
 
In human disease, the importance of altered basement membrane charges is supported by the finding 
of decreased sialic acid content and anionic binding sites in many studies (Hirsch et al. 1981, Levin 
et al. 1985, Quatacker et al. 1987), but also opposite findings exist (Kanwar & Jakubowski 1984, 
Furness et al. 1986). The glomerular size and charge selectivity in normal and nephrotic humans 
have been defined by fractional sieving of charged and neutral dextrans (Winetz et al. 1981, Deen et 
al. 1985). Abnormal permeation of serum proteins has been demonstrated by the presence of protein 
A-immunogold -stained albumin throughout the GBM in biopsies of humans with proteinuria 
whereas albumin is confined to the subendothelial space in glomeruli from nonproteinuric patients 
(Russo & Bendayn 1990). 
 
3.3.2. Immunological mechanisms 
 
It is now becoming increasingly apparent that many immunologically mediated glomerular diseases 
in man are autoimmune diseases. These lesions result from the glomerular binding of antibodies 
directed specifically against normal glomerular structures or planted antigens at different locations. 
Many types of immunological glomerular diseases are inflammatory in nature with glomerular 
hypercellularity due to infiltration by circulating inflammatory cells and proliferation of intrinsic 
glomerular cells, particularly mesangial cells. In other types, notably membranous 
glomerulonephritis, the morphology has a non-inflammatory pattern, with minimal or absent 
hypercellularity (Couser 1993).  
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Inflammatory mechanisms 
Neutrophils are found infiltrating glomeruli in variable numbers in many types of 
glomerulonephritis, in response to immune complex deposition and complement activation. Their 
role in mediating subsequent glomerular injury is established through the release of oxidants and 
proteases (Johnson et al. 1994). Toxic oxygen metabolites such as H2O2 and myeloperoxidase 
interact to produce substances capable of directly damaging the GBM. Macrophages also localize in 
inflammatory glomerular lesions (Main et al. 1992). They are attracted by chemotactic factors 
produced by mesangial cells. Like neutrophils they cause glomerular injury through the release of 
oxidants (e.g. nitric oxide) and proteases (Main et al. 1992). Through the release of cytokines such 
as interleukin-1 (IL-1) and TGF-β, macrophages may also stimulate mesangial cells to proliferate 
and synthesize extracellular matrix proteins. As activated, mesangial cells release many 
inflammatory mediators, such as platelet-derived growth factor (PDGF) and TGF-β. PDGF may 
stimulate mesangial proliferation apparently by an autocrine mechanism. In response to TGF-β, 
mesangial cells increase their production of extracellular matrix components contributing matrix 
expansion, glomerulosclerosis and irreversible damage (Yoshika et al. 1993, Gibson & More 1998). 
This characteristic response has been well documented in IgA nephropathy, a disease which 
primarily affects the mesangium (Gibson & More 1998).  
 
Non-inflammatory mechanisms 
In membranous glomerulonephritis (membranous nephropathy), the glomerular lesion is non-
inflammatory in pattern. However, there are extensive subepithelial deposits of antibody and 
complement components including C3 and C5b-9 (Couser 1998). Many aspects of the 
immunopathogenesis of membranous glomerulonephritis are now understood based on studies of 
the Heymann nephritis models in rats which closely simulate the human lesion. In Heymann 
nephritis complement fixing antibodies bind to antigens on the podocyte cell membrane. The best 
characterized of these antigens is gp330/megalin, which is localized in clathrin-coated pits 
(Farquhar et al. 1995). Complement activation results in production of C5b-9 membrane attack 
complex. The resulting podocyte damage causes oxidant production which in turn damages the 
GBM and the consequent altered permeability leads to the nephrotic syndrome in rats. The nature of 
the circulating antibody and the pathogenic epitopes of human idiopathic membranous 
glomerulonephritis remain unknown, but the investigations have revealed that the defect in 
membranous glomerulonephritis results mainly from a loss of size selectivity of the filtration barrier 
(Couser 1998). 
 
Antibodies to glomerular antigens  
Studies of the effects of the antibodies on the filtration barrier give clues to alterations in cell 
membrane interactions in for example minimal change nephropathy (MCN) and focal segmental 
glomerulosclerosis (FSGS). Antibodies to GBM components may act by disrupting the organization 
of the matrix, by altering the fixed charges of the matrix, or by interacting with podocytes to 
produce secondary changes in metabolic activities or interactions with the matrix (Savin 1993). 
However, the majority of the injury appears to depend on the activation of complement and on 
inflammation, rather than on direct effects of interaction between matrix, antibodies, and cells. Anti-
GBM antibody is primarily directed against an antigen on type IV collagen of the GBM (Gunwar et 
al. 1991). Injection of anti-GBM antibody results in acute inflammatory injury produced by 
complement, platelets, neutrophils and monocytes. Reaction to inflammation may lead to loss of 
negative charge (Kreisberg et al. 1979, Salant 1987). Antibodies to heparan sulfate cause milder 
and variable glomerular responses. Rabbit anti-heparan sulfate antibodies are only weakly  
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nephritogenic when administered to rats resulting in antibody binding, complement fixation, 
monocytic infiltration, endothelial cell injury and basement membrane thickening, but not 
proteinuria (Makino et al. 1986, Miettinen et al. 1986). Injection of monoclonal antibody against 
heparan sulfate induced transient, dose-dependent, selective proteinuria immediately after injection 
in rats (van den Born et al. 1992). The investigators surmised that this was secondary to 
neutralization of heparan sulphate-associated anionic sites in GBM. Antibodies to laminin formed 
linear deposits along the GBM, but did not induce either inflammation or proteinuria (Feintzeig et 
al. 1986).  
 
Antibodies to components of the podocyte membrane may also result in the induction of 
proteinuria. In Heymann nephritis, antibody binding to the podocyte membrane induces complement 
activation and proteinuria (see "Non-inflammatory mechanisms"). A monoclonal antibody to a 
sialoglycoprotein (SGP115/107) of podocytes and proximal tubules induced foot process 
obliteration, vacuole formation, microvillus transformation and focal retraction from underlying 
basement membrane (Mendrick & Rennke 1988a and 1988b). Another monoclonal antibody (5-1-6) 
which binds to slit diaphragms causes massive proteinuria. The investigators speculated that the 
antigen to which the antibody binds may regulate the permeability of the capillary wall, and that its 
decrease may lead to proteinuria (Orikasa et al. 1988, Kawachi et al. 1992). Later they have shown 
that this nephritogenic antibody is directed against nephrin, the CNF gene product (Topham et al. 
1999, see "5.7. Identification and characterization of the CNF gene"). A model for renal injury using 
mesangial specific anti-Thy-1 antibody has also been described. Administration of antibody leads to 
lysis of mesangial cells, subsequent regeneration of mesangium, and later mesangial sclerosis 
(Bagchus et al. 1986, Johnson et al. 1992).   
 
3.3.3. Circulating factors 
 
In the primary glomerulopathies associated with nephrotic syndrome and glomerular proteinuria 
without cellular infiltration or immune complex deposition, e.g. in MCN and FSGS, the glomerular 
damage may partially be mediated by circulating permeability factors (Savin 1993). In these 
diseases, the podocyte is morphologically damaged with swelling, alterations in charge density, 
extensive foot process effacement and sometimes detachment from the GBM; these changes are 
associated with changes in the functional integrity of the slit diaphragm. Possible injury mechanisms 
include stimulation of release of materials which directly damage underlying GBM such as oxidants 
and proteases, or interference with molecules such as intergrins which regulate cell-matrix 
interaction leading to cell detachment from GBM (Couser 1998, Gibson & More 1998). Putative 
circulating permeability factors are probably not immunoglobulins but are thought to be most likely 
T-lymphocyte derived lymphokines, circulating cationic proteins or other permeability factors such 
as vascular permeability factor (VPF), human focal sclerosis factor or vasoactive serum factor, 
which neutralize anionic sites in glomerular capillaries or otherwise increase glomerular 
permeability to proteins (Bakker & van Luijk 1989, Savin 1993).  
 
Several lines of evidence implicate circulating factors in the pathogenesis of MCN and FSGS. The 
decrease in proteinuria following plasma exchange in FSGS has been used as evidence in favor of 
the presence of a permeability factor, and there are reports of transfer of proteinuric activity by 
injecting serum into experimental animals (Zimmerman 1984, Wilkinson et al. 1986) or in isolated 
glomeruli (Savin 1993). The finding of the specific serum factors can lead to therapeutic 
interventions such as removal of the causative factor by plasmapheresis (Koyama et al. 1991) or by 
plasma protein absorption (Ingulli & Tejani 1991). The proteinuria in MCN is thought to result  
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mainly from a loss of charge selectivity of the glomerular filtration barrier. Much has been learned 
recently regarding the molecular mechanisms which regulate the adherence of glomerular cells to 
GBM, and disorders of these processes may also be important in the pathogenesis of MCN (Cosio & 
Orosz 1993). 
 
3.3.4. Toxic injury 
 
Administration of puromycin aminonucleoside (PAN) or doxorubicin has been used to induce injury 
to podocytes (Caulfield et al. 1976, Messina et al. 1987, Whiteside et al. 1989). These treatments 
resulted in proteinuria, renal insuffuciency and eventual mesangial sclerosis. Structural changes in 
the podocytes and their slit-junctions occur and include formation of occluding junctions and 
epithelial cell detachment. Micropuncture studies have defined both size- and charge-selective 
abnormalities, as well as decrease in hydraulic permeability (Bohrer et al. 1977). The primary 
effects of these agents appear to be on the podocyte, as suggested by the finding of direct toxicity to 
these cells in culture (Fishman & Karnovsky 1985). Podocyte toxicity may result in alterations in 
the composition of the charge barrier of the glomerular capillary. Mahan et al. (1986) showed that a 
decrease in anionic sites in the GBM preceded foot process widening or proteinuria in PAN 
nephritis. Some alterations in metabolism of matrix have been shown (Abrahamson et al. 1983, 
Nakamura et al. 1991), but interestingly, no decrease in heparan sulphate could be detected  
(Lelongt et al. 1987).   
 
 
4. NEPHROTIC SYNDROME 
 
4.1. Manifestation of nephrotic syndrome 
 
Reduced glomerular permselectivity leads to proteinuria and ultimately to nephrotic syndrome (NS). 
Clinically NS is characterized by the presence of proteinuria, lipiduria, hypoalbuminemia, 
hypercholesterolemia, and variable tendency for edema (Abrass 1997, Eddy & Schnaper 1998). 
Classically, NS is thought to be initiated when integrity of the glomerular capillary wall is disrupted 
and increased amounts of albumin and other plasma proteins pass into the urinary space. Primarily, 
intermediate size (60-200 kDa) plasma proteins are lost, which leads to a marked change in plasma 
protein composition. Plasma oncotic pressure falls and plasma viscosity rises because of the relative 
increase in higher molecular weight proteins. The changes in plasma protein composition and 
oncotic pressure determine most of the secondary consequences of NS (Abrass 1997). In the milder 
forms of NS, plasma albumin levels are reasonably preserved (>25 g/l) and the plasma volume is 
expanded. Severe NS is characterized by marked hypoalbuminemia (< 20 g/l and can fall below 10 
g/l), severe edema and occasionally hypovolemia that is reflected by normal or low blood pressure 
(Abrass 1997). 
 
4.2. Classification of nephrotic syndromes 
 
NS is not a disease per se, but rather a manifestation of various diseases that cause proteinuria. It 
can be cathegorized as primary and secondary NS; the former is due to primary or idiopathic 
glomerular disease, while the latter is associated with specific etiologic events or a complication of 
other diseases, certain systemic diseases or a part of general malformation syndromes (syndromic 
NS). On the basis of their etiology glomerular injurys can be divided into acquired diseases caused  
by e.g. metabolic or environmental (toxins, infection) factors and genetic diseases which include  
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hereditary and familial kidney diseases. It appears, that these categories may have significant 
overlap with each other and in some cases, the cause of the disease is less apparent. Furthermore, 
NS with onset in the first year of life is conventionally divided into congenital and infantile types, 
the arbitrary age limit being 3 months of age (Rapola 1987). This division is, however, of quite 
limited diagnostic value since the onset of clinical symptoms in congenital NS can vary significantly 
between different forms of the disease. The use of renal biopsies has been accompanied by 
considerable improvement in the classification of glomerular disease, but still the clinical and 
histological tools available in diagnosis sometimes lack accuracy (Peten & Striker 1994). Recently, 
the classification has been aided by applying molecular genetics to identify genes involved in the 
pathogenesis of NS. Some examples of primary and secondary glomerular kidney diseases are 
introduced here, mostly in respect of their pathology and basic defects (if known). 
 
4.3. Idiopathic glomerular diseases 
 
According to histologic lesions, primary NS can be categorized as several classes including minimal 
change nephropathy, focal segmental glomerulosclerosis, mesangial proliferative 
glomerulonephritis, IgA nephropathy, membranous glomerulonephritis and membranoproliferative 
glomerulonephritis (Abrass 1997). 
 
Minimal change nephropathy  
Minimal change nephropathy (MCN) is the most frequent cause of NS in children, with an 
incidence peak from 3 to 5 years accounting for almost 80 % of pediatric NS cases (Savin 1993, 
Eddy & Schnaper 1998). Patients classically present with edema, selective proteinuria and normal 
glomerular filtration rate (Savin 1993). The disease is also called minimal change lesion or minimal 
change disease, to stress the relative paucity of glomerular findings under light microscopy. The 
glomeruli appear largely normal, with mild increase of cellularity in the mesangial area and 
enlargement of epithelial cells. Proximal tubules may contain fine lipid droplets (Glassock et al. 
1991a). The glomeruli lack of deposits of immunoglobulins and complement. In electron 
microscopy, effacement and retraction of the epithelial podocytes has been shown. The obliteration 
of the slit pore membrane complex is also noted in most glomeruli and glomerular capillaries 
(Glassock et al. 1991a). Several factors have been considered to explain the dysfunction of the 
glomerular permselectivity in MCN. Proposed etiologic factors include (1) charge neutralization of 
GBM-related molecules by circulating cationic proteins, (2) glomerular permeability factors, (3) 
lymphokines, (4) allergens, and (5) overproduction of oxygen radicals (Kanwar & Farquhar 1979, 
Savin 1993, Couser 1998). These findings have been mimiced in a rat PAN model, which is widely 
utilized to explore the pathogenesis of MCN. 
 
Focal segmental glomerulosclerosis 
Focal segmental glomerulosclerosis (FSGS), like MCN, presents with insidious onset of NS. It 
occurs both in children and adults, accounting for 7-15 % and 15-20 % of the primary NS, 
respectively. Pathological findings on light microscopy show focal and segmental sclerotic lesions 
affecting a variable minority of the glomeruli, usually those in the deeper, juxtamedullary cortex 
due to the higher perfusion pressure (Glassock et al. 1991a). Electron microscopy examination 
presents, in most cases, the characteristics of the effacement of podocytes and the detachment of 
foot processes from the GBM, especially when heavy proteinuria is observed (Glassock et al. 
1991a). In addition, there exists IgM and C3 deposition in the glomeruli. Patients with FSGS have 
variable responses to corticosteroid therapy. FSGS may recur after renal transplantation, but 
treatment with plasma exchange has resulted in a decrease or disapperance of proteinuria. This has  
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strongly suggested that a circulating substance may be responsible for glomerular injury in some 
patients with this entity (Savin 1993). In some certain types of FSGS, genetic factors in the 
pathogenesis of this disorder has been noticed (Eddy & Schnaper 1998, see chapter "4.4. Genetic 
defects"). 
 
Mesangial proliferative glomerulonephritis 
According to the components of deposits in the mesangium, mesangial proliferative 
glomerulonephritis can be divided to non-IgA glomerulonephritis and IgA nephropathy (Glassock et 
al. 1991a). Non-IgA glomerulonephritis is a relatively uncommon type of NS. It is characterized 
by hematuria and nonselective proteinuria. Typical findings in light microscopy are accumulation of 
mesangial matrix and increased cellularity of the mesangium (Glassock et al. 1991a). In addition, 
sedimentation of IgM and C3 are frequently found in the mesangium. The pathogenesis of non-IgA 
glomerulonephritis is not fully known, but based on the observation of IgM and C3 deposits as well 
as circulating immune complexes, it appears to be an immune complex disease. An anti-Thy-1.1 
(anti thymocyte serum, ATS) rat model shows similar mesangial changes in the glomeruli 
(Jefferson & Johnson 1999). In this model, the injection of antibody to the Thy-1.1 antigen on the 
mesangial cell membrane induces an initial phase of mesangiolysis followed by platelet infiltrate 
and mesangial cell proliferation (Couser & Johnson 1994). A variety of factors, such as IL-1, TGF-
β, and PDGF, might participate in the mediation of pathologic mesangial cell proliferation 
(Jefferson & Johnson 1999).  
 
IgA nephropathy is definied as prominent and diffuse granular deposits of IgA in the glomerular 
mesangium (Nolin & Courteau 1999). In many cases, deposits of IgG are concomitantly seen in the 
mesangium. Other changes in glomeruli may be variable, but mesangial hypercellularity and matrix 
accumulation are typical (Glassock et al. 1991a). Several lines of evidence indicate that IgA 
nephropathy is some kind of immune complex glomerulonephritis. The effects of reactive oxygen 
species, IL-6, viral infection and genetic factors have also been reported (Glassock et al. 1991a). 
 
Membranous glomerulonephritis 
Membranous glomerulonephritis (MGN) is the leading cause of primary NS in adults (Shankland 
2000). MGN refers to a specific entity of NS associated with diffuse deposits of immune complexes 
under the epithelium. The typical feature is diffuse thickening of the GBM and increase in 
mesangial matrix, usually without any significant proliferation of endothelial, mesangial, or 
epithelial cells (Ambrus & Sridhar 1997). The findings on electron microscope reveal subepithelial 
and in advanced cases intramembranous electron-dense deposits (Ambrus & Sridhar 1997). 
Immunofluorescence reveals, in almost all cases, that IgG and C3 are present in a uniform granular 
distribution in capillary loops (Glassock et al. 1991a). The pathogenesis of human MGN is not 
clearly known. A rat model of Heymann nephritis has been widely used for the exploration of the 
mechanism, owing to its similarity with the features of human MGN (Miettinen et al. 1980). Several 
pathogenetic possibilities have been proposed, such as circulating or in situ formed immune 
complexes (Shankland 2000). 
 
Membranoproliferative glomerulonephritis 
Membranoproliferative glomerulonephritis (MPGN) is mainly found in children and adolescents 
rather than in the elderly. The clinical features are variable, but proteinuria often with NS, is usually 
present (Ambrus & Sridhar 1997). Based on ultrastructural and immunofluorescence patterns, 
idiopathic MPGN can be further categorized as three subtypes (Glassock et al. 1991a). In type I, 
subendothelial and mesangial electron-dense deposits are noted. Immune complexes can be IgG,  
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C3, C1q or C4. This type accounts for 65-75 % of all MPGN patients. In type II, electron-dense 
deposits can be found along the GBM (“dense deposit disease”). C3 is predominant in immune 
complex deposits, IgG is not usually found. This type accounts for 20-30 % of all cases. Type III is 
very rare; the electron dense deposits are mainly found under endothelium, epithelium, and in the 
mesangium. C3 is predominant, accompanied by IgG. MPGN is thought to be an immune complex 
disease and also genetically related (Ambrus & Sridhar 1997). Lack of successful animal models has 
restricted the delineation of the mechanisms. Heterogenity in pathogenesis is suggested due to 
diversity characteristics in pathology. 
 
4.4. Genetic defects 
 
The pathomechanisms of kidney disease manifested by proteinuria and NS have been a mystery for 
decades. The underlying causes of these diseases often lie in changes of the glomerular filtration 
barrier, but the molecular properties of these alterations have been poorly understood. Recent 
molecular genetic research has, however, identified the causes of many rare familial kidney 
diseases, such as steroid-resistant NS, FSGS, and congenital nephrotic syndrome of the Finnish 
type. The identification of podocyte-specific proteins affected in these diseases, has increased our 
knowledge of the kidney ultrafilter, especially of podocytes and the slit diaphragm. Similarly, the 
studies on Alport syndrome have improved our knowledge of the glomerular basement membrane. 
In addition to these known genetic defects, there are a number of glomerular diseases which are 
thought to have a genetic, yet unidentified, component based on family clustering. Diseases in this 
category include IgA nephropathy, diabetic nephropathy, and human immunodeficiency virus (HIV) 
nephropathy (Striker et al. 1994). 
 
Steroid-resistant nephrotic syndrome  
Steroid-resistant NS (SRN or NPHS2) is an inherited autosomal recessive disease, which is mostly 
observed in children between three months and five years of age. The patients do not respond to 
steroid treatment and, after onset of proteinuria, progression towards end-stage renal disease is 
rapid. The causative gene NPHS2 was mapped to chromosome 1q25-q32 by Fuchshuber et al. 
(1995) and has also been isolated recently (Boute et al. 2000). The gene product, named podocin, is 
a putative 42 kDa integral membrane protein with a short extracellular domain, followed by a 
transmembrane spanning region and a long carboxy-terminal cytoplasmic end. Expression of the 
gene is restricted to glomerular podocytes, and it has been speculated that podocin may be involved 
in organizing the cytoskeleton of podocyte foot processes at the cytoplasmic site of the slit 
diaphragm (Khoshnoodi & Tryggvason 2001). 
 
Focal segmental glomeruloclerosis 
Another genetic cause of NS has been clarified recently by positional cloning of a gene from 
patients with adult onset of FSGS. This disease represents a heterogenous group of autosomal 
dominant kidney disorders that are manifested by proteinuria and slow progression of segmental 
glomerular sclerosis, and finally end-stage renal disease in adulthood (Khoshnoodi & Tryggvason 
2001). Two genes have been located to chromosomes 19q13 (FSGS1, Mathis et al. 1998) and 
11q21-22 (FSGS2, Winn et al. 1999). The gene for FSGS1 has been cloned recently by Kaplan et al. 
(2000) and shown to encode α-actinin-4; the gene for FSGS2 has not been identified yet. Actinins 
are proteins that crosslink actin filaments in cytoskeleton, and their expression patterns vary 
throughout the body (Honda et al. 1998). Four α-actinin coding ACTN genes are known in man 
(ACTN1-ACTN4). ACTN4 is widely expressed in different tissues, and it has been shown to be 
highly expressed in glomerular podocytes (Kaplan et al. 2000). Analysis of mutations in affected  
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individuals showed non-conservative amino acid substitutions in the actin-binding region of α-
actinin-4. On the basis of co-sedimenation studies, the investigators (Kaplan et al. 2000) have 
proposed that the dominant mutations in the ACTN4 gene might lead to an increased affinity for 
actin filaments. This finding implicates the importance of proper organization of the cytoskeleton 
for normal function of podocyte foot processes (Khoshnoodi & Tryggvason 2001). 
 
Denys-Drash syndrome 
Denys-Drash syndrome (DDS) is characterized as a congenital or early onset NS associated with 
severe urogenital aberrations, pseudohermaphroditism and Wilms´ tumor (Pelletier et al. 1991). 
Wilms´ tumor, or nephroblastoma, is the most common pediatric kidney cancer resulting in the 
formation of tumors and developmental abnormalities (Mrowka & Schedl 2000). The characteristic 
glomerular lesion - diffuse mesangial sclerosis and nephropathy- is usually discovered at birth or 
within the first months of life. DDS arises from mutations in WT-1 gene, encoding a transcription 
factor known as the Wilms´ tumor suppressor (Pelletier et al. 1991). The gene, located at 
chromosome 11p13, has a critical role in kidney and gonad development, as demonstrated in WT-1 
knockout mice lacking both kidneys and gonads (Pritchard-Jones et al. 1990). WT-1 is highly 
expressed during the embryonic development, but in mature kidney its expression persist only in 
podocytes and epithelial cells of the Bowman´s capsule (Kreidberg et al. 1993). The protein has 
transcriptional regulatory region and four zinc-finger DNA-binding domains. The mutations in WT-
1 found in DDS patients seem to act as a dominant trait, and nearly all are heterozygous missense 
mutations affecting zinc-finger regions of the protein (Pelletier et al. 1991). The WT-1 gene product 
has a down-regulatory effect on large number of genes, such as transcription factors Pax-2, Pax-8, 
novH and the WT-1 gene itself, and some growth hormones and their receptors, such as IGF-2, IGF 
receptor, PDGF-A, TGF-β and epidermal growth factor receptor (Mrowka & Schedl 2000). The 
alterations in the binding capacity of the mutated protein and the loss of suppression may explain 
the glomerular lesions found in DDS patients.  
 
Disorders of GBM 
Advances in our knowledge of the biology of the GBM and the molecular genetics of specific genes, 
have contributed the understanding of glomerular diseases of GBM components. The biochemistry 
of the GBM involves a complex interaction of collagen IV with laminin and other crosslinking 
proteins and proteoglycans. The first defect described in molecular terms was Alport syndrome. 
Alport syndrome is a hereditary nephritis presenting as hematuria, proteinuria and end-stage renal 
disease (Barker et al. 1990). It shows wide genetic heterogeneity with X-linked, autosomal 
dominant and autosomal recessive forms (Goodyer & Kashtan 1998). It has been unequivocally 
identified as the phenotypic expression of mutations affecting type IV collagen; to date, variable 
mutations in genes COL4A5, COL4A6, COL4A3 or COL4A4 have been documented (Tryggvason 
et al. 1993, Goodyer & Kashtan 1998). During the past few years, several other matrix-associated 
glomerular diseases have been described, such as collagen type III glomerulopathy, fibronectin 
glomerulopathy and lipoprotein glomerulopathy. These are all slowly progressive familial 
diseases and usually present with proteinuria or NS (Abt & Cohen 1996, Gibson & More 1998).  
 
Congenital nephrotic syndrome of the Finnish type 
Congenital nephrotic syndromes (CNS) are defined as severe proteinuria leading to the clinical 
symptoms of NS already the first months of life (Holmberg et al, 1996). Congenital nephrotic 
syndrome of the Finnish type (CNF) is an inherited type of CNS with massive proteinuria; the  
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nature of CNF and the specific genetic defect are introduced thoroughly in the next chapter (Chapter 
5). 
 
4.5. Systemic or syndromic nephrotic syndromes 
  
Systemic diseases that may lead to nephrotic proteinuria include diabetes mellitus, amyloidosis and 
systemic lupus erythematosis (Glassock et al. 1991b, Abrass 1997). Diabetes mellitus is the most 
prevalent single metabolic disease assosiated with progressive glomerulosclerosis, and diabetic 
nephropathy is the most common cause of nephrotic proteinuria in adults (Ritz & Stefanski 1996). 
In diabetes, the size selectivity of the GBM can become altered by disease-associated chemical 
modifications. Nonenzymatic glycation of the GBM may alter the pore size creating channels that 
allow proteins larger than albumin to reach the subepithelial space more easily. However, recent 
data have shown that the risk for renal disease in diabetics is familial indicating the existence of a 
genetic component too (Seaquist et al. 1989, Borch-Johnsen et al. 1992). NS may also be a part of 
general malformation syndromes, such as central nervous system malformations, Nail-Patella 
syndrome and DDS (Rapola 1987, for DDS see chapter "4.4. Genetic defects"). 
 
4.6. Acquired types of nephrotic syndrome 
 
The most common types of acquired NS are those associated with bacterial or viral infections, drug 
reactions and toxins (Glassock et al. 1991b). For example, human immunodeficiency virus 
nephropathy typically causes nephrotic proteinuria and renal insufficiency, occasionally as the first 
clinical manifestations of the acquired immunodefiency syndrome. Infection-associated 
glomerulonephritis may be caused also by hepatitis B or C or malaria viruses and some bacteria 
(Eddy & Schnaper 1998, Orth & Ritz 1998). The patients with Goodpasture syndrome, an anti-
GBM antibody disease, develop rapidly progressive nephropathy during adulthood, but presumably 
have normal kidneys prior to the onset of specific antibody response (Striker et al. 1994). The 
Goodpasture antigen has been identified as collagen IV, more specifically the NC1 domains of 
α3(IV) and α4(IV) chains (Hudson et al. 1993). It has been suggested that a primary event such as 
infection or toxin exposure triggers the unmasking of these epitopes, causing the initial production 
of anti-GBM antibodies (Hudson et al. 1993, Gibson & More 1998). A role for many environmental 
factors, such as heavy metal intoxication, in the initiation or progression of some glomerular 
diseases have also been implicated, but their nephrotoxicity in the general population is not yet clear 
(Striker et al. 1994). 
 
 
5. CONGENITAL NEPHROTIC SYNDROME OF THE FINNISH TYPE (CNF) 
 
5.1. Basics of the disease 
 
CNS are kidney diseases which are manifested by the leakage of normal circulating proteins into the 
urine and which are present at or soon after birth (Rapola 1987). CNS are a heterogeneous group of 
diseases, and the molecular pathomechanisms of leaky glomerular filtration barrier in most CNS are 
still obscure. CNF was first described in 1956 by Hallman et al. (1956). CNF forms a distinct entity 
among CNS with its typical clinical picture and an autosomal recessive pattern of inheritance (Norio 
1966, Hallman et al. 1973, Rapola 1987). It is much more common in Finland than anywhere else, 
but a few cases have been reported throughout the world (Rapola et al. 1992, Habib 1993, Savage et 
al. 1999, Aya et al. 2000). In recent years, 2-8 CNF children have been born in Finland each year. 
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The incidence has been reported to be 14.2 in 100 000 newborns during years 1975-1988, including 
births and aborted CNF pregnancies (Laakso et al. 1992).  
 
5.2. Clinical features 
 
The clinical picture of CNF is quite uniform. The disease is manifested already at the fetal stage as 
heavy proteinuria in utero, which can be diagnosed by elevated concentrations of alpha-fetoprotein 
in the amniotic fluid and maternal serum (Seppälä et al. 1976, Aula et al. 1978). The typical clinical 
signs are prematurity ranging from 35th to 38th gestation weeks, low birth weight, and large 
placenta equivalent to over 25 % of child´s birth weight (Kouvalainen et al. 1962, Huttunen 1976). 
Severe NS with massive urinary loss of proteins, serum hypoproteinemia, edema and secondary 
manifestations is usually detected immediately or shortly after birth (Huttunen 1976, Holmberg et 
al. 1995). CNF infants suffer from different kinds of infections, thromboembolism and seizure 
(Huttunen 1976, Laine et al. 1993). Developmental delay and bony deformities are common 
(Hallman et al. 1973).  
 
5.3. Pathology of the kidney 
The pathology of CNF kidneys has been characterized thoroughly, but the basic defect leading to 
proteinuria remained obscure until very recently. Extensive morphological, histological and 
biochemical studies on CNF kidneys have been performed by several investigators from the fetal 
period to infancy, but none of the findings seemed to be causative for the CNF. The weights of the 
kidneys of CNF children have been reported to be 2-3 times larger compared to normal kidneys 
(Huttunen et al. 1980). The number, density and size of kidney glomeruli are increased in infants 
with CNF (Tryggvason & Kouvalainen 1975, Tryggvason 1978), althought this was not evident in 
16-to-22-week CNF fetuses (Autio-Harmainen & Rapola 1981). It has been suggested that in CNF 
the glomerular formation does not cease normally but continues beyond the 35th gestational week 
resulting in about 70 % higher number of glomeruli (Autio-Harmainen & Rapola 1981). 
Furthermore, glomerular maturation is suggested to be enhanced in CNF, because a proportional 
increase in mature glomeruli and decrease in glomerular visceral epithelial cells in fetal CNF 
kidneys could be detected by light microscopy (Huttunen et al. 1980, Autio-Harmainen & Rapola 
1981).  
Typical histological findings of CNF kidneys are the dilation of proximal tubular lumina and 
expansion of the mesangial area. The fetal tubular dilations are sparse and found mostly at the 
medullary portion of the cortex, but the dilations increase and extend during the patient´s postnatal 
life (Huttunen et al. 1980, Autio-Harmainen & Rapola 1981). The epithelium of the dilated tubules 
is first swollen and filled with eosinophilic colloid-like material, but later becomes flattened and 
atrophic (Huttunen et al. 1980, Rapola et al. 1984). Mesangial hyperplasia can be detected both in 
fetal and postnatal kidneys (Huttunen et al. 1980, Autio-Harmainen & Rapola 1981). In infants, 
progressive accumulation of mesangial matrix is seen; sclerosis and fibrosis of the glomeruli can be 
detected in patients approaching one year of age (Huttunen et al. 1980). The late changes include 
also interstitial fibrosis, lymphocytic inflammation (Hallman et al. 1973, Huttunen et al. 1980) and 
thickening of parietal Bowman’s capsule (Huttunen et al. 1980, Autio-Harmainen et al. 1985). 
Electron microscopy reveals the near total loss of podocyte foot processes in both fetal and infant 
CNF glomeruli (Autio-Harmainen 1981, Rapola et al. 1984 and 1992). 
The molecular composition of the GBM in CNF has been characterized by immunofluoresence 
microscopy and biochemical analysis. The basic defect leading to proteinuria in CNF has most often 
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been suggested to lie in the structure of GBM. Several changes have been found in the amino acid 
composition of the GBM in CNF kidneys. A decrease in 3- and 4-hydroxyproline, hydroxylysine 
and glycine, amino acids characteristic for type IV collagen, has been reported by Tryggvason 
(1977). Similar changes are however seen in other kidney diseases as well and the 
immunohistochemical staining for laminin, type IV collagen and fibronectin have not revealed any 
changes in CNF compared to age matched controls (Rapola et al. 1984). HSPG is considered to be 
mainly responsible for the charge selectivity in the GBM, and a decrease in HSPG concentration has 
been thought to cause the increased GBM permeability (Vermylen et al. 1989). However, in CNF 
children, the total glycosaminoglycan content of the GBM, the number of anionic sites, and the 
urinary excretion of heparan sulphate were all found to be normal (van den Heuvel et al. 1992, 
Ljungberg 1994, Ljungberg et al. 1995).  
 
5.4. Diagnosis 
 
Traditionally, the prenatal diagnosis of CNF is based on high alpha-fetoprotein concentrations in the 
amniotic fluid or maternal serum in the second trimester of pregnancy (Seppälä et al. 1976, Aula et 
al. 1978, Holmberg et al. 1996).  This is not specific for CNF, as elevated α-fetoprotein levels can 
also been found in other fetal disorders, mostly structural anomalies such as neural tube defects and 
abdominal wall defects. In addition, the α-fetoprotein screening method may lead to false-positive 
results and subsequent abortions of healthy fetuses (Männikkö et al. 1995). However, CNF is, 
especially in Finland, a likely cause for very high amniotic fluid α-fetoprotein in pregnancies where 
ultrasound shows no fetal abnormalities. 
 
Clinically, the postnatal diagnosis of CNF, suspected prenatally on the basis of an increased α-
fetoprotein level, can be made using the following criteria: (1) positive family history, (2) severe 
proteinuria (>20g/l when serum albumin has been corrected to >15 g/l) of intrauterine onset, (3) a 
large placenta, (4) exclusion of other types of CNS, and (5) normal glomerular filtration rate during 
the first six months of life (Holmberg et al. 1996). The diagnosis can be further strengthened by a 
typical renal histology after the first three to six months of life. 
 
The localization of the CNF gene to chromosome 19q13.1 (Kestilä et al. 1994a, Männikkö et al. 
1995) and the strong linkage equilibrium of the genetic markers in this region enabled prenatal 
diagnosis based on haplotype analysis (Männikkö et al. 1997). Haplotype analysis can be made as 
early as in the 12th to 13th gestational weeks and with up to 95% accuracy. The recent identification 
of the CNF gene and disease-causing mutations (Kestilä et al. 1998) has now made the exact DNA-
based diagnosis and reliable carrier screening possible. Mutation analysis can be done by PCR-
restriction fragment lenght polymorphism (RFLP) and by a dual-color oligonucleotide ligation assay 
(Romppanen & Mononen 2000). 
 
5.5. Treatment and prognosis 
 
Until the beginning of 1980´s, CNF children died, most of them as infants, but at present the 
prognosis is good. Treatment with aggressive protein supplementation, bilateral nephrectomy and 
dialysis, and subsequent renal transplantation have been successful and have made normal growth 
and development of CNF patients possible (Holmberg et al. 1991 and 1995). These treatments were 
started in Finland in 1985 (Holmberg et al. 1990), and no extrarenal manifestations have developed 
in patients during the over 10 years follow-up. Some complicated problems, such as lipid 
abnormalities (Antikainen et al. 1994), anemia (Siimes et al. 1992) and infections (Jalanko et al.  
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1989) have been, however met. Severe lipid abnormalities, such as hypertriglyceridaemia and 
abnormal cholesterol levels, indicate increased risk of arteriosclerosis in CNF. Renal transplantation 
substantially improves lipid abnormalities, but significant disturbances still persist (Antikainen et al. 
1994). Furthermore, six patients during years 1987-1992, representing seven out of 29 
transplantations performed, developed post-transplantation nephrosis (Laine et al. 1993). The reason 
for this recurrence has been unknown, but very recently, after identification of the CNF gene, Wang 
et al. (2001) and Patrakka et al. (2002) reported that recurrence of NS in CNF transplantation 
patients is associated with preceding high levels of specific antibodies to the CNF gene product, 
nephrin, possibly explaining the recurrence mechanism. 
 
5.6. Candidate genes for CNF 
 
CNF is thought to be a highly kidney specific disease, and it has been proposed that it is caused by a 
mutation in a gene coding for either a structural basement membrane component or a component 
otherwise crucial for the filtration process. Testing the hypotheses, Kestilä et al. (1994b) analyzed 
eight genes coding for basement membrane components using intragenic polymorphisms and 
linkage analysis. They excluded the genes for α1-4(IV)chains of type IV collagen, β1, γ1 and γ2 
chains of laminin and HSPG as causative for CNF on the grounds of recombination between the 
CNF and intragenic RFLP markers. At least two unrelated transgenic mice models have been 
described for nephrotic syndrome. Weiher et al. (1990) described a recessive lethal mouse strain 
generated by inactivation of the Mpv17 gene coding for a ubiquitous peroxisomal protein. Affected 
Mpv17 mice developed NS with proteinuria, hypoalbuminemia, and hyperlipidemia, and died from 
renal failure. Kidney injury was found to be at the glomerular level. However, the human Mpv17 
gene localizing to chromosome 2 p21-p23 has been excluded as a disease gene for CNF (Karasawa 
et al. 1993, Zwacka et al. 1994). Later, Binder et al. (1999) have shown that glomerular damage in 
this murine model is due to overproduction of oxygen radicals and accumulation of lipid 
peroxidation adducts causing podocyte foot process flattening and proteinuria. A report by Dressler 
et al. (1993) demonstrated that deregulation of Pax-2 transcription factor gene led to CNS in 
transgenic mice resembling that of human CNF. Pax-2 is normally expressed in induced kidney 
mesenchyme, in early epithelial structures derived from the mesenchyme and in ureter epithelium, 
and in Wilms´ tumor tissue. Overexpression of the Pax-2 in mice kidneys resulted in development 
of microcysts, loss of podocyte foot processes and proteinuria, and it was suggested that these mice 
represent an animal model for congenital nephrotic syndrome. The Pax-2 gene lies in the 
chromosomal region 10q22-q25 but this location has also been excluded as a mutated CNF locus 
(Kestilä et al. 1994c). Recently, NS has also been shown in knock-out mice lacking CD2AP, an 
actin-binding protein that is expressed in many cell types (Shih et al. 1999). CD2AP was first 
characterized as a cytoplasmic ligand of the CD2 receptor protein in T-cells and natural killer cells 
(Dustin et al. 1998). CD2AP-deficient mice had certain immune function compromises, but 
surprisingly they died from NS at the age of 6-7 weeks. Electron microscopy examination of 
kidneys showed a loss of podocyte foot process integrity accompanied by mesangial cell hyperplasia 
and extracellular matrix deposition (Shih et al. 1999). Interestingly, by co-precipitation studies, Shih 
et al. (1999) demonstrate a direct interaction between CD2AP and the CNF gene product 
(characterized below), and suggest their role in slit diaphragm function.  
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5.7. Identification and characterization of the CNF gene 
 
Recently, Kestilä et al. (1998) reported a positional cloning of putative CNF gene (NPHS1) and 
characterization of its predicted protein product, which they termed nephrin. The NPHS1 gene is 
26 kilobases in size and comprises 29 exons. It encodes a transcript of about 4.3 kb, which was 
shown to be strongly expressed in human embryonic and adult kidneys, but not in any other human 
tissues studied. In situ hybridization revealed intense expression signals in the periphery of mature 
and developing glomeruli, apparently in epithelial podocytes (Kestilä et al. 1998). Further 
histochemical studies (Holthöfer et al. 1999) with nephrin-specific antipeptide antibodies confirmed 
the exclusively glomerular localization of nephrin in the kidney, with a preferentially epithelial-like 
staining pattern. By immunoelectron microscopy Holthöfer et al. (1999), Ruotsalainen et al. (1999) 
and Holzman et al. (1999) demonstrated nephrin localization in the podocyte foot processes 
prominently at the level of filtration slits, as well as occasionally in the plasma membrane of 
podocytes (Holthöfer et al. 1999).  
 
The cDNA-predicted amino acid sequence of nephrin is comprised of 1241 residues, with a 
calculated molecular mass of 134,742 Da without posttranslational modifications (Kestilä et al. 
1998). Because of posttranslational glycosylation, the mature nephrin migrates as a 180 kDa protein 
when analyzed by Western blot analysis (Ruotsalainen et al. 1999). Based on similarity comparisons 
and protein structure prediction programs, nephrin was considered as a transmembrane protein of 
the immunoglobulin superfamily, with a 22-residue amino-terminal signal peptide, an extracellular 
domain containing eight immunoglobulin-like modules followed by a fibronectin type III domain, a 
single short transmembrane region and a cytosolic carboxy-terminal end (Figure 5) (Kestilä et al. 
1998). Several mRNA splicing variants that mainly lack the transmembrane region have also been 
reported (Holthöfer et al. 1999). 
 
 
 
Figure 5. Predicted domain structure of nephrin. Nephrin is composed of eight extracellular Ig-like modules (partial 
circles), one fibronectin-like motif (octagon), a transmembrane region (rectangle in a membrane lipid bilayer), and a 
short intracellular domain. The locations of three free cysteine residues are indicated by c. N, amino terminal end; C, 
carboxy terminal end. Adapted from Kestilä et al. (1998). 
 
 
With CNF patients, exon sequencing analysis of the NPHS1 gene revealed the presence of two 
major mutations representing over 90% of the Finnish CNF chromosomes: (1) a 2 bp deletion in 
exon 2 causing a frameshift and a premature 90-residue long protein, and (2) a nonsense mutation in 
exon 26 leading to an early stop codon in the cytoplasmic domain of the protein (Kestilä et al. 
1998). These two mutations were much more rare in non-Finnish populations, which showed a large 
number of missense mutations, small deletions and insertions, nonsense, splice-site and promoter 
mutations, making the total number of known mutations to about 50 (Lenkkeri et al. 1999, Aya et al. 
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2000, Beltcheva et al. 2001). CNF kidney samples (except one of the 28 studied) failed to show 
nephrin reactivity with either the extra- or intracellular nephrin antibodies in immunohistochemical 
studies (Holthöfer et al. 1999). However, some nephrin-specific signals were obtained with 
immunoelectron microscopy in some of the CNF samples, preferentially at the flattened apical 
surface of podocytes. 
 
The role of nephrin remains unknown, but it is likely to be a cell adhesion molecule and a signalling 
protein, as its domain structure resembles that of the many cell adhesion receptors participating in 
cell-cell and cell-matrix interactions. Kestilä et al. (1998) discussed the possible importance of 
nephrin for the integrity or anchorage of the podocyte foot processes, and the development and 
function of the glomerular filtration barrier. The results of its key localization in glomerulus, in 
podocyte slit membranes (Holthöfer et al. 1999), support this crucial role of nephrin in glomerular 
filtration and thus, proteinuria in CNF. It has been hypothesized that nephrin may form an isoporous 
zipper-like membrane structure that functions as the ultrafilter of the glomerular filtration barrier 
(Figure 6) (Ruotsalainen et al. 1999, Tryggvason 1999, Khoshnoodi & Tryggvason 2001). The 
central role of nephrin in the formation and function of the slit membrane is also demonstrated by 
the generation of NPHS1 knock-out mice (Putaala et al. 2001). The NPHS1 null mice completely 
lack a slit diaphragm and develop massive non-selective proteinuria at birth and die within 24 hours. 
In addition, changes in nephrin expression have been suggested in other pediatric kidney diseases 
(Furness et al. 1999, Doublier et al. 2001) and experimental animal models (Ahola et al. 1999, 
Kawachi et al. 2000, Luimula et al. 2000), but not unequivocally (Patrakka et al. 2001). 
 
 
 
 
Figure 6. Nephrin - a key component of the slit diaphragm. Hypothetical assembly of nephrin molecules to form an 
isoporous filter of podocyte slit diaphragm. Ig-like repeats (grey circles) 1-6 of a nephrin molecule associate in an 
interdigitating fashion with Ig-like repeats 1-6 in a neighboring molecule. Molecules from opposite foot processes are 
predicted to interact with each other in the center of the slit through disulfide bridges. According to Ruotsalainen et al. 
(1999) and Tryggvason (1999). 
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AIMS OF THE PRESENT STUDY 
 
 
The outline of the present study was to learn more about the molecular mechanisms of proteinuria 
by using congenital nephrotic syndrome of the Finnish type (CNF) as a model disease. CNF appears 
an ideal human model disease to study pathogenesis and mechanisms associated with proteinuria, 
which have remained thus far poorly understood. CNF is a kidney specific, one-gene defect, and 
results in massive, treatment resistant proteinuria already in utero. At the time of this research, the 
basic defect of CNF was still unknown, but it had been suggested that it involves a gene essential to 
establish a functional glomerular filtration barrier, either primarily or secondarily. Several different 
hypotheses have been proposed to explain the mechanisms of proteinuria in CNF, including the 
aspects of the development of functional glomeruli and the molecular regulation of the filtration. 
The first part of this study (I, II, III) was undertaken to test these hypotheses. The second series of 
experiments (IV, V) was planned to find new candidate molecules involved in the pathogenesis of 
CNF.  
 
 
The specific aims were: 
 
- to characterize morphological and developmental abnormalities of CNF kidneys and 
glomeruli in more detail using cell-type and differentiation stage-specific markers (I), 
-  to test systematically the expression of kidney development and maturation associated genes 
in CNF kidneys and cultured glomerular cells thereof  (II), 
-  to explore the putative involvement of vascular permeability factor (VPF) in the pathogenesis 
of proteinuria (III), 
-  to proceed to screening for the differentially expressed gene products in CNF glomeruli 
compared with normal human glomeruli (IV), 
-  to further characterize the gene products identified by differential display analysis and 
examine their association with the pathogenesis of proteinuria in CNF (IV, V). 
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MATERIALS AND METHODS 
 
 
1. TISSUE SAMPLES 
 
1.1. CNF patients and kidney samples 
Kidney samples of patients with congenital nephrotic syndrome of the Finnish type (CNF, n=8) 
were obtained at nephrectomies performed according to an established treatment protocol 
(Children's Hospital, University of Helsinki, Helsinki, Finland). Prior to nephrectomy, treatment of 
the patients included daily albumin infusions and aggressive nutrition and, as the weight of 8-9 kg 
was achieved (at an age of 9-18 months), nephrectomy of both kidneys was performed (Holmberg et 
al. 1995). Diagnosis of CNF was based on the typical clinical picture (large placenta, massive 
proteinuria at birth) and exclusion of other types of congenital nephroses, and later by the typical 
pathology at nephrectomy (Rapola 1987). Some kidneys at nephrectomy were immediately perfused 
with Ringer's buffer solution (Orion Pharmaceuticals, Espoo, Finland) via the renal arteries. 
 
1.2. Control kidney samples  
As control human kidneys we used cadaver kidneys (n=7; ages 3, 12, 18, 22, 25, 37 and 48 years) 
unsuitable for renal transplantation due to vascular anatomic reasons (Division of Transplantation 
Surgery, University of Helsinki), or macroscopically normal parts of the kidneys obtained at 
nephrectomy due to renal carcinoma (n=3; adults; Division of Urology, University of Helsinki) or 
Wilms' tumor (n=2; ages 3 and 5 years; Division of Urology, University of Helsinki). The fetal 
kidney sample was from a legal, prostaglandin induced abortion at the 16th week of gestation due to 
a severe maternal illness (Department of Obstetrics and Gynecology, University of Helsinki). 
 
1.3. Other kidney samples (II, V)  
The Wilms´ tumor tissue was obtained from a clinical nephrectomy (n=1; age 5 years; sporadic 
case; Division of Urology, University of Helsinki) and diagnosed at the Pathology Unit of the 
Department of Pediatrics (University of Helsinki) based on routine diagnostic procedures combining 
clinical and histological data. Kidney biopsies from patients with membranous glomerulonephritis 
(n=3; ages >18 years) and adult minimal change disease (n=3; ages >18 years) were obtained from 
routine diagnostic biopsies (University of Helsinki).  
 
1.4. Other tissues (V) 
Other human tissues used included samples from extrarenal arteries from CNF patients and control 
humans (Department of Surgery, University of Helsinki). 
 
All procedures used in this study were approved by the Ethical Committees of the respective 
departments of the University Central Hospital, Helsinki. 
 
2. PREPARATION OF TISSUE SAMPLES 
 
After removal, CNF kidneys were cut into two halves along the longitudinal axis across the renal 
pelvis to reveal the gross anatomic appearance of the corticomedullary relationship. Then 
immediately, the cortical tissues were mechanically separated from medulla and dissected into 
cubes of about 0.5-1 cm3. Samples were (a) frozen in liquid nitrogen for RNA extractions, (b) 
prepared for isolation of glomeruli, (c) snap frozen in isopentane cooled with liquid nitrogen for  
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histochemistry and immunohistochemistry, or (d) fixed in 3.5% paraformaldehyde and frozen in 
isopentane cooled with liquid nitrogen for in situ hybridization.  For electron microscopy, the 
samples were fixed and processed as described earlier by Neale et al. (1994) and Shirato et al. 
(1996). Control kidney samples were processed as CNF samples, usually in 18-48 hours after 
removal (stored in appropriate conditions for transplantation). For later experiments, all samples 
were stored at -70°C or liquid nitrogen. In addition, kidney biopsy samples and arterial samples 
were snap frozen and stored in liquid nitrogen until analyzed. 
  
3. ISOLATION OF GLOMERULI 
 
Glomeruli were isolated from fresh kidney samples as described previously (Striker & Striker 1985, 
Holthöfer et al. 1991). Aseptically isolated cortical tissue was placed into ice cold PBS, minced to 
macroscopic homogeneity, and pushed sequentially through sieves of 250 µm and 150 µm pore 
sizes. The glomeruli were collected by rinsing from a third sieve of 106 µm pore size. The 
preparation was examined under light microscopy for purity and usually 94-96 % pure glomeruli 
were obtained. Isolated glomeruli were then used immediately for the establishment of glomerular 
cell culture or isolation of glomerular RNA. 
 
4. CELL CULTURES (II, III) 
 
4.1. Establisment of glomerular cell culture 
For culture, the isolated glomeruli were placed in 25 cm2 plastic tissue culture bottles (Greiner 
Labortechnik, Frickenhausen, Germany) in RPMI-1640 medium (Gibco Biocult, Paisley, Scotland) 
supplemented with penicillin (100 E/ml; NordCell, Skärholmen, Sweden), streptomycin (100 
µg/ml; NordCell), glutamine (2 mM; NordCell) and 10 % fetal calf serum (Collaborative Research, 
Cambridge, MA, USA). The medium was changed twice a week after the proliferating cells 
appeared typically by day five of culture. For fetal cell culture, the fetal kidney sample was 
throughly homogenized with a razor blade and placed in culture bottles in medium as described 
above.  
 
4.2. Identification of glomerular cell types 
The outgrowing glomerular cell types were identified by their morphology and the expression of 
cell-type specific epitopes studied by immunofluorescence microscopy as described earlier (Dekan 
et al. 1990, Holthöfer et al. 1990 and 1991, Miettinen et al. 1990). For mesangial cells these 
included antibodies against Thy-1.1 (clone OX-7; Serotec, Oxford, UK), alpha smooth muscle actin 
(Progen Biotechnik GmbH, Heidelberg, Germany), fibronectin (Locus Genex, Helsinki, Finland), 
integrin alpha-1 (Becton-Dickinson, San Jose, CA, USA) and alpha-5 (Telios Pharmaceuticals, San 
Diego, CA, USA), and Ricinus communis agglutinin (RCA I; Vector Laboratories Inc., Burlingame, 
CA, USA). For epithelial markers we used anti-PHM5 (Dakopatts, Glostrup, Denmark) and anti-
gp44 (kindly provided by Dr. Peter Mundel, University of Heidelberg, Heidelberg, Germany) 
antibodies, and wheat germ agglutinin (WGA; Vector Laboratories Inc.). The cells used in the 
present study (passages 3 to 5) contained both epithelial and mesangial cells, with a predominance 
of mesangials, ranging from 66 to 78 % of the total cell counts. 
 
4.3. Other cell lines 
Adenovirus-transformed human embryonic kidney epithelial cell line A293 (cell repository line 
(CRL) 1573; American Type Culture Collection (ATCC), Rockville, MD, USA) was cultured in the 
same conditions as the glomerular cells. 
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5. HISTOLOGICAL STAININGS 
 
5.1. Histochemistry (V)  
Frozen sections 3-4 µm thick were cut with a cryostat from the cortical kidney samples. Fresh 
cryostat sections were incubated with specific substrate solutions, producing coloured insoluble 
granular deposits at sites of enzymatic activity. Histochemical methods for respiratory chain 
complex II (succinate dehydrogenase, SDH) and IV (cytochrome-c oxidase, COX) were used in this 
study (Seligman et al. 1968, Bancroft 1975). 
   
5.2. Immunohistochemistry  
Fozen tissue sections (as for histochemistry) were fixed for 3 min in acetone at -20°C, washed in 
phosphate buffered saline (PBS, pH 7.4), incubated with the appropriate dilutions of the primary 
antibodies overnight at 4°C, washed with PBS, then incubated for 1-2 hours with the secondary 
antibodies conjugated with fluorescein isothiocyanate (FITC) and finally mounted in a nonfading 
mounting medium (Mowiol; Calbiochem Corp., La Jolla, CA, USA). The immunofluorescence 
microscopy and photography were performed with an Olympus Ox50 microscope (Olympus Co., 
Japan) with a filter system for FITC fluorescence, as previously described (Dekan et al. 1990, 
Miettinen et al. 1990) .  
 
5.3. Antibodies and lectins used  
The following primary antibodies were used (I): rabbit (R) anti-fibronectin (Serotec), R anti-laminin 
(Bethesda Research Laboratories, Gaithersburg, MD, USA), mouse (M) anti-cytokeratin (Pkk1; 
Labsystems, Helsinki, Finland), M anti-human monocytes/macrophages (M 718; Dakopatts), M 
anti-human leukocyte common antigen (M701; Dakopatts) M anti-stem cell factor (SCF; R&D 
Systems, Minneapolis, MN, USA), M anti-Bcl-2 (Upstate Biotechnology, Lake Placid, NY, USA), 
R anti-Wilms' tumor gene protein product (WT-1, clone HC17; kindly provided by Dr. Frank 
Rauscher, The Wistar Institute, Philadelphia, PA, USA; described by Amin et al. 1995),  M anti-
proliferating cell nuclear antigen (PCNA; Boehringer Mannheim Biochemica, Mannheim, 
Germany), R anti-heparin binding growth associated molecule (HB-GAM; kindly provided by Dr. 
Heikki Rauvala, Institute of Biotechnology, University of Helsinki), and R anti-midgestation and 
kidney (MK; kindly provided by Dr. Takashi Muramatsu, University of Nagoya, Nagoya, Japan; 
(Muramatsu & Muramatsu 1991, Tsutsui et al. 1991)); (III): R anti-vascular permeability factor 
(VPF, VEGF-A20; Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA); (V): M anti-cytochrome-
c oxidase subunit I (COX I, clone 1D6-E1-A8, kindly provided by Dr. Jan-Willem Taanman, 
Department of Clinical Neurosciences, University of London, London, UK), M anti-COX  IV (clone 
10G8-D12-C12, from J.-W. Taanman) (Taanman et al. 1993, 1996 and 1997), R anti-
malonyldialdehyde (kindly provided by Dr. Thomas Montine, Department of Pathology, Duke 
University Medical Center, Durham, NC, USA (Montine et al. 1996)). The secondary antibodies 
used were FITC-conjugated anti-rabbit (R) or anti-mouse (M) IgG antibodies (Jackson Laboratories, 
West Growe, PA, USA (I, V) or Zymed, San Francisco, CA, USA (III)). In addition, FITC-Triticum 
vulgaris-lectin (WGA; Vector Laboratories Inc.) and, to detect apoptosis (method described by 
Abrams et al. (1993)), acridine orange (Sigma Chemical Co., St. Louis, MO, USA) were used for 
histological stainings (I).  
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6. IN SITU HYBRIDIZATION (III, IV) 
 
6.1. Hybridization experiments 
Tissue sections 3-4 µm thick were cut from the froxen kidney samples on glass slides pretreated 
with 3'-triethoxysilylpropylamine (TESPA; Sigma Chemical Co.). Prehybridization and 
hybridization were performed according to Wilcox's (1993) procedure for frozen sections. 
Posthybridization washes were as follows: (1.) 5xSSC (salt sodium citrate; 1xSSC: 150 mM NaCl, 
15 mM NaCitrate) and 10 mM dithiothreitol (DTT; Calbiochem Corp.) for 30 min at 50°C, (2.) 50 
% formamide, 2xSSC, and 30 mM DTT for 30 min at 65°C, (3.-5.) 0,5 M NaCl, 10 mM Tris-HCl 
pH 8, and 5 mM EDTA (NTE) for 3x 10 min at 37°C, (6.) 20 mg/ml RNase A (Sigma Chemical 
Co.) in NTE for 30 min at 37°C, (7.) NTE for 15 min at 37°C, (8.) same as (2.), (9.) 2xSSC for 15 
min at 65°C, and (10.) 0,1xSSC for 15 min at 65°C. After dehydration with increasing 
concentrations of ethanol and air drying the sections were covered with NTB-2 photoemulsion 
(Eastman Kodak Co., Rochester, NY, USA), exposed at 4°C, developed by the protocol of Kodak 
and counterstained with hematoxylin (Shandon Inc., Pittsburgh, PA, USA). 
 
6.2. Preparation of probes 
III: VPF complementary RNA (cRNA) probes were synthesized from Hind III (antisense) or Eco RI 
(sense) restriction enzyme (Promega Corp., Madison, WI, USA) linearized pGem3Zf(+) plasmid 
containing nucleotides 57-638 of the VPF165 coding region (kindly provided by Dr. Daniel 
Connolly, Monsato Co., St. Louis, MO, USA; Leung et al. 1989),  using T7 and SP6 polymerases 
(Promega Corp.) and 35S-UTP (Amersham Corp., Amersham, UK) (Sambrook et al. 1989).  For 
VPF kinase-insert domain receptor KDR probes, the fragment covering base pairs 6-715 of KDR 
cloned into pBluescript KS (kindly provided by Dr. Bruce Terman, Lederle Laboratories, Pearl 
River, NY, USA; Terman et al. 1992) was linearized with Eco RI (antisense) or Hind III (sense) 
enzyme and transcripted correspondingly. IV: cRNA probes were synthesized from Sac I and Apa I 
(Promega Corp.) linearized PCR-clones (see "9. Differential display RT-PCR") and transcripted as 
described above. 
 
7. PREPARATION OF RNA 
 
Total glomerular RNA was extracted by guanidine isothiocyanate (Fluka BioChemica, Buchs, 
Switzerland) lysis and subsequent purification by CsCl-gradient (Serva Feinbiochemika, 
Heidelberg, Germany) centrifugation (Chirgwin et al. 1979), either from tissue samples of 300-500 
mg, from 50-100 µl of freshly isolated glomeruli, or from about 107 cells harvested from 
subconfluent cultures. If required, poly(A)+-RNA was prepared by oligo(dT) cellulose 
chromatography (Boehringer Mannheim Biochemica). Isolated RNA was then used for Northern 
blotting experiments, for differential display reverse transcription-polymerase chain reaction 
(DDRT-PCR) analysis or for semiquantitative RT-PCR. 
 
8. NORTHERN BLOTTING 
 
8.1. Hybridization 
30 µg of total-RNA or 3 µg of poly(A)+-RNA per lane were electrophoresed in 0,8-1 % agarose gels 
containing 2,2 M formaldehyde (Riedel de Haén, Seelze, Germany), and transferred to nylon 
membranes (Pall Biodyne, New York, NY, USA (II, III) or Hypond-N, Amersham Corp. (IV, V)) 
(Sambrook et al. 1989). Membranes were cross-linked according to manufacturers´ suggestions, and 
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prehybridized in 5x SSC (see ”in situ hybridization"), 50% formamide, 5x Denhardt's reagent, 0,1% 
sodium dodecyl sulphate (SDS), 50 mM Na-phosphate buffer pH 6,5 and 250 µg/ml salmon sperm 
DNA (all reagents from Sigma Chemical Co.) at 42°C. The probes were labelled with (α-32P)dCTP 
(>3000 Ci/mmol; Amersham Corp. (II, III) or DuPont NEN, Boston, MA, USA (IV, V) by random 
priming method (Cunningham et al. 1990) using Random Primer DNA Labelling Kit (Boehringer 
Mannheim Biochemica) and hybridized to blots in prehybridization solution for 16 h. 
Posthybridization washes varied from the low-stringency (1x SSC, 0,1% SDS at 42°C) to very high-
stringency (0,1x SSC, 0,1% SDS at 65°C) conditions depending on the probe used. To control the 
total RNA content and lack of degradation in the analyzed preparations, the blots were rehybridized 
with a human β-actin probe. For autoradiography, the filters were exposed on medical X-ray film 
(Fuji Photo Film Co., Japan) at -70°C with intensifying screens (II, III, IV) or on Fuji Bas IIIS 
Imaging Plates (V), and the expression was quantified using a phosphorimager and accompanying 
MacBAS software (Fuji Photo Film Co.). 
 
8.2. Probes used 
The cDNA probes used here were for (II): human WT-1 (clone WT-33; kindly provided by Dr. 
Melissa Little, Western General Hospital, Edingburgh, UK; Call et al. 1990), insulin like growth 
factor I (IGF-1, clone phigf1; ATCC; Bell et. al. 1984, Tricoli et al. 1984), IGF-2 (clone phigf2, 
ATCC; Bell et al. 1984, Dull et al. 1984), IGF binding protein 1 (IGFBP-1, clone PP12; kindly 
provided by Dr. Riitta Koistinen, Department of Obstetrics and Gynecology, University of Helsinki; 
Julkunen et al. 1988), tyrosine kinase trk-B (prepared by our own; see below) and MK genes (clone 
hMK-1; kindly provided by Dr. Takashi Muramatsu, University of Nagoya; Tsutsui et al. 1991), and 
for mouse WT-1 (clone pKS/2; kindly provided by Dr. Jane Armstrong, Western General Hospital, 
Edingburgh; Buckler et al. 1991), early growth response 1 (EGR-1, clone zif/268, ATCC; Christy et 
al. 1988) and paired box 2 (Pax-2, clone c31A; kindly provided by Dr. Greg Dressler, National 
Institutes of Health, Bethesda, MD, USA; Dressler et al. 1990) genes, and for rat HB-GAM gene 
(clone P18/6 kindly provided by Dr. Heikki Rauvala, Institute of Biotechnology, University of 
Helsinki; Merenmies & Rauvala 1990); (III): human VPF and its receptor KDR (both clones as in 
”in situ hybridization”); (V): COX I and COX II (mitochondrial DNA clone pCOX2 containing the 
complete gene for COX II and 714 bp of the gene for COX I; kindly provided by Dr. Jan-Willem 
Taanman, Department of Clinical Neurosciences, University of London), COX IV (clone pCOX4 
containing 682 bp COX IV cDNA fragment; kindly provided by Dr. M. Lomax, Department of 
Anatomy and Cell Biology, University of Michigan Medical School, Ann Arbor, MI, USA) and 
COX VIb  (clone pCOX6 containing a 450 bp COX IVb cDNA fragment; provided by J.-W. 
Taanman). 
 
8.3. Probe preparation for trk-B (II) 
First strand (anti-sense) cDNA was synthesized from 2 µg of total RNA from human kidney cortex 
using random hexanucleotide primers (Promega Corp.) and Moloney murine leukemia virus (M-
MLV) reverse transcriptase (Promega Corp.), as described by Kawasaki & Wang (1989). The 702 
bp fragment from the coding sequence of trk-b gene was amplified by PCR in a thermal cycler 
(PTC-100, MJ Research Inc., Watertown, MA, USA) using ampli-Taq DNA polymerase (Perkin 
Elmer Cetus, Norwalk, CT, USA) and 1mM synthetic oligonucleotide primers (Department of 
Biochemistry, University of Helsinki). The amplified DNA fragment was cloned and sequenced, 
and used for Northern hybridization.  
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9. DIFFERENTIAL DISPLAY RT-PCR (IV, V) 
 
9.1. cDNA synthesis 
Contaminating genomic DNA was removed from glomerular total RNA preparations with RNase-
free DNase I (Boehringer Mannheim Biochemica) incubation in a presence of human placental 
RNase inhibitor (Promega Corp.). After purification by phenol-chloroform extraction and ethanol 
precipitation, RNA samples were split into identical aliquots and reverse transcribed using 
"anchored" oligonucleotide primers (Anchor Kit Version 1, Operon Technologies Inc., Alameda, 
CA, USA or GenHunter, Boston, MA, USA) following manufacturers´ instructions. All reactions 
were done in duplicate. 
 
9.2. PCR amplification 
PCR reactions were performed as previously described (Liang & Pardee 1992, Bauer et al. 1993) 
with some minor modifications using anchored cDNA-products, PCR-buffer, dNTPs, specific 
random decamer oligonucleotides (OP-DDRT 26x10-mer Primer Set, Operon Technologies Inc. or 
GenHunter), anchored primers (as above), 35S-dATP (Amersham Corp.) and ampli-Taq DNA 
polymerase (Perkin Elmer Cetus). The amplification conditions consisted of initial denaturation at 
94°C for 3 min followed by 40 cycles of amplification with denaturation at 94°C for 30 sec, 
annealing at 40°C for 2 min, extension at 72°C for 30 sec, and a final extension at 72°C for 15 min. 
The PCR products were then denatured at 80°C for 5 min in the presence of formamide loading 
buffer, and separeted side by side on a 6 % denaturing polyacrylamide gel. After electrophoresis 
gels were dried and exposed to a medical X-ray film (Fuji Photo Film Co.) for 2-4 days. 
 
9.3. Cloning 
Reproducibly differentially expressed bands were excised from the dried polyacrylamide gels, 
extracted and re-amplified using the same primers and conditions as for the initial PCR. Products 
were run on 2 % agarose gel, purified with Micropure Separators (Amicon Inc., Beverly, MA, USA) 
and subcloned using the TA-cloning system (Promega Corp. or Invitrogen, San Diego, CA, USA; 
Sambrook 1989). For each PCR product, 3-8 colonies from a single transformation were prepared 
(Kretzler et al. 1996) for sequencing. Sequencing was done with T7 and SP6 primers (Promega 
Corp.) by the modified dideoxy chain termination method (Hsiao 1991) using DNA Sequencing Kit 
(version 2.0; USB, Cleveland, OH, USA) and (α-35S)dATP (>1000 Ci/mmol; Amersham Corp.) or 
by automated DNA sequencer (ABIPrism model version 2.1.1, Perkin Elmer Cetus). Sequences 
were screened for homologies with database sequences using the BLAST search algorithm via 
Internet at the National Center for Biotechnology (Washington D.C., USA). Reconfirmations of 
differential expression of the candidate DDRT-PCR clones were done by Northern blotting analysis. 
 
10. SEMIQUANTITATIVE RT-PCR (V)  
 
Sequence-specific oligonucleotide primers were designed and produced (in Department of 
Biochemistry, University of Helsinki) for mitochondrially encoded COX I and cytochrome b as well 
as for nuclearly encoded COX VIIa. Semiquantitation of their expression was done from glomerular 
total RNA fractions as described by Kretzler et al. (1996), basing on the serial dilutions of control 
plasmid DNA and sample cDNAs in the linear range of amplification and on the amount of house-
keeping (β-actin) amplification product.  
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11. BLUE NATIVE GEL ELECTROPHORESIS  (V) 
 
The steady-state levels of the mitochondrial respiratory complexes I to V were analyzed from 
kidney tissues of CNF patients (n=3) and control humans (n=3). 10 mg of each kidney sample was 
solubilized and separated in the native state by blue native polyacrylamide gel electrophoresis (BN-
PAGE) and then processed by SDS-PAGE in a second dimension, and quantified by densitometry 
as described previously (Schägger & von Jagov 1991, Schägger 1995). The staining intensities of 
individual complexes were normalized to the intensity of complex III. 
 
12. ELECTRON MICROSCOPY (V) 
 
Electron microscopy studies were done as previously described  by Neale et al. (1994) and Shirato 
et al. (1996). 
 
13. STATISTICS (V) 
  
For mitochondrial quantitations, statistics were performed with unpaired two-tailed t-tests. P-values 
less than 0.05 were considered significant. Data were obtained by direct counting from the electron 
micrographs at 4500x magnification. Multiple sections were analyzed from each sample.  
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RESULTS AND DISCUSSION 
 
 
1. MORPHOLOGY AND HISTOLOGY OF CNF KIDNEYS (I) 
 
1.1. Renal tubules and interstitium 
 
At macroscopic examination, kidneys of patients with congenital nephrotic syndrome of the Finnish 
type (CNF) regularly revealed a decreased cortical thickness to an average of only 3-6 mm. Areas of 
poor demarcation between the cortical and medullary compartments were found and sometimes the 
cortical tissue appeared to ectopically extend to the medullar region. In early studies, Tryggvason 
and Kouvalainen (1975) have described CNF kidney cortex as thick and medullary tissue as scanty. 
These partly incompatible findings may be explained by the poor demarcation of areas and also by 
morphological variability between patients. In histological analyses, we found normal appearing 
tubular profiles with morphologically distinguishable epithelial cells of the proximal tubules (cells 
with distinct brush border), loops of Henle (smaller caliber tubular profiles with more flat 
epithelium), distal tubules (number of tubular profiles within cortex, no brush border) and collecting 
ducts (heterogeneity in epithelial cell size and morphology, bifurcation of ducts). However, 
characteristic areas of tubular dilatations as described for CNF also earlier (Hallman et al. 1967) 
were seen. In all CNF kidneys studied some tubules were focally surrounded by areas of poorly 
organized cells. When studied by immunohistochemistry, these areas were faintly positive for anti-
fibronectin, anti-stem cell factor (SCF) and anti-cytokeratin antibodies, whereas no laminin-specific 
staining could be detected. Staining for human lymphocytes and monocyte/macrophages colocalized 
only partially with these areas, and only occasional cells staining with the anti-Bcl-2 (anti-apoptotic 
factor) and anti-proliferating cell nuclear antigen (PCNA) antibodies or cells with acridine orange 
reactive compacted nuclei (typical for apoptosis) were found. These results indicate no aberrations 
in the apoptotic (Bcl-2, acridine orange) or cell proliferation (PCNA) pathways, the mechanisms 
normally controlling the ultimate cell number of the mature kidney (Herzlinger et al. 1992). 
However, these peritubular areas expressing markers of early differentiation (fibronectin, stem cell 
factor, cytokeratin) suggest retarded differentiation in CNF kidneys in this compartment.  
 
1.2. Glomeruli 
 
The arrangement of CNF glomeruli in most samples studied differed characteristically from that of 
the control kidneys: densely clustered glomeruli separated by narrow Bowman's capsules were often 
seen especially at the corticomedullary demarcation zone resulting in an abnormally high density of 
glomeruli in these areas. This observation is in agreement with the early results of Tryggvason & 
Kouvalainen (1975), who reported an increase in the total number of glomeruli in CNF kidneys. The 
finding of clustered glomeruli with abnormally high numbers may suggest a failure in the 
coordinated mesenchymo-epithelial interaction during nephrogenesis in CNF. Furthermore, we 
could occasionally find large glomeruli suggesting fusion of two to three individual glomeruli. 
These "fused" glomeruli were typically surrounded by a continuous Bowman's capsule, as 
demonstrated by laminin staining. The cellular composition within these glomeruli appeared 
balanced, with no prominence of podocyte, mesangial or endothelial elements, based on the 
morphology and reactivity for podocyte specific Wilms´ tumor protein (WT-1) antibodies and wheat 
germ agglutinin (WGA) lectin. No signs of continued cell proliferation (anti-PCNA staining) nor 
cells with aberrations in the apoptotic pathway (anti-Bcl-2 and acridine orange stainings) could 
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be seen within the CNF samples as compared to control kidneys. In addition, the functionally 
important anionic charge seemed to appear normally within the epithelial cells and glomerular 
basement membranes of the "fused" CNF glomeruli both in intensity and distribution as shown by 
WGA lectin staining.  
 
The possibility that abnormal early developmental events may lead to a distinct functional 
abnormality of glomeruli is intriguing and supported by the findings in studies with mice. The early 
developmental gene Pax-2 deregulation in mice results in proteinuria and morphologic changes 
closely resembling those in congenital nephrotic syndrome (Dressler et al. 1993). Mice deficient for 
laminin B2 gene, encoding the mature type of laminin β chain of GBM, similarly produce a 
phenotype closely resembling that of human congenital nephroses (Noakes et al. 1995). In early 
studies with CNF, (Tryggvason & Kouvalainen 1975), some CNF glomeruli were found to be 
immature, but also opposite findings exist (Huttunen et al.1980).  Sharif et al. (1998) have shown 
changes in glomerular epithelial protein 1 (GLEPP1) expression in CNF and considered that as a 
consequence of failure to complete normal podocyte development. They also stated a 
dedifferentiation hypothesis for the nephrotic syndrome. In addition, there is evidence that e.g. in 
the postischemia model of tubular injury and in animal models of liver injury, reverse differentiation 
or dedifferentiation may take place (Safirstein 1994, Sell & Pierce 1994). Furthermore, Holthöfer et 
al. (1992, 1994) have earlier shown that the cell type specific glomerular ganglioside, O-acetyl GD3, 
found only transiently during early stages of glomerulogenesis remain atypically expressed in the 
CNF kidney glomeruli. Our findings of morphologic abnormalities in CNF kidneys and glomeruli, 
and the local areas showing lack of appropriate differentiation suggest the possibility of 
developmental failure or arrest in CNF kidneys. However, the markers used here did not appear 
optimal to characterize the functional disturbance of CNF kidneys and the resulting proteinuria, 
which could be consequences of such a proposed developmental arrest. 
 
 
2. DEVELOPMENTAL STAGE SPECIFIC GENE EXPRESSION IN CNF KIDNEYS (II) 
 
Several genes transiently expressed during the maturation of the metanephrogenic mesenchyme 
have been reported in recent years. On the basis of our histological results introduced above, as well 
as suggestions of other investigators (Tryggvason & Kouvalainen 1975, Dressler et al. 1993, Kestilä 
et al. 1994c, Sharif et al. 1998), it is possible, that the CNF kidneys never reach the stage with 
normally functioning glomeruli. If so, one would expect to see a developmental arrest with the 
expression of genes transiently expressed during normal kidney maturation. We studied the 
expression of nine such candidate marker genes, including transcription factors, growth factors and 
other signalling molecules associated with renal maturation, by Northern blotting analysis. We 
compared the expression pattern in CNF kidneys, in renal Wilms' tumor tissue and in normal human 
kidneys of various ages. Subsequently, we studied cultured glomerular cells for the corresponding 
expression pattern.  
 
2.1. Kidney tissue samples 
 
WT-1 and paired box gene Pax-2 are transcription factors expressed early during nephrogenesis. In 
this study, Pax-2 and WT-1 gene expressions were preferentially found in fetal kidney (gestational 
age of 16 weeks) and in Wilms' tumor tissue, as expected. The CNF kidneys resembled the normal 
adult and child kidney cortex in maintaining a low, basal level expression of these mRNAs. Thus, 
both Pax-2 and WT-1 revealed considerable changes in expression levels between different  
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developmental and functional stages of the kidney, but we could not find specific changes in their 
expression levels in CNF. Direct association of Pax-2 defects to proteinuria has been suggested by 
Dressler et al. (1993) who demonstrated that deregulated Pax-2 expression in transgenic mice 
results in histologically abnormal and dysfunctional renal epithelium with properties similar to 
congenital nephrotic syndrome: multifocal microcystic tubular dilation, paucity of podocyte foot 
processes and proteinuria. However, Kestilä et al. (1994c) have previously excluded a defect in the 
Pax-2 gene locus in CNF kidneys. Kreidberg et al. (1993) have shown that in WT-1 knockout mice 
the inductive events that lead to formation of metanephric kidney are seriously affected. During 
normal kidney maturation WT-1 activation turns off the expression of molecules involved in 
embryonal cell proliferation and turns on genes whose expression is required for terminal 
differentiation. The third transcription factor analyzed here was the early growth response gene 
EGR-1, a ubiquitous transcriptional activator. The expression pattern of EGR-1 did not show any 
considerable developmental stage-specific regulation at the transcriptional level, but a basal level 
expression was seen in every sample. In the metanephric kidney EGR-1 is normally upregulated as 
mesenchymal cells receive a mitogenic signal, but as differentiation proceeds and e.g. WT-1 levels 
rise, mitogenic molecules icluding EGR-1 are downregulated (Sukhatme 1992).  
   
Insulin like growth factor IGF-2 was found to be heavily expressed in fetal kidney and in embryonal 
Wilms' tumor tissue as well, but it was totally downregulated and not detectable in postnatal kidney 
samples, not in CNF nor in control kidneys. The expression of IGF-2 mRNA in fetal kidneys has 
been shown to be largely confined to the stromal and blastemal cells providing a stimulus for the 
growth and differentiation of epithelial structures. Thus, the continuous expression of IGF-2 in 
Wilms' tumor proposedly reflects a failure of complete differentiation of the tumor cells (Hirvonen 
et al. 1989). The expression of IGF-1 only in renal cortex of the 12 year-old child, but not in any 
other tissue sample tested, reflects most likely the growth hormone induced expression of IGF-1, as 
reported earlier (Murphy et al. 1987). IGF binding protein IGFBP-1 mRNA was detected in control 
adult and CNF samples only after prolonged exposure of poly(A)+RNA fractions indicating very 
low but comparable expression levels. 
   
Neural elements including neurons, neurotrophic factors and their receptors seem to be crucially 
involved in the induction and development of the nephrogenic mesenchyme (Sariola et al. 1991). 
The high affinity neurotrophin receptor trk-B has previously been found to be differentially 
expressed during renal development with a highly restricted expression pattern in the cortical 
mesenchyme cells that will differentiate into stroma (Durbeej et al. 1993). In this study, however, 
trk-B showed a low, but equal level of expression in every kidney sample tested without any 
considerable maturation stage specific regulation. In addition, heparin binding growth and 
differentiation associated molecule HB-GAM appeared to be expressed at a constant level in all 
kidney samples, reducing its usefulness as a marker for kidney maturation level. The midkine 
(midgestation and kidney) MK mRNA was readily detected in the 5-year-old child and CNF 
kidneys, and at a much elevated level in the fetal kidney tissue. This is well in agreement with the 
results with mouse kidney showing the highest expression during the fetal life and to be still 
expressed after birth (Kadomatsu et al. 1990, Nakamoto et al. 1992). Taken together these results, 
on the basis of the gene expression profiles studied we could not find any conclusive evidence of 
developmental abnormality in the CNF kidneys. 
 
Recent identification of nephrin as a first and key component of the podocyte filtration slit has 
opened new possibilities for studying the development of the glomerular filtration barrier. 
According to Ruotsalainen et al. (2000), nephrin is first expressed in late S-shaped bodies during  
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human glomerulogenesis. Nephrin localizes in the ladder-like structures between differentiating 
podocytes before the formation of foot processes and mature slit diaphragms. They also found that 
the slit diaphragms were completely missing in CNF kidneys lacking the nephrin molecule 
(Patrakka et al. 2000, Ruotsalainen et al. 2000). In addition, the results of nephrin knock-out mice 
showed early lethality within 24 hours after birth due to nephrotic syndrome and the histological 
findings of dilated renal tubules, foot process effacement and mesangial hypercellularity were very 
similar to those observed in CNF patients (Putaala et al. 2001). These results favor the idea that 
nephrin is essential for the normal maturation of podocytes and formation of the slit diaphragm and 
its disorder is causative for the massive proteinuria in CNF. However, other functional properties of 
nephrin e.g. in podocyte signaling, as well as its potential role in other morphological changes 
observed in CNF kidneys (e.g. increased number of glomeruli, abnormal glomerular morphology) 
and in renal pathology in general remain to be determined.  
 
2.2. Cultured glomerular cells 
 
Glomerular cell culture allows a specific approach to study the role of individual glomerular cell 
types in renal physiology and pathology. Also, several inflammatory, metabolic and genetic diseases 
that affect the kidney have been studied using culture of kidney glomeruli (Oberley et al. 1981, 
Lovett & Sterzel 1986, Floege et al. 1992). However, when working with cells isolated from 
glomeruli and when attempting to extrapolate to the in vivo situation, several issues need to be 
addressed, including morphological characteristics, expression profiles, synthetic activities and 
response patterns of the cultured cells compared to those observed in vivo (Floege et al. 1994). 
There are many reports on glomerular cell morphology and cell-type specific gene expressions in 
glomerular cultures (e.g. Striker & Striker 1985, Dekan et al. 1990, Holthöfer et al. 1990 and 1991, 
Miettinen et al. 1990). Many of these cell-type specific markers were also tested by us when 
establishing cell cultures from CNF glomeruli (see Material and methods: "4. Cell cultures"). To 
further characterize these cultured glomerular cells and to explore their usefulness in CNF studies 
we tested the cells for the same developmental expression pattern as for kidney tissues.  
 
Cultured cells from the adult and CNF kidney glomeruli expressed Pax-2 mRNA, but the message 
was not seen in cultured fetal kidney cells or in the fetal kidney cell line A293. Thus, there seemed 
to be distinct difference in Pax-2 expression between tissues and cultured cells, as tissues that can 
be considered less mature (fetal kidney and Wilms' tumor) readily expressed Pax-2, whereas the 
cultured cells from fetal kidney failed to do so. Instead, the expression of WT-1 and EGR-1 
transcripts appeared somewhat elevated in the fetal cells compared to other cultured cells.  
 
In cell cultures both adult and CNF glomerular cells produced IGF-1, IGF-2 and IGFBP-1 
transcripts as comparable levels, but in fetal kidney cells no expression was observed. For IGF-2 
signal, only the 6.0 kb mRNA was seen in cultured cells even in isolated poly(A)+ fractions, in 
contrast to three approximately 6.0 kb, 4.9 kb and 1.9 kb transcripts detected in tissue samples. This 
may be due to differencies in splicing of the precursor RNA in different cell types. In addition, all 
cultured kidney cells tested expressed MK and HB-GAM. With MK, fetal kidney cell line A293 
showed the strongest expression. Cultured cells did not show any trk-B expression. 
 
The information obtained here from glomerular cell cultures appeared very restricted. The results 
showed remarkable inconsistency between respective tissue samples and cultured cells thereof e.g. 
for Pax-2, MK and IGFs expressions. In vitro culture conditions may themselves lead to the 
changed expression pattern, because of the uncoupling of cultured cells from local factors regulating  
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the normal cell proliferation and gene expression in intact tissue. Alternatively, the cells may in fact 
represent cells clonally selected in culture due to some secondary properties irrelevant to their 
differentiation stage. 
 
 
3. VASCULAR PERMEABILITY FACTOR IN CNF KIDNEYS (III) 
 
Vascular permeability factor (VPF), or vascular endothelial growth factor (VEGF), is a potent 
microvascular permeability-enhancing mediator and a selective mitogen for vascular endothelium. 
In the kidney, it is expressed preferentially in the glomerular visceral epithelial cells, the podocytes. 
It has been speculated that injury to podocytes may lead changes in VPF synthesis or secretion and 
to abnormal glomerular permeability (Brown et al. 1992a, Shulman et al. 1996). Thus, VPF has 
been among the candidate molecules proposed to be involved in the pathogenesis of proteinuria. We 
considered it highly interesting and informative to clarify the proposed role of VPF in increased 
glomerular permeability in CNF. For that, we studied normal human, fetal and CNF kidney tissues 
and the corresbonding cultured glomerular cells for VPF and its receptor expression.  
 
In Northern blotting analysis, an abundant expression of VPF mRNA was observed in all kidney 
tissues and in cultured kidney cells studied. Fetal kidney seemed to express the highest level of VPF 
mRNA. The major VPF transcript was detected at the ~3,8 kb, but additional faint bands of 
approximately 1,9 kb, 4,5 kb and 6,5 kb were seen on longer exposures with polyA+-RNA samples. 
In in situ hybridization experiments glomeruli labeled strongly for VPF mRNA in a fashion 
suggesting labeling of podocytes, in accordance with previous reports (Brown et al. 1992a). No 
significant differences were observed in the amount or localization of VPF mRNA between normal 
and CNF kidney samples. Rare tubular profiles, identified as collecting ducts based on their 
morphology, were also labeled. Immunohistochemical staining confirmed collecting duct and the 
visceral epithelial localization of VPF in the normal and CNF kidneys. In some sections intense 
juxtaglomerular staining of the protein product could also be seen. In fetal kidney, both the 
epithelium of the invading ureter and collecting duct as well as the developing glomeruli showed 
VPF protein expression. 
 
The expression of the VPF kinase-insert domain receptor KDR was also studied. The KDR probe 
detected a single mRNA of 7,0 kb in Northern blots. The most abundant KDR expression was seen 
in the samples of normal adult and CNF kidneys and a slightly weaker expression in fetal kidney. 
Cultured kidney cells showed no KDR-specific signal. In situ hybridization revealed a distinct 
pattern of KDR expression centrally in the glomerular tuft resembling the pattern of glomerular 
endothelial reactivity. No KDR-specific signal was seen in the peritubular capillaries. The KDR 
labeling pattern in the CNF kidneys was comparable to that of the normal kidney. Thus, these 
findings failed to show any significant differences in the expression of VPF or KDR in CNF 
kidneys. Other pathogenetic mechanisms involving VPF or members of the growing VPF receptor 
family cannot, however, be excluded. 
 
In contrast to its transient expression reported in many fetal tissues during development and 
maturation VPF expression persists in adult kidney, but is reduced into the glomerular visceral 
epithelium. Interestingly, a constitutive VPF expression has also been reported in the epithelium of 
the choroid plexus, where the endothelium is similarly highly fenestrated and involved in filtration 
of the cerebrospinal fluid (Breier et al. 1992). These findings suggest that VPF may be important for 
the differentiation and maintenance of organotypic endothelial cells with specific filtration  
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functions. The action of VPF (as VEGF) in inducing endothelial proliferation may not be its 
function in glomeruli, since proliferation of glomerular endothelial cells is not usually seen in adult 
kidney. Our observation of VPF expression in a previously unrecognized site, i.e. the 
juxtaglomerular area of the nephron, is interesting, but a role for VPF in juxtaglomerular regulation 
of fluid homeostasis is only speculative. 
 
 
4. NEW CANDIDATE GENES FOR THE PATHOGENESIS OF CNF AND PROTEINURIA 
(IV, V) 
 
4.1. Differential display analysis 
 
The changes in glomerular gene expression in CNF were studied by a newly developed method 
called mRNA differential display or differential display RT-PCR (DDRT-PCR, Liang & Pardee 
1992). DDRT-PCR analysis combines both the power of PCR amplification and the high resolution 
of denaturing polyacrylamide gel electrophoresis. The basic principle is to reverse transcribe and 
systematically amplify the 3' termini of mRNAs with a set of anchored oligo(dT) primers and 
arbitrary decamers. By changing primer combinations, most of the RNA species in a tissue can be 
represented. Side-by-side comparison of radioactively labeled PCR products from different RNA 
samples in a polyacrylamide gel allows the identification of differentially expressed genes. 
Corresponding DNA fragments are then recovered, cloned, sequenced, and used as probes for 
hybridization and library screening experiments. Since its presentation, many modifications and 
improvements to the original technique have been reported (e.g. Bauer et al. 1993, Liang et al. 1993 
and 1994, Callard et al. 1994, Hadman et al. 1994, Li et al. 1994, Mou et al. 1994, Sompayrac et al. 
1995, Zhao et al. 1995, Vogeli-Lange et al. 1996). The major advantages to other, more classical 
comparative gene expression screen methods, like subtractive or differential hybridization 
techniques, are its speed and sensitivity. In addition, only a modest amount of starting material is 
required making the study with also rare human material possible. 
 
DDRT-PCR technique has been successfully applied in studies on mouse renal organogenesis 
(Kretzler et al. 1996), human liver carcinoma (Begum et al. 1995), hyperglycemia and diabetes 
(Aiello et al. 1994, Nishio et al. 1994 and 1995), mouse preimplantation development 
(Zimmermann & Schultz 1994), graft vasculopathy (Chen et al. 1996), TGF-β (Subramaniam et al. 
1995) and fibroblast growth factor-1 (Hsu et al. 1993, Donohue et al. 1994) regulated gene 
expression, metastatic capacity of human melanoma cells (van Groningen et al. 1995), nerve injury 
(Kiryu et al. 1995), pathogenesis of myelodysplastic syndrome (Kroef et al. 1996), and stomach 
cancer (Salesiotis et al. 1995) among many other studies. Since all the evidence suggests that the 
pathology of the CNF defect is restricted to the kidney glomeruli, we considered the application of 
DDRT-PCR to isolated glomeruli as an effective possibility to identify the proteinuria-associated 
genes in CNF. 
 
In applying this method to screening of glomerular genes as presented here, the only assumption is 
that the selected genes are differentially expressed in glomeruli of CNF kidneys compared with 
normal glomeruli. Thus, the method enables not only the diagnosis of changes in gene expression 
pattern involved in the pathogenesis of CNF and proteinuria but also the characterization of novel 
glomerular genes. By using isolated glomeruli from CNF patients and normal human donors and 58 
different primer pair combinations a total of approximately 3800 reproducibly displayed 
amplification products were identified. Of these, 37 PCR products showed systematic differences  
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between CNF and control glomeruli: 8 (22%) were either only seen in CNF or greatly increased in 
intensity, 11 (30%) showed moderate increase in CNF, whereas 12 and 6 (32% and 16%, 
respectively) of the bands showed moderate or greatly reduced intensity in CNF. We succeeded in 
cloning 27 of the differentially expressed PCR fragments, sizes between 100-600 bp, but more than 
half of these were undetectable by Northern analysis, probably because of low expression level or 
presence of contaminating sequences, or gave several mRNA signals indicating unspecificity of the 
probe. Finally, 12 PCR products showing distinct changes in expression levels were chosen for 
further characterization including reconfirmation of expression differences, sequencing and 
screening of genetic databases for homologies. 
 
4.2. Identification of new candidate genes 
 
Sequence comparisons and databank searches for the differentially expressed PCR products from 
CNF glomeruli could reveal some genes not previously associated to proteinuria. Most prominently, 
one of the products showed a 98 % similarity with mitochondrially encoded cytochrome-c oxidase 
subunit I (COX I), a gene centrally involved in the oxidative phosphorylation and cellular energy 
metabolism (Suomalainen 1997). The other homologies identified included the genes for integrin-
linked kinase (ILK), eotaxin and insulin-like growth factor 2 receptor (IGF-2R) and also fragments 
resembling anchyrin and cadherin adhesion molecule family like consensus sequences. All these 
molecules are of interest in respect to glomerular filtration function.  
 
The finding of ILK-like gene as one of the differentially expressed genes in CNF glomeruli is 
intriguing. Integrins are expressed in podocyte foot processes regulating their firm attachment to the 
underlying glomerular basement membrane (Adler 1992). The classic morphologic sign of 
proteinuria is fusion and retraction of the podocyte foot processes. Thus, recognition of a novel 
signalling molecule involved in cytoskeleton-cell matrix interaction as downregulated in CNF 
glomeruli is interesting, and should be studied further. Recently, the role of ILK in regulating 
podocyte phenotype and permeability changes has been demonstrated by Kretzler et al. (2001). 
IGF-2R gene (also known as mannose-6-phosphate receptor) encodes a receptor which targets IGF-
2 to the lysosomes for degradation (Zhang et al. 1997) and, therefore, inhibits the mitogenic 
function of IGF-2. In kidney, changes in the expression of IGF-2 and IGF-2R are associated with 
many pathological situations including Wilms' tumor and clear cell sarcoma (Reeve et al. 1985, Yun 
1993). Overexpression of a receptor for IGF-2 in CNF kidneys might indicate defective regulation 
of kidney growth and development. This would be well in line with our results of abnormal 
glomerular morphology in CNF (I). The finding of overexpressed PCR product with marked 
homology to eotaxin could also be functionally appropriate in proteinuria. Eotaxin is among 
recently identified chemokines important in attracting eosinophils to tissues (Hein et al. 1997). 
Among many other tissues, kidney shows significant constitutive eotaxin expression (Hein et al. 
1997). Upon activation eosinophils release histamine with its known effects in cellular permeability. 
Our earlier results have also shown the markedly increased levels of histamine as measured both 
immunohistochemically and by mass spectrometry in CNF cortical kidney (Holthöfer et al. 
unpublished data), but the meaning of this finding has remained unclear.  
  
Among the other DDRT-PCR identified expression differencies we also found clones showing 
limited homologies to cadherin and anchyrin molecules. The cadherin superfamily is a large and 
diverse group of calcium-dependent, membrane associated glycoproteins, which play a prominent 
role in the mediation of intercellular interactions, cell recognition and adhesion. Kidney-specific 
cadherins have been implicated in tissue morphogenesis and cell polarization during development  
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(Xiang et al. 1994, Thompson et al. 1995). If any of our clones represents new family members of 
the extensive cadherin and anchyrin superfamilies remains to be explored until the corresponding 
full length cDNAs have been cloned and characterized. 
 
The observation that one of the DDRT-PCR products (clone CNF B36) showed 98% similarity over 
363 bp to the mRNA of mitochondrial cytochrome-c oxidase subunit I (COX I) is striking. In 
Northern blotting analysis with this clone, a mRNA of the expected size for COX I could be 
detected and the intensity of the signal was 70% lower in CNF than in controls. The decreased 
expression of COX I in CNF kidneys has since been verified with several independent methods, as 
described below, indicating defects in energy metabolism of CNF glomeruli.  
 
 
5. CHARACTERIZATION OF MITOCHONDRIAL INVOLVEMENT IN CNF KIDNEYS 
(V)  
 
5.1. Normal and abnormal mitochondrial function 
 
Mitochondria are the cytoplasmic organelles responsible for cellular energy production. The basis 
for energy production is oxidative phosphorylation system, an enzymatic cascade located in the 
inner mitochondrial membrane (Singh et al. 1996). Functionally the oxidative phosphorylation 
system consists of five distinct multimeric protein assemblies: (1) NADH-dehydrogenase (complex 
I), (2) succinate dehydrogenase (complex II), (3) cytochrome b-c1 (complex III), (4) cytochrome-c 
oxidase (complex IV), and (5) ATP synthase (complex V) (Hatefi 1985). The first four complexes, 
with ubiquinone and cytochrome-c, comprise the mitochondrial respiratory chain, also called the 
electron transport chain (Figure 7). The operation of the respiratory chain is characterized by two 
distinct, but linked processes, electron transport and proton pumping. Because of the resulting 
gradient, the protons flow back from the intermembrane space to the mitochondrial matrix through 
complex V, ATP synthase, and the released energy is captured in the form of ATP (Hatefi 1985). 
 
The majority of mitochondrial proteins are nuclear encoded and imported into the mitochondria 
from the cytoplasm. In addition, mitochondria possess their own unique genome, which 
demonstrates maternal inheritance in humans carried by the ovum, because the sperm mitochondria 
do not survive after fertilization. Human mitochondria usually contain from two to ten copies of 
mitochondrial genome (mtDNA). MtDNA is a double-stranded circular molecule which contains 16 
569 base pair (Figure 8). It is a compact piece of genetic information with little intervening, non-
coding sequences with the exception of its short regulatory region termed displacement- or D-loop. 
MtDNA encodes two ribosomal RNAs (12S and 16S rRNAs), 22 transfer RNAs (tRNAs) and 13 
messenger RNAs (mRNAs). The protein coding mRNAs are transcripted and translated in the 
mitochondria using the mitochondrial rRNAs and tRNAs, independently of nuclear DNA (Clayton 
1992, Johns 1995). These mitochondrially encoded polypeptides are all components of the oxidative 
phosphorylation system. MtDNA has a high mutation rate, about ten times that of nuclear DNA, 
probably because the mtDNA polymerase lack the proofreading ability and because there are no 
histone proteins protecting the mitochondrial genome. Moreover, the high oxygen consumption in 
mitochondria produces toxic reactive oxygen species (ROS), which may result in DNA damage 
(Singh et al. 1996). 
 
Mitochondrial diseases are a diverse group of disorders that result from the structural, biochemical, 
or genetic derangement of mitochondria. The molecular defects that underlie these disorders may  
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arise from mutations of either the mitochondrial or the nuclear genomes or both. The variable tissue 
involvement observed in many patients is generally ascribed to the tissue-specific differencies in 
their dependence on energy production and the degree of heteroplasmy (Taanman et al. 1997). 
Heteroplasmy is a condition, where both normal and mutant mtDNA coexist within the same cell. 
The proportion of mutant mtDNA required for the occurrence of a deleterious phenotype and 
clinical symptoms, known as the threshold effect, varies among persons, among organs systems, and 
within a given tissue. The threshold effect depends on the delicate balance between oxidative supply 
and demand (Johns 1995). Furthermore, tissues with a high mitotic index are able to select against 
heteroplasmic cells, whereas in tissues with little mitotic activity the ratio of mutant to normal 
mitochondria rather increases (Larsson et al. 1990).  
 
 
 
 
 
Figure 7. Mitochondrial respiratory chain and ATP-synthase. Complexes I-IV form the electron transfer chain: first, 
NADH is oxidized by complex I and succinate by complex II, followed by electron transfer to ubiquinone, and then 
further to complex III, to cytochrome-c, to complex IV and to the final electron acceptor, oxygen. The electron transport 
is coupled to proton pumping from the matrix to the intermembrane space, producing an electrochemical gradient. The 
gradient is used by complex V to make ATP. C I-V = complexes I-V, Q = ubiquinone, cyt = cytochrome. Direction of 
electron (e-) and proton (H+) flow is indicated by arrows. 
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Figure 8. Mitochondrial DNA. The duoble-stranded circular mitochondrial genome consists of an outer H-strand 
(heavy) and an inner L-strand (light). MtDNA encodes two rRNAs (12S, 16S) and 22 tRNAs (black areas) for its own 
protein synthesis, and 13 mRNAs for protein subunits of the respiratory chain complexes: ND1-6 for complex I, Cyt b 
for complex III, COX I-III for complex IV, and A6 and A8 for complex V. D-loop, displacement loop; OH and OL, 
replication origins of H- and L-strands; HSP and LSP, promoters for transcription from H- and L-template strands. 
 
 
 
In adult patients, abnormalities of oxidative phosphorylation are often associated with 
rearrangements or point mutations affecting a subpopulation of mitochondrial genomes, i.e. these 
mutations are usually heteroplasmic (Schon et al. 1994, Taanman et al. 1997). An important cause 
of mitochondrial dysfunction in neonates and infants is a depletion of mtDNA (Moraes et al. 1991, 
Taanman et al. 1997). These patients present soon after birth with muscle weakness, hepatic failure 
or renal tubulopathy associated with defective oxidative phosphorylation and a severe depletion of 
mtDNA (88-99 %) in affected tissues. The infants usually die before 9 months of age. Patients often 
show a deficiency of complex IV (COX) and other enzyme complexes containing mtDNA encoded 
subunits (Moraes et al. 1991, Taanman et al. 1997). The molecular defect responsible for mtDNA 
depletion syndrome has not yet been identified. Although the basic mechanism of mtDNA 
replication has been elucidated, knowledge of the regulatory factors is still limited and only a few 
protein factors have been purified. Furthermore, knowledge concerning maintenance of mtDNA in 
the cell is scarce, making it difficult to suggest candidate genes that could be defective. Autosomal 
recessive inheritance of mtDNA depletion syndrome suggests a mutation in nuclear DNA as the 
primary cause of the defect (Moraes et al. 1991). In the study by Bodnar et al. (1993), mtDNA levels 
could be restored by complementation with nuclear DNA from a control cell line, providing further 
evidence for the involvement of nuclear-encoded controlling factor. Taanman et al. (1997) have 
speculated that the replication is arrested due to the nuclear-encoded factor, which is tissue- 
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specifically and developmentally regulated reflecting tissue-specific and neonatal expression of 
symptoms. This factor could be involved in the fine tuning of mtDNA levels to the demands of the 
cell and tissue. 
 
Mitochondrial diseases often show changes in the kidney as a part of multiorgan involvement, more 
frequently in children (Szabolcs et al. 1994, Hsieh et al. 1996, Singh et al. 1996, van Biervliet et al. 
1977, Jansen et al. 1997, Niaudet & Rötig 1997). The most frequent renal manifestations are 
proximal tubular damage, glomerular disease with nephrotic syndrome and tubulointerstitial 
nephropathy. Renal filtration is highly dependent on mitochondrial energy production (Singh et al. 
1996) and the kidney shows strong COX activity in histochemical staining earlier than most other 
tissues at the second trimester of pregnancy (Moggio et al. 1989), coinciding with the onset of 
glomerular filtration. It is noteworthy, that the vicinity of the nephrin gene NPHS1 locus in the long 
arm of chromosome 19 contains some genes involved in energy metabolism or mitochondrial 
function, including genes for COX VIb (Taanman et al. 1991), ATPase ATP4A (Song et al. 1992), 
and phospholipid hydroperoxide glutathione peroxidase (PHGPx) (Kelner & Montoya 1998). In this 
respect, it is interesting that Männikkö et al. (1995) have reported an apparent mitochondrial disease 
in one of their CNF families. Whether this genomic region, or the nephrin in general, has any 
connections to our mitochondrial findings remains to be studied. 
 
5.2. Cytochrome-c oxidase subunit (COX) gene expression  
 
Cytochrome-c oxidase (COX) is the terminal enzyme in the respiratory chain. The mammalian 
enzyme is composed of 13 subunits (Capaldi et al. 1995). The three largest subunits (I, II, and III) 
are encoded on mtDNA and are synthesized inside the mitochondrion. The remaining subunits (IV, 
Va, Vb, VIa, VIb, VIc, VIIa, VIIb, VIIc, and VIII; nomenclature of Kadenbach et al. 1983) are 
encoded in the nucleus, synthesized in the cytosol, and imported into mitochondria. The catalytic 
site of the COX enzyme complex is composed mainly of mitochondrially synthesized subunits 
(Capaldi et al. 1995, Liu & Wong-Riley 1995). The occurrence of tissue-specific isoforms of some 
nuclear encoded subunits (VIa, VIIa, and VIII) suggests that they confer a regulatory role by 
adjusting the enzyme activity to the metabolic demands of various tissues (Liu & Wong-Riley 
1995).  Enhanced interest in cytochrome-c oxidase has come from the realization that deficiences of 
this enzyme are associated with a number of human diseases, including Leigh syndrome, chronic 
progressive ophthalmoplegia, Kears-Sayre syndrome, and fatal and benign infantile mitochondrial 
myopathy (Larsson et al. 1990, Moraes et al. 1991, Schon et al. 1994, Capaldi et al. 1995, Johns 
1995, Singh et al. 1996). 
 
Because of our findings with COX I in CNF, we continued analyzing the expressions of also other 
components of the cytochrome-c oxidase complex. Mitochondrially encoded subunit COX II as well 
as two nuclearly encoded subunits COX IV and VIb were studied by Northern blotting analysis. 
Similarly to COX I, COX II mRNA showed consistent underexpression, about 30 % of normal, in 
CNF kidney tissues. In contrast, the levels of the nuclearly encoded mRNAs for subunits COX IV 
and VIb did not differ from the levels of controls. To localize the mRNA expressions we performed 
in situ hybridization experiments with our DDRT-PCR clone CNF B36, COX I, COX II, COX IV, 
and COX VIb. Decreased expressions of CNF B36, COX I and COX II mRNAs were observed 
especially in the proximal and distal tubuli in CNF cortical kidneys as compared to the controls, but 
again, the nuclearly encoded COX IV and VIb mRNAs failed to show any difference in signal 
intensity between CNF and control kidney samples. Due to the overwhelming number of 
mitochondria in tubular cells, only a very faint reactivity of COX mRNAs could be seen in  
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glomeruli. Thus, we analyzed the transcript levels directly from isolated glomeruli by semi-
quantitative RT-PCR. We found the same downregulation of COX I but not the nuclearly encoded 
subunits also in CNF glomeruli. In order to extend the analysis to other complexes of the respiratory 
chain, we also performed RT-PCR for glomerular cytochrome b expression, a respiratory chain 
complex III component encoded by the mitochondrial genome. This showed an underexpression 
comparable to that of COX I in CNF glomeruli.  
 
To study the mitochondrial defect in CNF at the protein level, we first used immunohistochemical 
analysis. A monoclonal antibody recognizing the mitochondrially encoded COX I showed an 
intense, finely granular pattern of protein expression in the proximal and distal tubular cells, 
whereas glomerular reactivity was diffuse and faint. Again, a consistent decrease in staining was 
seen in tubuli of CNF kidneys as compared to controls. Immunohistochemical staining for the 
nuclear encoded COX IV showed intense reactivity in tubular cells, but no difference was apparent 
between CNF and control tissues.  
 
COX biosythesis is a very complex process not only because it is involved in the expression of both 
nuclear and mitochondrial genomes, but also because the regulatory factors required for gene 
expression differ between the two genomes. Moreover, modulations of transcriptional and 
translational controls may be via tissue and cell type-specific factors, and the same subunit may be 
regulated differently among tissues or cell types. COX subunits may also be regulated independently 
from one another. The maintenance of an optimal mitochondrial function requires finely tuned 
participation of tens of nuclear and mitochondrial encoded, tissue-, cell type- and developmental 
stage specific factors which must be correctly targeted, recognized, processed and assembled into 
the mitochondria in stoichiometric amounts (Voos et al. 1994). It has been reported that, at steady 
state, nuclear and mitochondrial genomes are proportionally regualted for COX subunit mRNAs. 
This is evident from studies where the ratio of COX III mRNA to COX VIc mRNA is equal in each 
rat tissue analysed on slot blots (Hood 1990, Gagnon et al. 1991) and a similar pattern of 
distribution of subunits I, IV and VIII mRNA in in situ hybridization (Hevner & Wong-Riley 1993). 
However, little is known about the regulation of gene products from the two genomes in response to 
the altered cellular activity. Hevner & Wong-Riley (1993) and Liu & Wong-Riley (1995) have 
shown that nuclear and mitochondrial genomes are disproportionately regulated at COX subunit 
mRNA and protein levels by altered neuronal activity. In addition, the disproportionate regulation of 
the two genomes is found to be true in skeletal muscles of patients with partial COX deficiencies 
(Mita et al. 1989). Our findings of a constant underexpression of mitochondrially encoded mRNAs 
and proteins indicate a disproportionate expression of the two genomes in CNF kidneys. This may 
result from a defective nuclear-mitochondrial interaction or from a primary mitochondrial defect 
(Nagley 1991, Scarpulla 1997). We could, however, exclude the mitochondrial defect at the 
posttrancriptional level, because the levels of mitochondrial mRNAs were comparable to protein 
levels.  
 
5.3. Other respiratory chain complexes  
 
To further study the respiratory chain impairment in CNF kidneys, we performed histochemical 
analysis for the activity of respiratory complex II (succinate dehydrogenase, SDH) and complex IV 
(cytochrome-c oxidase, COX). Similar to the in situ hybridization and immunohistochemistry, the 
histochemical reaction products in the glomeruli were weak in both control and CNF kidneys 
precluding reliable comparison. However, the tubular reactivity of both SDH and COX were 
remarkably decreased in CNF in comparison to control kidney cortex. The steady state levels of also  
 
   
 
 63 
  
other mitochondrial respiratory chain complexes were determined with the blue native gel 
electrophoresis technique (BN-PAGE). Here, CNF patient kidneys showed a consistent decrease of 
all respiratory chain complexes from 10% (complex I) to 30% (complexes II-V) of controls. These 
findings indicate that the enzymatic activities and the amounts of complexes show a good 
correlation not only to each other but also to mitochondrial expression of subunit protein and 
mRNA levels. Thus, it appears as the levels of mitochondrial subunits are the limiting factor in the 
formation of functional enzyme complexes in CNF kidneys, and in this respect, the nuclear subunits 
are overexpressed. Interestingly, also complex II, which is completely nuclearly encoded and thus 
apparently trancripted in normal levels in CNF, shows decreased activity. 
 
The normal ratios of the complexes II-V in BN-PAGE excluded a specific deficiency in any of these 
complexes in CNF. Rather, these findings suggest an impaired mitochondrial transcription 
machinery or defective replication of mtDNA leading to mtDNA depletion. Indeed, Solin et al. 
(2000) have later continued these studies and found a general decrease of mtDNA level in CNF 
kidney tissues in Southern blotting analysis, suggesting a mtDNA depletion in CNF. This could well 
explain our findings of the underexpression of mitochondrial mRNA and protein subunit levels.   
  
Interestingly, Bentlage et al. (1995) have described neuron specific symptoms in a disease with a 
similar remnant mitochondrial activity. This was explained by the fact that terminally differentiated 
neurons can not compensate functional over non-functional mitochondria due to lack of cell (and 
interrelated mitochondrial) proliferation (Johns 1995). This could also apply to glomerular 
podocytes which in general do not proliferate (Pabst & Sterzel 1983). Furthermore, Mandel et al. 
(1993) have shown that a decline in cellular ATP levels leads to increased epithelial permeability in 
MDCK (cockerspaniel kidney epithelial) cells; such a decrease of ATP content specifically disrupts 
the architecture of actin and intermediate filaments (Gabai & Kabakov 1993) which are considered 
especially important for the maintenance of the complex structure of podocytes (Shirato et al. 1996). 
These findings could explain the common morphologic changes including flattening and retraction 
of podocyte foot processes seen in CNF. 
 
5.4. Mitochondrial morphology  
 
The size, shape and quantity of mitochondria vary between tissues and even in different locations 
within the same tissue (Yaffe 1999). A common feature of all mitochondria is the presence of a 
double membrane. By electron microscopy, we wanted to study the amount and morphology of 
mitochondria in CNF and control kidney cortex. No statistically significant differences were found 
in the amount or density of mitochondria in CNF samples as compared to controls (51.7+6.6 / study 
area in CNF, 61.5+2.1 in controls, p-value not significant). As a morphological sign of possible 
mitochondrial involvement in CNF, we found characteristic concentric intramitochondrial bodies 
consisting mostly of double membranes within otherwise normal appearing mitochondria. In the 
CNF samples studied, these morphologic changes were present in 13.0 to 44.4% of all mitochondria 
(mean 26.9%); in controls, only 0 to 2% of such abnormal mitochondria (mean 0.7%, p<0.001) 
were found. Thus, the morphological abnormality in CNF is apparent, but as the amount of 
abnormal mitochondria does not directly correlate to the decreased expression levels, the meaning 
remains unclear. However, it is known that many mitochondrial diseases are defined by 
morphologically abnormal mitochondria in addition to defects in energy metabolism (Moraes et al. 
1991, Szabolcs et al. 1994, Hsieh et al. 1996, Niaudet & Rötig 1997). 
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5.5. Reactive oxygen species (ROS) and lipid peroxidation (LPO) 
  
Mitochondria consume about 90 % of the body´s oxygen and are particularly rich source of reactive 
oxygen species (ROS) (Chance et al. 1979). Molecular oxygen that is needed for energy production 
is itself toxic and its further reactions produce additional ROS, such as superoxide and hydroxyl 
radicals, singlet oxygens, and hydrogen peroxide (Halliwell 1991). ROS are constantly generated in 
cells like granulocytes and are benefical in many situations. However, an imbalance between 
generation and the defence mechanisms against ROS can result in damage. ROS can cause DNA 
damage, protein oxidation, and lipid peroxidation (LPO) affecting critical enzyme systems and 
destroying membranes (Halliwell 1991). ROS have been connected with several disease states, such 
as neurological damage, diabetic cataract, Down´s syndrome and immunological conditions. 
Furthermore, in tissue injury due to another cause, free radicals may exacerbate destruction. There is 
also plenty of recent evidence that ROS and LPO are distinctly associated with various types of 
experimental glomerulonephritis (Thakur et al. 1988, Diamond 1992, Johnson et al. 1994, Neale et 
al. 1994, Binder et al. 1999). 
 
It has been postulated that mitochondrial respiratory chain-associated diseases also may involve 
toxicity caused by ROS and recently, a deficiency of mitochondrial complex I has been shown to 
result in excessive production of superoxide radicals, which in turn causes excessive formation of 
hydroxyl radicals and aldehydic lipid peroxidation (Pitkänen & Robinson 1996, Luo et al. 1997). 
Whether free radicals are a major cause of cell injury in mitochondrial disease or whether they arise 
as secondary products in deteriorating tissue has not been fully established. As a secondary 
indication of mitochondrial dysfunction in CNF, we wanted to analyze local lipid peroxidation 
within CNF glomeruli. LPO is an autocatalytic process that damages lipid-containing structures, 
such as membranes and intracellular lipids, and yields reactive by-products, such as 
malondialdehyde (MDA) (Montine et al. 1996). In immunohistochemistry with anti-MDA 
antibodies, we found finely granular glomerular staining within podocytes and along the glomerular 
basement membrane in CNF, whereas neglible reactivity was seen in the control samples. This 
suggests enhanced glomerular LPO in CNF kidneys. This is an intriguing finding as glomerular lipid 
peroxidation has been implicated as an important factor in the generation of proteinuria. A detailed 
analysis of the pathogenesis of proteinuria in the Heymann nephritis rat model has revealed a chain 
of events that include intraglomerular overproduction of ROS, generation of LPO adducts in the 
podocytes and GBM, and crosslinking of type IV collagen via its NC-1 domains (Neale et al. 1994, 
Kerjaschki  & Neale 1996). Furthermore, in rats with PAN nephritis overproduction of ROS and 
local accumulation of LPO adducts were identified as prime causes for glomerular damage (Johnson 
et al. 1994). Interestingly, we have found (Holthöfer et al., unpublished data) that in puromycin 
induced glomerular damage mitochondrial dysfunction develops prior to the onset of proteinuria 
suggesting of a causal relationship. Overproduction of ROS and intraglomerular LPO are also 
clearly involved in the glomerular disease of Mpv 17-inactivated mice in knock out mice model. 
Mpv 17 gene product is a peroxisomal membrane protein which probably plays a major role in the 
peroxisomal metabolism of ROS (Zwacka et al. 1994). 
 
Together these data suggest a pathogenic role for ROS and LPO in proteinuria, also in CNF, but the 
exact mechanisms involved are yet to be defined. In the kidney, antioxidant enzyme expression has 
been shown to be particularly high compared with several other organs (Marklund 1984, Gwinner et 
al. 1998). However, despite this high antioxidant expression, the glomerulus seems to be a target for 
oxygen radical attack in many glomerular diseases (Gwinner et al. 1998). In CNF, we have later  
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confirmed a distict increase of local LPO products 4-hydroxynonenal (4-HNE) and MDA especially 
in the glomerular epithelial cells, and also shown that the local antioxidant defence against LPO 
provided by the enzyme phospholipid hydroperoxide glutathione peroxidase (PHGPx) was 
decreased (Solin et al. 2001). This could make CNF glomeruli even more susceptible to oxygen 
stress and damage. Based on these considerations and on our results of decreased mitochondrial 
activity and enhanced LPO in CNF kidneys the following hypothesis can be stated: in CNF, an 
unknown damage leads to mtDNA depletion which results in a decrease in local energy production 
and modification of ROS generation. Together with defective antioxidant defense, as shown in CNF 
glomeruli, this may result in severe functional consequences, such as proteinuria.  
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SUMMARY AND CONCLUSIONS 
 
 
The pathomechanisms of kidney disease manifested by proteinuria and nephrotic syndrome have 
been a mystery for decades, and the molecular properties of the underlying causes have remained 
poorly understood. Congenital nephrotic syndrome of the Finnish type (CNF) is a clinically well-
characterized disorder of the Finnish disease inheritage, with severe primary proteinuria. CNF is 
now known to be caused by a mutation in the recently described nephrin gene. At the time of this 
study, the basic defect of CNF was still unknown, although several hypotheses on its pathogenesis 
and mechanisms of proteinuria had been presented. The first part of this thesis was undertaken to 
test the prevailing theories on failed kidney maturation (I, II) and abnormal regulation of filtration 
(III) in CNF. The second series of experiments (IV, V) was planned to find new candidate 
molecules possibly involved in the pathogenesis of CNF and proteinuria.  
 
In morphological examination (I), CNF kidneys revealed a decreased cortical thickness and areas of 
poor demarcation between cortical and medullary compartments. Peritubular areas of poorly 
organized cells expressing markers of early differentiation (fibronectin, stem cell factor, cytokeratin) 
were found in CNF, which suggests retarded differentiation in this compartment; however, we could 
not show aberrations in the apoptotic (Bcl-2, acridine orange) or cell proliferation pathways (PCNA) 
by immunohistochemical stainings. In CNF, densely clustered glomeruli were often seen at the 
corticomedullary demarcation zone resulting in abnormally high density of glomeruli in these areas. 
This may reflect abnormal mesenchymo-epithelial interactions during renal development in CNF. 
Furthermore, we could occasionally find large glomeruli suggesting fusion of two to three 
individual glomeruli. Taken together, these findings of morphologic abnormalities and areas of 
irregular tissue organization in CNF kidneys and glomeruli suggest the possibility of developmental 
failure or arrest in CNF kidneys.  
 
In the second study (II) of this thesis, we systematically studied the expression of nine genes 
associated with kidney maturation from samples of normal human fetal, juvenile and adult kidneys 
and cultured glomerular cells using Northern blotting analysis. Subsequently, kidneys from patients 
with CNF were studied for evidence of dedifferentiation or persistence of a fetal expression pattern. 
The candidate marker genes for kidney maturation level analyzed here included transcription factors 
Pax-2, WT-1 and EGR-1, growth factors IGF-1, IGF-2, MK and HB-GAM and receptors IGFBP-1 
and trk-B. However, on the basis of these gene expression profiles, we could not find any 
conclusive evidence of developmental abnormality in the CNF kidneys. The cultured glomerular 
cells showed remarkable inconsistency to respective tissue samples reducing their usefulness in 
developmental studies. 
 
Vascular permeability factor (VPF) has been among the candidate molecules proposed to be 
involved in the pathogenesis of proteinuria. The third study (III) was designed to clarify the role of 
VPF in increased glomerular permeability in CNF kidneys. For that, we studied normal human, fetal 
and CNF kidney tissues and the corresponding cultured glomerular cells for VPF and its receptor 
KDR expression using Northern and in situ hybridization techniques and immunohistologic 
stainings. Our findings failed to show any significant differences in their expressions in CNF 
kidneys and thus, propose that VPF system is not directly involved in the pathogenesis of 
proteinuria in CNF. However, we observed VPF expression in a previously unrecognized site, in the 
juxtaglomerular area of the nephron. 
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Differential display RT-PCR is a new powerful technique for identification and characterization of 
altered gene expression. Using DDRT-PCR approach and isolated glomeruli, we compared the gene 
expression patterns of normal human and CNF kidney glomeruli (IV). Differential expression of 
candidate genes was verified by Northern blotting, and the corresbonding PCR fragments were 
sequenced and compared to known sequences in databanks. We found several genes and sequence 
tags with altered expression in CNF glomeruli including fragments with close homologies to 
cytochrome-c oxidase subunit I, integrin-linked kinase, insulin-like growth factor 2 receptor and 
eotaxin, and also fragments resembling anchyrin and cadherin family-like consensus sequences. 
Thus, the method enabled us not only to diagnose changes in gene expression pattern involved in 
the pathogenesis of proteinuria but also to reveal potentially novel glomerular members of known 
gene families.  
 
Especially, the observation that one of the DDRT-PCR products showed 98% similarity to the 
subunit I of the mitochondrial respiratory chain enzyme cytochrome-c oxidase (COX I) is striking: 
in Northern blotting analysis with the DDRT-PCR clone, a mRNA of the expected size for COX I 
was detected and the intensity of the signal appeared 70% lower in CNF than in controls. Renal 
filtration is highly dependent on mitochondrial energy production and the kidney shows strong COX 
activity earlier than most other tissues during fetal life, coinciding with the onset of glomerular 
filtration. Furthermore, a decrease of ATP content specifically disrupts the architecture of 
cytoskeletal filaments which are considered especially important for the maintenance of the 
complex structure of the podocytes. 
 
In the fifth study of this thesis (V), we proceeded to further characterize the mitochondrial 
involvement in CNF kidneys. We found a constant underexpression, about 30 % of normal, of all 
the mitochondrially encoded respiratory chain complex subunit mRNAs and proteins tested, but the 
nuclearly encoded subunits did not differ from the levels of controls, as examined by Northern and 
in situ hybridization, by immunohistochemical staining and by semiquantitative PCR of isolated 
glomeruli. This indicates a disproportionate expression of the nuclear and mitochondrial genomes in 
CNF kidneys resulting probably from a defective nuclear-mitochondrial interaction or from a 
primary mitochondrial defect.  
 
In histochemical analysis, the activities of respiratory chain enzyme complexes were remarkably 
decreased in CNF in comparison to control kidney cortex. By blue native polyacrylamide gel 
electrophoresis (BN-PAGE) technique, CNF patient kidneys showed a consistent decrease of all 
enzyme complexes from 10% to 30% of controls. These findings indicate that the enzymatic 
activities and the amounts of complexes show a good correlation to each other and also to 
mitochondrial expression of subunit protein and mRNA levels. Thus, it appears that the levels of 
mitochondrial subunits are the limiting factor in the formation of functional enzyme complexes in 
CNF kidneys. The normal ratios of the complexes in CNF excluded a specific deficiency in any of 
these complexes, but suggest an impaired mitochondrial transcription machinery or defective 
replication of mtDNA leading to mtDNA depletion. Solin et al. (2000) have later studied these 
possibilities and found a general decrease of mtDNA level in CNF kidney tissues in Southern 
blotting analysis, suggesting a mtDNA depletion in CNF. This could well explain our findings of 
the underexpression of mitochondrial mRNA and protein subunit levels. 
   
By electron microscopy, no statistically significant differences were found in the amount or density 
of mitochondria in CNF samples as compared to controls. As a morphological sign of possible  
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mitochondrial involvement in CNF, we found characteristic concentric intramitochondrial bodies 
within otherwise normal appearing mitochondria. In the CNF samples studied, these morphologic 
changes were present in 26.9% of all mitochondria; in controls, only 0.7% of such abnormal 
mitochondria were found. Thus, the morphological abnormality in CNF is apparent. As a secondary 
indication of mitochondrial dysfunction in CNF, we analysed a local lipid peroxidation (LPO) 
product, malondialdehyde (MDA) within CNF glomeruli. In immunohistochemistry with anti-MDA 
antibodies, we found glomerular staining within podocytes and along the glomerular basement 
membrane in CNF, whereas neglible reactivity was seen in the control samples. This suggests also 
enhanced glomerular LPO in CNF kidneys. This is an intriguing finding as reactive oxygen species 
(ROS) and glomerular LPO have been implicated as important factors in the generation of 
proteinuria in experimental types of glomerulonephritis. 
 
In conclusion, based on all these considerations and on our results of decreased mitochondrial 
activity and enhanced LPO in CNF kidneys the following hypothesis can be stated: in CNF, an 
unknown damage leads to mtDNA depletion and subsequently to a decrease in local energy 
production and modification of ROS generation. Together with defective antioxidant defense, as 
shown in CNF glomeruli, this may result in severe functional consequences, such as proteinuria. If 
this chain of events could somehow be triggered by a change in nephrin gene remains to be studied.  
   
 
 69 
  
 
ACKNOWLEDGEMENTS 
 
 
This thesis was carried out at the Department of Bacteriology and Immunology, Haartman Institute, Universtity 
of Helsinki during the years 1992-1997. I wish to thank the present and previous heads of the department, professor Olli 
Mäkelä, M.D., professor Martti Vaara, M.D., docent Seppo Meri, M.D. and docent Risto Renkonen, M.D. for the 
excellent working facilities. 
I want to express my gratitude also to the present and previous heads of the Department of Genetics, University 
of Helsinki, professor Olli Halkka, Ph.D., docent Liisa Halkka, Ph.D. and professor Hannu Saarilahti, Ph.D. for their 
valuable advice and liberal attitude to my studies and work.  
My deepest gratitude belongs to my supervisor docent Harry Holthöfer, M.D. He gave me the oppurtinity to 
work on a very interesting and challenging project, and his guidance and warm support during all these years have made 
my work most pleasant. Harry´s enthusiastic attitude to research and life and his never-ending optimism deserve all my 
respect. 
My sincere thanks are due to docent Aaro Miettinen, M.D. for his encouragement and interest in my work. 
Aaro's vast knowledge of kidney pathology and his perspective comments in many occasions have been invaluable 
during this work. 
I have been privileged to work with Maiju Solin, M.Sc. She deserves my warmest gratitude not only for the 
enormous help in every part of this project, but also for her friendship and support during my years in Sero. Without 
Maiju´s help the completion of this work would not have been possible. Ms Riitta Väisänen, and Ms Liisa Pirinen in 
later phases of this work, are gratefully acknowledged for excellent technical assistance, and for being always so kind 
and helpful. I also want to thank Jukka Reivinen, Ph.D., Pauliina Luimula, M.Sc. and all the other past and present 
members of the research group, for a collaboration and nice company, and especially, for so many fun moments at our 
late party nights. From our "neighbouring" laboratory navigated by docent Seppo Meri, M.D., I especially remember 
Sami Junnikkala, M.Sc., Juha Hakulinen, M.Sc., Jorma Tissari, M.Sc., Sakari Jokiranta, M.D., Timo Lehto, Ph.D. and 
Antti Väkevä, M.D. 
Päivi Tissari, M.D. is warmly acknowledged for sharing with me her vast knowledge and interest in the world 
of CNF. I would also like to express my gratitude to our collaborators docent Christer Holmberg, M.D. and docent 
Hannu Jalanko M.D. for their interest in my work and for providing the CNF kidney material at our disposal. Docent 
Mathias Kretzler, M.D. I thank for pleasant collaboration, and for the invaluable support during our DDRT-PCR work. I 
will never forget my visit in your lab in Munich! 
I am very grateful to docent Helena Autio-Harmainen, M.D., and docent Eero Honkanen, M.D. for reviewing 
this thesis and improving it with their constructive comments and criticism. I also appreciate their understanding attitude 
to my strict timetable. I sincerely thank docent Malcolm Richardson, Ph.D. for revising the language of this thesis. 
I wish to express my warm thanks to Timo Tuuri, Kristiina Hildén, Kari Asikainen and Ritva Javanainen for the 
relaxing coffee breaks and all the help I got from them in any problems met during this work. All my friends, especially 
Sunna Airaksinen, I want to thank for sharing my interests outside the lab and for so many fun moments during these 
years. I will always remember our great annual canoe trips, football games and our legendary team LisPoT, and sähly 
games in Meilahti. 
My present co-workers in The Family Federation Of Finland, Turku Clinic, Tuula Penttilä, Anna-Kaisa 
Poranen, Leena Antila, Hilkka Jylhä, Gabriella Katter, Taru Emelianov, Marja Tervonen and Tuija Lamerto are warmly 
acknowledged for their lovely company and understanding during the final preparation of this thesis. Without their 
positive attitude to my "extra-work" the completion of this thesis would have been much more difficult. 
 I also want to thank my parents and the other family members for being supportive and helpful when I needed. 
My nearest family, Jake and Aukusti Korhonen, I thank for their love and support. Jake has also done a huge work in 
proofreading my references and citations, which is warmly acknowledged. 
This work has been financially supported by the grants from Sigrid Juselius Foundation, the Finnish Cultural 
Foundation, University of Helsinki, Maud Kuistila Foundation, and the Finnish Kidney Foundation. 
 
 
Turku, April 2002 
 
 
 
Anni Haltia 
   
 
 70 
  
 
REFERENCES 
 
Abrahamson, D. R., Hein, A., Caulfield, J. P. (1983) Laminin in glomerular basement membrane of aminonucleoside nephrotic rats. 
Lab. Invest. 49:38-47. 
 
Abrahamson, D. R., Robert, B., Hyvink, D. P., St. John, P. L., Daniel, T. O. (1998) Origins and formation of microvasculature in the 
developing kidney. Kidney Int. 54 (Suppl. 67): S7-S11. 
 
Abrams, J. M., White, K., Fessler, L. I., Steller, H. (1993) Programmed cell death during Drosophila enbryogenesis. Development 
117:29-43. 
 
Abrass, C. K. (1997) Clinical spectrum and complications of the nephrotic syndrome. J. Investig. Med. 45:143-153. 
 
Abt, A. B., Cohen, A. H. (1996) Newer glomerular diseases. Semin. Nephrol. 16:501-510. 
 
Adler, S. (1992) Integrin receptors in the glomerulus: potential role in glomerular injury. Am. J. Physiol. 262:F697-F704. 
 
Ahola, H., Wang, S.-W., Luimula, P., Solin, M.-L., Holzman, L. B., Holthöfer, H. (1999) Cloning and expression of the rat nephrin 
homolog. Am. J. Pathol. 155:907-913. 
 
Aiello, L. P., Robinson, G. S., Lin, Y.-W., Nishio, Y., King, G. L. (1994) Identification of multiple genes in bovine retinal pericytes 
altered by exposure to elevated levels of glucose by using mRNA differential display. Proc. Natl. Acad. Sci. USA 91:6231-6235. 
 
Ambrus, J. L., Sridhar, N. R. (1997) Immunologic aspects of renal disease. JAMA 278:1938-1945. 
 
Amin, K. M., Litzky, L. A., Smythe, W. R., Mooney, A. M. Morris, J. M., Mews, D. J. Y., Pass, H. I., Kari, C., Rodeck, U., 
Rauscher, F. J., Kaiser, L. R., Albelda, S. M. (1995) Wilms´ tumor I susceptibility (WT1) gene products are selectively expressed in 
malignant mesothelioma. Am. J. Pathol. 146:344-356. 
 
Antikainen, M., Holmberg, C., Taskinen, M.-R. (1994) Short-term effects of renal transplantation on plasma lipids and lipoprotein 
lipase in children with congenital nephrosis. Clin. Nephrol. 41:284-289. 
 
Aufderheide, E., Chiqúet-Ehrismann, R., Ekblom, P. (1987) Epithelial-mesenchymal interactions in the developing kidney lead to 
expression of tenascin in the mesenchyme. J. Cell Biol. 105:599-608. 
 
Aula, P., Rapola, J., Karjalainen, O., Lindgren, J., Hartikainen, A.-L., Seppälä, M. (1978) Prenatal diagnosis of congenital nephrosis 
in 23 high-risk families. Am. J. Dis. Child. 132:984-987. 
 
Aumailley, M., Battaglia, C., Mayer, U., Reinhardt, D., Nischt, R., Timpl, R., Fox, J. W. (1993) Nidogen mediates the formation of 
ternary complexes of basement membrane components. Kidney Int. 43:7-12. 
 
Autio-Harmainen, H. (1981) Renal pathology of fetuses with congenital nephrotic syndrome of the Finnish type. A qualitative and 
quantitative electron microscopic study. APMIS (A) 89:215-222. 
 
Autio-Harmainen, H., Rapola, J. (1981) Renal pathology of fetuses with congenital nephrotic syndrome of the Finnish type. A 
qualitative and quantitative light microscopic study. Nephron 29:158-163. 
 
Autio-Harmainen, H., Karttunen, T., Risteli, L., Risteli, J., Rapola, J. (1985) Accumulation of laminin and type IV collagen in the 
kidney in congenital nephrosis. Kidney Int. 27:662-666. 
 
Aya, K., Tanaka, H., Seino, Y. (2000) Novel mutation in the nephrin gene of a Japanese patient with congenital nephrotic syndrome 
of the Finnish type. Kidney Int. 57:401-404. 
 
Bacallao, R., Fine, L. G. (1989) Molecular events in the organization of renal tubular epithelium: from nephrogenesis to 
regeneration. Am. J. Physiol. 257: F913-F924. 
 
Bagchus, W. M., Hoedemaeker, P. J., Rozing, J., Bakker, W. W. (1986) Glomerulonephritis induced by monoclonal anti-Thy 1.1 
antibodies. A sequential histological and ultrastructural study in the rat. Lab. Invest. 55: 680-687. 
 
Bakker, W. W., van Luijk, W. H. (1989) Do circulating factors play a role in the pathogenesis of minimal change  nephrotic 
syndrome? Pediatr. Nephrol. 3:341-349. 
 
 
 
   
 
 71 
  
Baldwin, C. T., Hoth, C. F., Amos, J. A., da-Silva, E. O., Milunsky, A. (1992) An exonic mutation in the HuP2 paired domain gene 
causes Waardenburg´s syndrome. Nature 355:637-638. 
 
Balling, R., Deutsch, U., and Gruss, P. (1988) Undulated, a mutation affecting the development of the mouse skeleton, has a point 
mutation in the paired box of Pax1. Cell 55:531-535. 
 
Bancroft, J. D. (1975) Histochemical techniques, 2nd ed. Butterworths, Boston p. 280-285. 
 
Bard, J. B. L., Woolf, A. S. (1992) Nephrogenesis and  the development  of renal disease. Nephrol. Dial. Transplant. 7:563-572. 
 
Bard, J. B. L., McConnell, J. E., Davies, J. A. (1994) Towards a genetic basis for kidney development. Mech. Dev. 48: 3-11. 
 
Barker, D., Hostikka, S. L., Zhou, J., Chow, L. T., Oliphant, A. R., Gerken, S. C., Gregory, M. C., Skolnick, M. H., Atkin, C. L., 
Tryggvason, K. (1990) Identification of mutations in the COL4A5 collagen gene in Alport syndrome. Science 248:1224-1227. 
 
Barnes, J. L., Radnik, R. A., Gilchrist, E. P., Venkatachalam, M. A. (1984) Size and charge selective permeability defects induced in 
glomerular basement membrane by a polycation. Kidney Int. 25:11-19. 
 
Bauer, D., Müller, H., Reich, J., Riedel, H., Ahrenkiel, V., Warthoe, P., Strauss, M. (1993) Identification of differentially expressed 
mRNA species by an improved display technique (DDRT-PCR). Nucleic Acids Res. 21:4272-4280. 
 
Begum, N. A., Mori, M., Matsumata, T., Takenaka, K., Sugimachi, K., Barnard, G. F. (1995) Differential display and integrin alpha 
6 messenger RNA overexpression in hepatocellular carcinoma. Hepatology 22:1447-1455. 
 
Bell, G. I., Merryweather, J. P., Sanchez-Pescador, R., Stempien, M. M., Priestley, L., Scott, J., Rall, L. B. (1984) Sequence of a 
cDNA clone encoding human preproinsulin-like growth factor II. Nature 310:775-777. 
 
Beltcheva, O., Martin, P., Lenkkeri, U., Tryggvason, K. (2001) Mutation spectrum in the nephrin gene (NPHS1) in congenital 
nephrotic syndrome. Human Mutation 17:368-373. 
 
Bennett, C. M., Glassock, R. J., Chang, R. L. S., Deen, W. M., Robertson, C. R., Brenner, B. M. (1976) Permselectivity of  the 
glomerular capillary wall: studies in experimental glomerulonephritis in rat using dextran sulphate. J. Clin. Invest. 57:1287-1294. 
 
Bentlage, H., de Coo, R., ter Laak, H., Sengers, R., Trijbels, F., Ruitenbeek, W., Schlote, W., Pfeiffer, K., Gencic, S., von Jagov, G. 
(1995) Human diseases with defects in oxidative phosphorylation. 1. Decreased amount of assembled oxidative phosphorylation 
complexes in mitochondrial encephalomyelopathies. Eur. J. Biochem. 227:909-915. 
 
van Biervliet, J. B. G. M., Bruinvis, L., Ketting, D., deBree, P. K., van der Heiden, C., Waldman, S. K. (1977) Hereditary 
mitochondrial myopathy with lactic acidemia, a de Toni-Fanconi-Debre syndrome, and a defective respiratory chain in voluntary 
striated muscles. Pediatr. Res. 11:1088-1090. 
 
Binder, C. J., Weiher, H., Exner, M., Kerjaschki, D. (1999) Glomerular overproduction of oxygen radicals in Mpv17 gene-
inactivated mice causes podocyte foot process flattening and proteinuria. Am. J. Pathol. 154:1067-1075. 
 
Bodnar, A. G., Cooper, J. M., Holt, I. J., Leonard, J. V., Schapira, A. H. V. (1993) Nuclear complementation restores mtDNA levels 
in cultured cells from a patient with mtDNA depletion. Am. J. Hum. Genet. 53:663-669. 
 
Bohle, A., Aeikens, B., Eenboom, A., Fronholt, L., Plate, W. R., Xiao, J.-C., Greschniok, A., Wehrmann, M (1998) Human 
glomerular structure under normal conditions and in isolated glomerular disease. Kidney Int. 54 (Suppl. 67):S186-S188. 
 
Bohrer, M. P., Baylis, C., Robertson, C., Brenner, B. M. (1977) Mechanisms of the puromycin induced defects in the 
transglomerular passage of water and macromolecules. J. Clin. Invest. 60:152-161. 
 
Bohrer, M. P., Baylis, C., Humes, H. D., Glassock, R. J., Robertson, C. R., Brenner, B. M. (1978) Permselectivity of the glomerular 
capillary walls: facilitated filtration of circulating polycations. J. Clin. Invest. 61: 72-78. 
 
Borch-Johnsen, K., Norgaard, K., Hommel, E., Mathiesen, E. R., Jensen, J. S., Deckert, T., Parving, H.-H. (1992) Is diabetic 
nephropathy an inherited complication? Kidney Int. 41:719-722. 
 
Border, W. A., Noble, N. A., Yamamoto T., Tomooka, S., Kagami, S. (1992) Antagonists of transforming growth factor-ß: A novel 
approach to treatment of glomerulonephritis and prevention of glomerulosclerosis. Kidney Int. 41:566-570. 
 
Border, W. A., Noble, N. A. (1993) Cytokines in kidney disease: The role of transforming growth factor-ß. Am. J. Kidney Dis. 
22:105-113. 
 
   
 
 72 
  
van den Born, J., van den Heuvel, L. P. W. J., Bakker, M. A. H., Veerkamp, J. H., Assmann, K. J. M., Berden, J. H. M. (1992) A 
monoclonal antibody against GBM heparan sulfate induces an acute selective proteinuria in rats. Kidney Int. 41:115-123. 
 
Boute, N., Gribouval, O., Roselli, S., Benessy, F., Lee, H., Fuchshuber, A., Dahan, K., Gubler, M. C., Niaudet, P., Antignac, C. 
(2000) NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. 
Nat. Genet. 24:349-354. 
 
Breier, G., Albrecht, U., Sterrer, S., Risau, W. (1992) Expression of vascular endothelial growth factor during embryonic 
angiogenesis and endothelial cell differentiation. Development 114:521-532. 
 
Brenner, B. M., Bohrer, M. P., Bayliss, C., Deen, W. M. (1977) Determinants of glomerular permselectivity: insights derived from 
observations in vivo. Kidney Int. 12:229-237. 
 
Brenner, B. M., Hostetter, T. H., Humes, H. D. (1978) Molecular basis of proteinuria of glomerular origin. N. Engl. J. Med. 298:826-
833. 
 
Brown, L. F., Berse, B., Tognazzi, K., Manseau, E. J., van de Water L., Senger D. R., Dvorak, H. F., Rosen, S. (1992a) Vascular 
permeability factor mRNA and protein expression in human kidney. Kidney Int. 42:1457-1461. 
 
Brown, L. F., Yeo, K. T., Berse, B., Yeo, T. K., Senger, D. R., Dvorak, H. F., Van De Water, L. (1992b) Expression of vascular 
permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J. Exp. Med. 176:1375-
1379. 
 
Bruijn, J. A., Kootstra, C. J., Sutmuller, M., Van Vliet,  A. I., Bergijk, E. C., de Heer, E. (1997) Matrix and adhesion molecules in 
kidney pathology: Recent observations J. Lab. Clin. Med. 130:357-364. 
 
Buck, C. A, Horwitz, A.F. (1987) Cell surface receptors for extracellular matrix molecules. Ann. Rev. Cell. Biol. 3:179-205. 
 
Buckler, A. J., Pelletier, J., Haber, D. A., Glaser, T., Housman, D. E. (1991) Isolation, characterization, and expression of the murine 
Wilms’ tumor gene (WT1) during kidney development. Mol. Cell Biol. 11:1707-1712. 
 
Burri, M., Tromvoukis, Y., Bopp, D., Frigerio, G., Noll, M. (1989) Conservation of the paired domain in metazoans and its structure 
in three isolated human genes. EMBO J. 8:1183-1190. 
 
Call, K. M., Glaser, T., Ito, C. Y., Buckler, A. J., Pelletier, J., Haber, D. A., Rose, E. A., Kral, A., Yeger, H., Lewis, W. H., Jones, C., 
Housman, D. E. (1990) Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms´ tumor 
locus. Cell 60:509-520. 
 
Callard, D., Lescure, B., Mazzolini, L. (1994) A method for the elimination of false positives generated by the mRNA differential 
display technique. BioTechniques 16:1096-1101. 
 
Cao, X., Koski, R. A., Gashler, A., McKiernan, M., Morris, C. F., Gaffney, R., Hay, R. V., Sukhatme, V. P. (1990) Identification and 
characterization of the Egr-1 gene product, a DNA-binding zinc finger protein induced by differentiation and growth signals. Mol. 
Cell. Biol. 10:1931-1939. 
 
Capaldi, R. A., Marusich, M. F., Taanman, J.-W. (1995) Mammalian cytochrome-c oxidase: characterization of enzyme and 
immunological detection of subunits in tissue extracts and whole cells. Methods Enzymol. 260:117-132. 
 
Caulfield, J. P., Reid, J. J., Farquhar, M. G. (1976) Alterations of glomerular epithelium in acute aminonucleoside nephrosis: 
Evidence for formation of occluding junctions and epithelial cell detachment. Lab. Invest. 34:43-59. 
 
Chance, B., Sies, H., Boveris, A. (1979) Hydroperoxide metabolim in mammalian organs. Physiol. Rev. 59:527-593. 
 
Chang, R. L. S., Deen, W. M., Robertson, C. R., Bennet, C. M., Glassock, R. J., Brenner, B. M. (1976) Permselectivity of the 
glomerular capillary wall: studies in experimental glomerulonephritis in rat using neutral dextran. J. Clin. Invest. 57:1272-1286. 
 
Chen, J., Myllärniemi, M., Akyürek, L. M., Häyry, P., Marsden, P. A., Paul, L. C. (1996) Identification of differentially expressed 
genes in rat aortic allograft vasculopathy. Am. J. Pathol. 149:597-611. 
 
Chin, E., Bondy, C. (1992) Insulin-like growth factor system gene expression in the human kidney. J. Clin. Endocrinol. Metab. 
75:962-968. 
 
 
 
 
   
 
 73 
  
Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J., Rutter, W. J. (1979) Isolation of biologically active ribonucleic acid from 
sources enriched in ribonuclease. Biochemistry 18:5294-5299. 
 
Chisaka, O., Capecchi, M. R. (1991) Regionally restricted developmental  defects resulting from targetted disruption of the mouse 
homeobox gene Hox 1.5. Nature 350:473-479. 
 
Christy, B. A., Lau, L. F., Nathans, D. (1988) A gene activated in mouse 3T3 cells by serum growth factors encodes a protein with 
"zinc finger" sequences. Proc. Natl. Acad. Sci. USA 85:7857-7861. 
 
Clayton, D. A. (1992) Structure and function of the mitochondrial genome. J. Inher. Metab. Dis. 15:439-447. 
 
Colognato, H., Winkelmann, D. A., Yurchenco, P. D. (1999) Laminin polymerization induces a receptor-cytoskeleton network. J. 
Cell Biol. 145:619-631. 
 
Conti, F. G., Striker, L. J., Lesniak, M. A., MacKay K., Roth, J., Striker, G. E. (1988) Studies on binding and mitogenic effect of 
insulin and insulin-like growth factor I in glomerular mesangial cells. Endocrinology 122:2788-2795. 
 
Conti, F. G., Elliot, S. J., Striker, L. J., Striker, G. E. (1989) Binding of insulin-like growth factor-1 by glomerular endothelial and 
epithelial cells: further evidence for IGF-I action in renal glomerulus. Biochem. Biophys. Res. Commun. 163:952-958. 
 
Cosio, F. G., Orosz, C. G. (1993) Adhesion molecules and the kidney in health and disease. J. Nephrol. 6:22-32. 
 
Couser, W. G. (1993) Pathogenesis of glomerulonephritis. Kidney Int. 44:S19-S26. 
 
Couser, W. G., Johnson, R. J. (1994) Mechanisms of progressive renal disease in glomerulonephritis. Am. J. Kidney Dis. 23:193-
198. 
 
Couser, W. G. (1998) Pathology of glomerular damage in glomerulonephritis. Nephrol. Dial. Transplant. 13 (Suppl. 1):10-15. 
 
Cunningham, M. W., Harris, D. W., Mundy, C. R. (1990) In vitro labelling. In: Radioisotopes in Biology (Slater, R. J., ed.). Oxford 
University Press, Oxford, p.137-191. 
 
Czech, M. P. (1989) Signal transmission by the insulin-like growth factors. Cell 59.235-238. 
 
Davies, J. A., Brandli, A. W. (2002) Kidney development database. http://golgi.ana.ed.ac.uk/kidhome.html 
 
Dearcangelis, A., Neuville, P., Boukamel, R., Lefebre, O., Kedinger, M., Simon-Assmann P. (1996) Inhibition of laminin α1-chain 
expression leads to alteration of basement membrane assembly and cell differentiation. J. Cell Biol. 133:417-430. 
 
Deen, W. M., Bridges, C. R., Brenner, B. M., Myers, B. D. (1985) Heteroporous model of glomerular size selectivity: Application to 
normal and nephrotic humans. Am. J. Physiol. 249:F374-F389. 
 
Dekan, G., Miettinen, A., Schnabel, E., Farquhar, M. G. (1990) Binding of monoclonal antibodies to glomerular epithelium 
endothelium, slit membranes, and epithelium after in vivo injection. Am. J. Pathol. 137:913-927. 
 
Dennis, V. W., Robinson, R. R. Proteinuria. In: The Kidney: Physiology and Pathophysiology (Seldin, D. W., Giebisch, G. eds). 
Raven Press, New York, 1985, p.1805-1816. 
 
Diamond, J. R. (1992) The role of reactive oxygen species in animal models of glomerular disease. Am. J. Kidney Dis. 19:292-300. 
 
Donohue, P. J., Alberts, G. F., Hampton, B. S., Winkles, J. A. (1994) A delayed-early gene activated by fibroblast growth factor-1 
encodes a protein related to aldose reductase J. Biol. Chem. 269:8604-8609. 
 
Doublier, S., Ruotsalainen, V., Salvidio, G., Lupia, E., Biancone, L., Conaldi, P. G., Reponen, P., Tryggvason, K., Camussi, G. 
(2001) Nephrin redistribution on podocytes is a potential mechanism for proteinuria in patients with primary acquired nephrotic 
syndrome. Am. J. Pathol. 158:1723-1731. 
 
Dressler, G. R., Deutsch, U., Chowdhury, K., Nornes, H. O., Gruss, P. (1990) Pax2, a new murine paired-box-containing gene and 
its expression in the developing excretory system. Development 109:787-795. 
 
Dressler, G. R., Douglass, E. C. (1992) Pax-2 is a DNA-binding protein expressed in embryonic kidney and Wilms´tumor. Proc. 
Natl. Acad. Sci. USA 89:1179-1183. 
 
Dressler, G. R., Wilkinson, J. E., Rothenpieler, U. W., Patterson, L. T., Williams-Simons, L., Westphal, H. (1993) Deregulation of 
Pax-2 expression in transgenic mice generates severe kidney abnormalities. Nature 362:65-67. 
 
   
 
 74 
  
Drummond, I. A., Madden, S. L., Rohwer-Nutter, P., Bell, G. I., Sukhatme, V. P., Rauscher III, F. J. (1992) Repression of the 
insulin-like growth factor II gene by the Wilms’ tumor suppressor WT1. Science 257:674-678. 
 
Dull, T. J., Gray, A., Hayflick, J. S., Ullrich, A. (1984) Insulin-like growth factor II precursor gene organization in relation to insulin 
gene family. Nature 310:777-781. 
 
Durbeej, M., Söderström, S., Ebendal, T., Birchmeier, C., Ekblom, P. (1993) Differential expression of neurotrophin receptors 
during renal development. Development 119:977-989. 
 
Dustin, M. L., Olszowy, M. W., Holdorf, A. D., Li, J., Bromley, S., Desai, N., Widder, P., Rosenberger, F., van der Merwe, P. A., 
Allen, P. M., Shaw, A. S., (1998) A novel adaptor protein orchestrates receptor patterning and cytoskeletal polarity in T-cell 
contacts. Cell 94:667-677. 
 
Eccles, M. R., Wallis, L. J., Fidler, A. E., Spurr, N. K., Goodfellow, P. J., Reeve, A. E. (1992) Exppression of the PAX2 gene in 
human fetal kidney and Wims´tumor. Cell Growth Differ. 3:279-289. 
 
Eccles M. R., Yun, K., Reeve, A. E., Fidler, A. E. (1995) Comparative in situ hybridization analysis of PAX2, PAX8, and WT1 gene 
transcription in human fetal kidney and Wilms´tumors. Am. J. Pathol. 146:40-45. 
 
Eddy, A. A., Schnaper, H. W. (1998) The nephrotic syndrome: From the simplex to the complex. Semin. Nephrol. 18:304-316. 
 
Ekblom, P. (1981a) Determination and differentiation of the nephron. Med. Biol. 59:139-160. 
 
Ekblom, P. (1981b) Formation of basement membranes in the embryonic kidney: immunohistological study. J. Cell Biol. 91:1-10. 
 
Ekblom, P. Lehtonen, E., Saxén, L. (1981) Shift in collagen type as an early response to induction of the metanephric mesenchyme. 
J. Cell Biol. 89:276-283. 
 
Ekblom, P. (1989) Developmentally regulated conversion of mesenchyme to epithelium. FASEB J. 3:2141-2150. 
 
Ekblom, M., Klein, G., Mugrauer, G., Fecker, L., Deutzmann R., Timpl, R., Ekblom, P. (1990) Transient and locally restricted 
expression of laminin A chain mRNA by developing epithelial cells during kidney organogenesis. Cell 60:337-346. 
 
Epstain, D. J., Vekemans, M., Gros, P. (1991) Splotch (Sp2H), a mutation affecting development of the mouse neural tube, shows a 
deletion within the paired homeodomain of Pax-3. Cell 67:767-774. 
 
Fagin, J. A., Melmed, S. (1987) Relative increase in insulin-like growth factor I messenger ribonucleic acid levels in compensatory 
renal hypertrophy. Endocrinology 120:718-724. 
 
Farquhar, M. G., Saito, A., Orlando, R. A. (1995) The Heymann nephritis antigenic complex: megalin (gp330) and RAP. J. Am. Soc. 
Nephrol. 6:35-47. 
 
Feintzeig, I. D., Abrahamson, D. R., Cybulsky, A. V., Ditmer, J. E., Salant, D. J. (1986) Nephritogenic potential of sheep antibodies 
against glomerular basement membrane laminin in the rat. Lab. Invest. 54:531-542. 
 
Fishman, J. A., Karnovsky, M. J. (1985) Effects of aminonucleoside of puromycin on glomerular epithelial cells in vitro. Am. J. 
Pathol. 118:398-407. 
 
Floege, J., Johnson, R. J., Gordon, K., Yoshimura, A., Campbell, C., Iruela-Arispe, L., Alpers, C. E., Couser, W. G. (1992) Altered 
glomerular extracellular matrix synthesis in experimental membranous nephropathy:Studies in two models and cultured glomerular 
epithelial cells. Kidney Int. 42:573-585. 
 
Floege, J., Radeke, H. R., Johnson, R. J. (1994) Glomerular cells in vitro versus the glomerulus in vivo. Kidney Int. 45:360-368. 
 
Forrester, L. M., Brunkow, M., Bernstein, A. (1992) Proto-oncogenes in mammalian development. Curr. Opin. Genet. Dev. 2:38-44. 
 
Fries, J. W., Sandstrom, D. J., Meyer, T. W., Rennke, H. G. (1989) Glomerular hypertrophy and epithelial cell injury modulate 
progressive glomerulosclerosis in the rat. Lab. Invest. 60:205-218. 
 
 
 
 
 
 
 
 
   
 
 75 
  
Fuchshuber, A., Jean, G., Gribouval, O., Gubler, M. C., Broyer, M., Beckmann, J. S., Niaudet, P., Antignac, C. (1995) Mapping a 
gene (SRN1) to chromosome 1q25-q31 in idiopathic nephrotic syndrome confirms a distinct entity of autosomal recessive nephrosis. 
Hum. Mol. Genet. 4:2155-2158. 
 
Furness, P. N., Turner, D. R., Cotoon, R. E. (1986) Basement membrane charge in human glomerular disease. J. Pathol. 150:267-
278. 
 
Furness, P. N., Hall, L. L., Shaw, J. A., Pringle, J. H. (1999) Glomerular expression of nephrin is decreased in acquired human 
nephrotic syndrome. Nephrol. Dial. Transplant. 14:1234-1237. 
 
Gabai, V. L., Kabakov, A. E. (1993) Rise in heat-shock protein level confers tolerance to energy deprivation. FEBS Lett. 327:247-
250. 
 
Gagnon, J., Kurowski, T. T., Wiesner, R. J., Zak, R. (1991) Correlations between a nuclear and a mitochondrial mRNA of 
cytochrome c oxidase subunits, enzyme activity and total mRNA content, in rat tissues. Mol. Cell. Biol. 107:21-29. 
 
Gavin, B. J., McMahon, J. A., McMahon, A. P. (1990) Expression of multiple novel Wnt -1/int-1-related genes during fetal and adult 
mouse development. Genes Dev. 4:2319-2332. 
 
Gibson, I. W., More, I. A. R. (1998) Glomerular pathology: Recent advances. J. Pathol. 184:123-129. 
 
Glassock, R. J., Adler, S. G., Ward, H. J., Cohen, A. H. (1991a) Primary glomerular diseases. In: The Kidney. (Brenner, B. M., 
Rector, F. C., eds). W.B. Saunders Company, Philadelphia, p. 1182-1279. 
 
Glassock, R. J., Cohen, A. H., Adler, S. G., Ward, H. J. (1991b) Secondary glomerular diseases. In: The Kidney. (Brenner, B. M., 
Rector F. C., eds). W.B. Saunders Company, Philadelphia, p. 1280-1368. 
 
Goode, N. P., Shires, M., Davison, A. M. (1996) The glomerular basement membrane charge-selectivity barrier: an oversimplified 
concept ? Nephrol. Dial. Transplant. 11:1714-1715. 
 
Goodyer, P., Kashtan, C. (1998) The genetic basis of pediatric renal disease. Sem. Nephrol. 18:244-255. 
 
Goto, S., Yaoita, E., Matsunami, H., Kondo, D., Yamamoto, T., Kawasaki, K., Arakawa, M., Kihara, I. (1998) Involvement of R-
cadherin in the early stage of glomerulogenesis. J. Am. Soc. Nephrol. 9:1234-1241. 
 
Green, J. B. A., Smith, J. C. (1991) Growth factors as morphogens: do gradients and tresholds establish body plan? Trends in 
Genetics 7:245-250. 
 
Groffen A. J., Ruegg M. A., Dijkman, H., van de Velden T. J., Buskens, C. A. van den Born, J., Assmann K. J., Monnens, L. A., 
Veerkamp, J. H., van den Heuvel, L. P. (1998) Agrin is a major heparan sulfate proteoglycan in the human glomerular basement 
membrane. J. Histochem. Cytochem. 46:19-27. 
 
Groffen A. J., Veerkamp, J. H., Monnens, L. A., van den Heuvel, L. P. (1999) Recent insights into the structure and functions of 
heparan sulfate proteoglycans in the human glomerular basement membrane. Nephrol. Dial. Transplant. 14:2119-2129. 
 
van Groningen, J. J. M., Bloemers, H. P. J., Swart, G. W. M. (1995) Identification of melanoma inhibitory activity and other 
differentially expressed messenger RNAs  in human melanoma cell lines with different metastatic capacity by messenger RNA 
differential display. Cancer Res. 55:6237-6243. 
 
Gruss, P., Walther, C. (1992) Pax in development. Cell 69:719-722. 
 
Gunwar, S., Ballester, F., Kalluri, R., Timoneda, J., Chonko, A. M., Edwards, S. T., Noelken, M. E., Hudson, B. G. (1991) 
Glomerular basement membrane. Identification of dimeric subunits of the noncollagenous domain (hexamer) of collagen IV and the 
Goodpasture antigen. J. Biol. Chem. 266:15318-15324. 
 
Gwinner, W., Deters-Evers, U., Brandes, R. P., Kubat, B., Koch, K.-M., Pape, M., Olbricht, C. J. (1998) Antioxidant-oxidant 
balance in the glomerulus and proximal tubule of the rat kidney. J. Physiol. 509:599-606. 
 
Habib, R. (1993) Nephrotic syndrome in the 1st year of life. Pediatr. Nephrol. 7:347-353. 
 
Hadman, M., Adam, B.-L., Wright Jr., G. L.,  Bos, T. J. (1994) Modifications to the differential display technique reduce backround 
and increase sensitivity. Anal. Biochem. 226:383-386. 
 
 
 
 
   
 
 76 
  
Halliwell, B. (1991) Reactive oxygen species in living systems: source, biochemistry and role in human disease. Am. J. Med. 91 
(Suppl. 3C):14S-22S. 
 
Hallman, N., Hjelt, L., Ahvenainen, E. K. (1956) Nephrotic syndrome in newborn and young infants. Ann. Pediatr. Fenn. 2:227-241. 
 
Hallman, N., Norio, R., Kouvalainen, K. (1967) Main features of the congenital nephrotic syndrome. Acta Pediatr. Fenn. 172:75-78. 
 
Hallman, N., Norio, R., Rapola, J. (1973) Congenital nephrotic syndrome. Nephron 11:101-110. 
 
Hammerman, M. R., Miller, S. B. (1997) Effects of growth hormone and insulin-like growth factor I on renal growth and function. J. 
Pediatr. 131:S17-S19. 
 
Hatefi, Y. (1985) The mitochondrial electron transport and oxidative phosphorylation system. Ann. Rev. Biochem. 54:1015-1069. 
 
Hein, H., Schluter, C., Kulke, R., Christophers, E., Schroder, J. M., Barlets, J. (1997) Genomic organization, sequence, and 
transcriptional regulation of the human eotaxin gene. Biochem. Biophys. Res. Commun. 237:537-542. 
 
Herzlinger, D., Koseki, C., Mikawa, T., Al-Awqati, Q. (1992) Metanephric mesenchyme contains multipotent stem cells whose fate 
is restricted after induction. Development 144:565-572. 
 
van den Heuvel, G. B., van den Born, J., Jalanko, H., Schröder, C. H., Veerkamp, J. H., Assman, K. J. M., Berden, J. H. M., 
Holmberg, C., Rapola, J., Monnens, L. A. H. (1992) Proteoglycan content of renal basement membranes in the Congenital nephrotic 
syndrome of the Finnish type. Pediatr. Nephrol. 6:10-15. 
 
Hevner, R. F., Wong-Riley, M. T. T. (1993) Mitochondrial and nuclear gene expression for cytochrome c oxidase subunits are 
disproportionately regulated by functional activity in neurons. J. Neurosci.13:1805-1819. 
 
Hill, R. E., Favor, J., Hogan, B. L. M., Ton, C. C. T., Saunders, G. F., Hanson, I. M., Prosser, J., Jordan, T., Hastie, N. D., van 
Heyningen, V. (1991) Mouse small eyeresults from mutations in a paired-like homeobox-containing gene. Nature 354:522-525. 
 
Hirsch, H. Z., Ainsworth, S. K., Spicer, S. S., Kurtz, E. H., Brissie, R. M. (1981) Ultrastructural assessment by colloidal iron of the 
distribution and localization of anionic sites in human glomerulonephritides. Am. J. Pathol. 102:99-107. 
 
Hirvonen, H., Sandberg, M., Kalimo, H., Hukkanen, V., Vuorio, E., Salmi, T. T., Alitalo, K. (1989) The N-myc proto-oncogene and 
IGF-II growth factor mRNAs are expressed by distinct cells in human fetal kidney and brain. J. Cell Biol. 108:1093-1104. 
 
Holmberg, C., Jalanko, H., Koskimies, O., Leijala, M., Salmela, K., Eklund, B., Wikström, S., Ahonen, J. (1990) Renal 
transplantation in children with congenital nephrotic syndrome of the Finnish type. Transplant. Proc. 22:158-159. 
 
Holmberg, C., Jalanko, H., Koskimies, O., Leijala, M., Salmela, K., Eklund, B., Ahonen, J. (1991) Renal transplantation in small 
children with congenital nephrotic syndrome of the Finnish type. Transplant. Proc. 23:1378-1379. 
 
Holmberg, C., Antikainen, M., Rönnholm, K., Ala-Houhala, M., Jalanko, H. (1995) Management of congenital nephrotic syndrome 
of the Finnish type. Pediatr. Nephrol. 9:87-93. 
 
Holmberg, C., Laine, J., Rönnholm, K., Ala-Houhala, M., Jalanko, H. (1996) Congenital nephrotic syndrome. Kidney Int. 49 (Suppl. 
53):51-56. 
 
Holthöfer, H., DeCandido, S., Schlondorff, D. (1990) Identification of specific glomerular cell types in culture by use of lectin and 
antibody binding. Cell Differ. Dev. 30:181-194. 
 
Holthöfer, H., Sainio, K., Miettinen, A. (1991) Rat glomerular cells do not express podocytic markers when cultured in vitro. Lab. 
Invest. 65:548-557. 
 
Holthöfer, H., Reivinen, J., Miettinen, A. (1992) Acidic glycolipids of human glomeruli. Evidence of specific changes in congenital 
nephrosis of the Finnish type. J. Am. Soc. Nephrol. (Abstr.) 3:525 
 
Holthöfer, H., Reivinen, J., Miettinen, A. (1994) Nephron segment and cell type specific gangliosides in the developing and adult 
kidney. Kidney Int. 45:123-130. 
 
Holthöfer, H., Ahola, H., Solin, M.-L., Wang, S., Palmen, T., Luimula, P., Miettinen, A., Kerjaschki, D. (1999) Nephrin localizes at 
the podocyte filtration slit area and is characteristically spliced in the human kidney. Am. J. Pathol. 155:1681-1687. 
 
 
 
 
   
 
 77 
  
Holzman, L. B., St John, P. L., Kovari, I. A., Verma, R., Holthöfer, H., Abrahamson, D. R. (1999) Nephrin localizes to the slit pore 
of the glomerular epithelial cell. Kidney Int. 56:1481-1491. 
 
Honda, K., Yamada, T., Endo, R., Ino, Y., Gotoh, M., Tsuda, H., Yamada, Y:, Chiba, H., Hirohashi, S. (1998) Actinin-4, a novel 
actin-bundling protein associated with cell motility and cancer invasion. J. Cell Biol. 140:1383-1393. 
 
Hood, D. (1990) Coordinate expression of cytochrome c oxidase subunit III and VIc mRNAs in rat tissue. Biochem. J. 269:503 -506. 
 
Horster, M. F., Braun, G. S., Huber S. M. (1999) Embryonic renal epithelia: Induction, nephrogenesis, and cell differentiation. 
Physiological Reviews 79: 1157-1191. 
 
Hsiao, K. (1991) A fast and simple procedure for sequencing double-stranded DNA with sequenase. Nucleic Acid Res. 19:2787. 
 
Hsieh, F., Gohh, R., Dworkin, L. (1996) Acute renal failure and the MELAS syndrome, a mitochondrial encephalomyopathy. J. Am. 
Soc. Nephrol. 7:647-652. 
 
Hsu, D., Olefsky, J. M. (1992) Characterization of insulin-like growth factor (IGF) binding proteins and their role in modulating 
IGF-I action in BHK cells. J. Biol. Chem. 267:25576-25582. 
 
Hsu, D. K. W., Donohue, P. J., Alberts, G. F., Winkles, J. A. (1993) Fibroblast growth factor-1 induces phosphofructokinase, fatty 
acid synthase and Ca2+-ATPase mRNA expression in NIH 3T3 cells. Biochem. Biophys. Res. Commun. 197:1483-1491. 
 
Hudson, B. G., Kalluri, R., Gunwar, S., Noelken, M. E., Mariyama, M., Reeders, S. T. (1993) Molecular characteristics of the 
Goodpasture autoantigen. Kidney Int. 43:135-139. 
 
Hunsicker, L. G., Shearer, T. P., Shaffer, S. J. (1981) Acute reversible proteinuria induced by infusion of the polycation 
hexadimethrine. Kidney Int. 20:7-17. 
 
Huttunen, N.-P. (1976) Congenital nephrotic syndrome of the Finnish type. A study of  75 patients. Arch. Dis. Child. 51:344-348. 
 
Huttunen, N.-P., Rapola, J., Vilska, J., Hallman, N. (1980) Renal pathology in congenital nephrotic syndrome of  finnish type: a 
quantitative light microscopic study on 50 patients. Int. J. Pediatr. Nephrol. 1:10-16. 
 
Ingulli, E., Tejani, A. (1991) Racial differencies in the incidence and renal outcome of idiopathic focal segmental glomerulosclerosis 
in children. Pediatr. Nephrol. 5:393-397. 
 
Jackson, I. J., Schofield, P., Hogan, B. (1985) A mouse homoeo box gene is expressed during embryogenesis and in adult kidney. 
Nature 317:745-748. 
 
Jalanko, H., Ljungberg, P., Holmberg, C., Seppälä, I., Repo, H., Hurme, M., Koskimies, O. (1989) Infections and immunological 
status of children with congenital nephrotic syndrome of the Finnish type (CNF). Pediatr. Nephrol. 3:C162. 
 
Jansen, J. J., Maassen, J. A., van der Woude, F. J., Lemmink, H. A. J., van den Ouweland, J. M. W., ´T Hart, L. M., Smeets, H. J. M., 
Bruijn, J. A., Lemkes, H. H. P. J. (1997) Mutation in mitochondrial tRNA Leu(UUR) gene associated with progressive kidney 
disease. J. Am. Soc. Nephrol. 8:1118-1124. 
 
Jefferson, J. A., Johnson, R. J. (1999) Experimental mesangial proliferative glomerulonephritis (the anti -Thy-1.1. model). J. Nephrol. 
12:297-307. 
 
Johns, D. R. (1995) Mitochondrial DNA and disease. New Engl. J. Med. 333:638-644. 
 
Johnson, R. J., Floege, J., Yoshimura, A., Lida, H., Couser, W. G., Alpers, C. E. (1992) The activated mesangial cell: a glomerular 
"myofibroblast"? J. Am. Soc. Nephrol. 2:S190-S197. 
 
Johnson R. J., Lovett, D., Lehrer, R. J., Couser, W. G., Klebanoff, S. J. (1994) Role of oxidants and proteases in glomerular injury. 
Kidney Int. 45:352-359. 
 
Julkunen, M., Koistinen, R., Aalto-Setälä, K., Seppälä, M., Jänne, O. A., Kontula, K. (1988) Primary structure of human insulin-like 
growth factor-binding protein/placental protein 12 and tissue-specific expression of its mRNA. FEBS Lett. 236:295-302. 
 
Kadenbach, B., Jarausch, J., Hartmann, R., Merle, P. (1983) Separation of mammalian cytochrome c  oxidase into 13 polypeptides 
by a sodium dodecyl sulfate-gel electrophoretic procedure. Anal. Biochem. 129:517-521. 
 
 
 
 
   
 
 78 
  
Kadomatsu, K., Huang, R.-P., Suganuma, T., Murata, F., Muramatsu, T. (1990) A retinoic acid responsive gene MK found in the 
teratocarcinomasystem is expressed in spatially and temporally controlled manner during mouse embryogenesis, J. Cell Biol. 
110:607-616. 
 
Kaipainen, A., Korhonen, J., Pajusola, K., Aprelikovam O., Graziella Persico, M., Terman, B. I., Alitalo, K. (1993) Related FLT4, 
FLT1, and KDR receptor tyrosine kinases show distinct expression patterns in human fetal endothelial cells. J. Exp. Med. 178:2077-
2088. 
 
Kanwar, Y. S., Farquhar, M. G. (1979) Presence of heparan sulfate in the glomerular basement membrane. Proc. Natl. Acad. Sci. 
USA 76:1303-1307. 
 
Kanwar, Y. S., Linker, A., Farquhar, M. G. (1980) Increased permeability of the glomerular basement membrane to ferritin after 
removal of glycosaminoglycans (heparan sulphate) by enzyme digestion. J. Cell. Biol. 86:688-693. 
 
Kanwar, Y. S. (1984) Biology of disease: Biophysiology of glomerular filtration and proteinuria. Lab. Invest. 51:7-21. 
 
Kanwar, Y. S., Jakubowski, M. L. (1984) Unaltered anionic sites of glomerular basement membrane in aminonucleoside nephrosis. 
Kidney Int. 25:613-618. 
 
Kanwar, Y. S., Liu, Z.Z., Kashihara, N., Wallner, E. I (1991) Current status of the structural and functional basis of glomerular 
filtration and proteinuria. Sem. Nephrol. 11:390-413. 
 
Kaplan, J. M., Kim, S. H., North, K. N., Rennke, H., Correia, L. A., Tong, H. Q., Mathis, B. J., Rodriquez-Perez, J. C., Allen, P. G., 
Beggs, A. H., Pollak, M. R. (2000) Mutations in ACTN4, encoding α-actinin-4, cause familial focal segmental glomerulosclerosis. 
Nat. Genet. 24:251-256. 
 
Karasawa, M., Zwacka, R. M., Reuter, A., Fink, T., Hsieh, C. L., Lichter, P., Francke, U., Weih er, H. (1993) The human homolog of 
the glomerulosclerosis gene Mpv17: structure and genomic organization. Hum. Mol. Genet. 2:1829-1834. 
 
Kashgarian, M., Sterzel, R. B. (1992) The pathobiology of the mesangium. Kidney Int. 41:524-529. 
 
Kawachi, H., Matsui, K., Orikasa, M., Morioka, T., Oite, T., Shimizu, F. (1992) Quantitative studies of monoclonal antibody 5-1-6-
induced proteinuric state in rats. Clin. Exp. Immunol. 87:215-219. 
 
Kawachi, H., Koike, H., Kurihara, H.Yaoita, E., Orikasa, M., Shia, M. A., Sakai , T., Yamamoto, T., Salant, D. J., Shimizu, F. (2000) 
Cloning of rat nephrin: Expression on developing glomeruli and in proteinuric states. Kidney Int. 57:1949-1961. 
 
Kawasaki, E., Wang, A. (1989) Detection of gene expression. In: PCR technology: Principles and applications for DNA 
amplification (Ehrlich, H., ed).  Stockton Press, New York, p. 89-97. 
 
Kelley, V. E., Cavallo, T. (1978) Glomerular permeability: transfer of native ferritin in glomeruli with decreased anionic sites. Lab. 
Invest. 39:547-553. 
 
Kelner, M. J., Montoya, M. A. (1998) Structural organization of the human selenium-dependent phospholipid hydroperoxide 
gluthatione peroxidase gene (GPX4). Chromosomal localization to 19q13.3. Biochem. Biophys. Res. Commun. 249:53-55. 
 
Kerjaschki, D., Sharkey, D. J., Farquhar, M. G. (1984) Identification and characterizationof podocalyxin - The major sialoprotein of 
the renal glomerular epithelial cell. J. Cell Biol. 98:1591-1596. 
 
Kerjaschki, D., Neale, J. T. (1996) Molecular mechanisms of glomerular injury in rat experimental membranous nephropathy 
(Heymann nephritis). J. Am. Soc. Nephrol. 7:2518-2526. 
 
Kerjaschki, D. (2001) Caught flat-footed: podocyte damage and the molecular bases of focal glomerulosclerosis. J. Clin. Invest. 
108:1582-1587 
 
Kessel, M., Balling, R., Gross, L. (1990) Variations of cervical vertebrae after expression of a Hox 1.1 transgene in mice. Cell 
61:301-308. 
 
Kessel , M., Gruss, P. (1990) Murine developmental control genes. Science 249:374-379. 
 
Kestilä, M., Männikkö, M., Holmberg, C., Gyapay, G., Weissenbach, J., Savolainen, E.-R., Peltonen, L., Tryggvason, K. (1994a) 
Congenital nephrotic syndrome of the Finnish type maps to the long arm of chromosome 19. Am. J. Hum. Genet. 54:757-764. 
 
 
 
 
   
 
 79 
  
Kestilä, M., Männikkö, M., Holmberg, C., Korpela, K., Savolainen, E.-R., Peltonen, L., Tryggvason, K. (1994b) Exclusion of eight 
genes as mutated loci in congenital nephrotic syndrome of the Finnish type. Kidney Int. 45:986-990. 
 
Kestilä, M., Männikkö, M., Holmberg, C., Tryggvason, K., Peltonen, L. (1994c) Congenital nephrotic syndrome of the Finnish type 
is not associated with the Pax-2 gene despite the promising transgenic animal model. Genomics 19:570-572. 
 
Kestilä, M., Lenkkeri, U., Männikkö, M., Lamerdin, J., McReady, P., Putaala, H., Ruotsalainen, V., Morita, T., Nissinen, M., Herva, 
R., Kashtan, C. E., Peltonen, L., Holmberg, C., Olsen, A., Tryggvason, K. (1998) Positionally cloned gene for a novel glomerular 
protein - nephrin - is mutated in congenital nephrotic syndrome. Mol. Cell 1:575-582. 
 
Khoshnoodi, J., Tryggvason, K. (2001) Congenital nephrotic syndromes. Curr. Opin. Genet. Dev. 11:322-327. 
 
Kiryu, S., Yao, G. L., Morita, N., Kato, H., Kiyama, H. (1995) Nerve injury enhances rat neuronal glutamate transporter expression: 
indentification by differential display. J. Neurosci. 15:7872-7878. 
 
Klein, G., Langegger, M., Goridis, C., Ekblom, P. (1988a) Neural adhesion molecules during embryonic induction and development 
of the kidney. Development 102:749-761. 
 
Klein, G., Langegger, M., Timpl, R., Ekblom, P. (1988b) Role of laminin A chain in the development of epithelial cell polarity. Cell 
55:331-341. 
 
Korhonen, M., Ylänne, J., Laitinen, L., Virtanen, I. (1990) The α1-α6 subunits of integrins are characteristically expressed in distinct 
segments of developing and adult human nephron. J. Cell Biol. 111:1245-1254. 
 
Koseki, C., Herzlinger, D., Al-Awqati Q. (1992) Apoptosis in metanephric development. J. Cell Biol. 119:1327-1333. 
 
Kouvalainen, K., Hjelt, L., Hallman, N. (1962) Placenta in congenital nephrotic syndrome. Ann. Paed. Fenn. 8:181-188. 
 
Koyama, A., Fujisaki, M., Kobayashi, M., Igarashi, M., Narita, M. (1991) A glomerular permeability factor produced by human T-
cell hybridomas. Kidney Int. 40:453-460. 
 
Kreidberg, J. A., Sariola, H., Loring, J. M., Maeda, M., Pelletier, J., Housman, D., Jaenisch R. (1993) WT-1 is required for early 
kidney development. Cell 74:679-691. 
 
Kreidberg, J. A., Donovan, M. J., Goldstein, S. L., Rennke, H., Shepherd, K., Jones, R. C., Jaenisch, R. (1996) Alpha 3 beta 1 
integrin has a crucial role in kidney and lung organogenesis. Development 122:3537-3547. 
 
Kreidberg, J. A., Symons, J. (2000) Integrins in kidney development, function, and disease. Am. J. Physiol. 279:F233-242. 
 
Kreisberg, J., Wayne, D., Karnovsky, M. (1979) Rapid and focal loss of negative charge associated with mononuclear cell infiltration 
early in nephrotoxic serum nephritis. Kidney Int. 16:290-300. 
 
Kress, C., Vogels, R., DeGraaff, W., Bonnerot, C., Meijlink, F., Nicholas, J. F., Deschmps, J. (1990) Hox 2.3 upstream sequences 
mediate lac Z expression in intermediate mesoderm derivatives of transgenic mice. Development 109: 775-786. 
 
Kretzler, M., Fan, G., Rose, D., Arend, L. J., Briggs, J. P., Holzman, L. B. (1996) Novel mouse embryonic renal marker gene 
products differentially expressed during kidney development. Am. J. Physiol. 271:770-777. 
 
Kretzler, M., Teixeira, V. P., Unschuld, P. G., Cohen, C. D., Wanke, R., Edenhofer, I., Mundel, P., Schlöndorff, D., Holthöfer, H. 
(2001) Integrin-linked kinase as a candidate downstream effector in proteinuria. FASEB J. 15:1843-1845. 
 
Kriz, W., Kaissling, B. (1985) Structural organization of the mammalian kidney. In: The Kidney: Physiology and Pathophysiology. 
(Seldin, D. W., Giebisch, G., eds). Raven Press, New York, p. 265-306. 
 
Kriz, W., Elger, M., Lemley, K., Sakai, T. (1990) Structure of the glomerular mesangium: a biomechanical interpretation. Kidney Int. 
38 (Suppl. 30) S2-S9. 
 
Kriz, W., Gretz, N., Lemley, K. V. (1998) Progression of glomerular diseases: Is the podocyte the culprit? Kidney Int. 54:687-697. 
 
Kroef, M. J., Jansen, J. H., Willmze, R., Landegent, J. E. (1996) Detection of partial cDNA sequences differentially expressed in 
patients with myelodysplasia. Ann. Hematol. 72:231-236. 
 
Kuroda, N., Yoshikawa, N., Nakanishi, K., Iijima, K., Hanioka, K., Hayashi, Y., Imai, Y., Sado, Y., Nakayama, M., Itoh, H. (1998) 
Expression of type IV collagen in the developing human kidney. Pediatr. Nephrol. 12:554-558. 
 
   
 
 80 
  
 
Kuure, S., Vuolteenaho, R., Vainio, S. (2000) Kidney morphogenesis: cellular and molecular regulation. Mech. Dev. 92:31-45. 
 
Laakso, O., Huttunen, N.-P., Rapola, J., Sarna, S., Holmberg, C., von Koskull, H., Leisti, J., Ryynänen, M., Norio, R. (1992) Onko 
suomalainen tautiperintö katoamassa? Duodecim 108:941-946. 
 
Laine, J., Jalanko, H., Holthöfer, H., Krogerus, L., Rapola, J., von Willebrand, E., Lautenschlager, I., Salmela, K., Holmberg, C. 
(1993) Post-transplantation nephrosis in congenital nephrotic syndrome of the Finnish type. Kidney Int. 44:867-874. 
 
Larsson, N. G., Holme, E., Kristianson, B., Oldfors, A., Tulinius, M. (1990) Progressive increase of the mutated mitochondrial DNA 
fraction in Kearns-Sayre syndrome. Pediatr. Res. 28:131-136. 
 
Latta, H. (1992) An approach to the structure and function of the glomerular mesangium. J. Am. Soc. Nephrol. 2:S65-S73. 
 
Lehnert, S. A., Akhurst, R. J. (1988) Embryonic expression pattern of TGF beta type-1 RNA suggests both  paracrine and autocrine 
mechansims of action. Development 104:263-273. 
 
Lelongt, B., Makino, H., Kanwar, Y. S. (1987) Status of glomerular proteoglycans in aminonucleoside nephrosis. Kidney Int. 
31:1299-1310. 
 
Lenkkeri, U., Männikkö, M., McCready, P., Lamerdin, J., Gribouval, O., Niaudet, P., Antignac, C., Kkashtan, C. E., Holmberg, C., 
Olsen, A., Kestilä, M., Tryggvason, K. (1999) Structure of the gene for congenital nephrotic syndrome of the Finnish type (NPHS1) 
and characterization of mutations. Am. J. Hum. Genet. 64:51-61. 
 
Leung, D. W., Cachianes, G., Kuang, W. J., Goeddel, D. V., Ferrara, N., (1989) Vascular endothelial growth factor is a secreted 
angiogenic mitogen. Science 246:1306-1309. 
 
Levin, M., Smith, C., Walters, M. D. S., Gascoine, P., Barrat, T. M. (1985) Steroid responsive nephrotic syndrome: a generalized 
disorder of membrane negative charge. Lancet 2:239-242. 
 
Li, F., Barnathan, E. S., Karikó, K. (1994) Rapid method for screening and cloning cDNAs generated in differential mRNA display: 
application of Northern blot for affinity capturing of cDNAs. Nucleic Acids Res. 22:1764-1765. 
 
Liang, P., Pardee, A. B. (1992) Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. 
Science 257:967-971. 
 
Liang, P., Averboukh, L., Pardee, A.B. (1993) Distribution and cloning of eukaryotic mRNAs by means of differential display: 
refinements and optimization. Nucleic Acids Res. 21: 32699-3275. 
 
Liang, P., Zhu, W., Zhang, X., Guo, Z., O´Connell, R. P. O., Averboukh, L., Wang, F., Pardee, A. B. (1994) Differential display 
using one-base anchored oligo-dT primers. Nucleic Acids Res. 22:5763-5764. 
 
Lin, J.-J., Tönshoff, B., Bouriquet, N., Casellas, D., Kaskel, F. J., Moore, L. C. (1998) Insulin-like growth factor-I restores 
microvascular autoregulation in experimental chronic renal failure. Kidney Int. 54 (Suppl. 67):S195-S198. 
 
Lindahl, P., Hellström, M., Kalén, M., Pekny, M., Pekna, M., Soriano, P., Betsholtz, C. (1998) Paracrine PDGF-B/PDGF-Rß 
signaling controls mesangial cell development in kidney glomeruli. Development 125: 3313-3322. 
 
Liu, S., Wong-Riley, M. (1995) Disproportionate regulation of nuclear- and mitochondrial-encoded cytochrome oxidase subunit 
proteins by functional activity in neurons. Neuroscience 67:197-210. 
 
Ljungberg, P. (1994) Glycosaminoglycans in urine and amniotic fluid in congenital nephrotic syndrome of the Finnish type. Pediatr. 
Nephrol. 8:531-536. 
 
Ljungberg, P., Rapola, J., Holmberg, C., Holthöfer, H., Jalanko, H. (1995) Glomerular anionic charge in congenital nephrotic 
syndrome of the Finnish type. Histochem. J. 27:536-546. 
 
Lovett, D. H., Sterzel, R. B. (1986) Cell culture approaches to the analysis of glomerular inflammation. Kidney Int. 30:246-252. 
 
Luimula, P., Aaltonen, P., Ahola, H., Palmen, T., Holthöfer, H. (2000) Alternatively spliced nephrin in experimental glomerular 
disease of the rat. Pediatr. Res. 48:759-762. 
 
 
 
 
 
   
 
 81 
  
Luo, X., Pitkänen, S., Kassovska-Bratinova, S., Robinson, B. H., Lehotay, D. C. (1997) Excessive formation of hydroxyl radicals 
and aldehyde lipid peroxidation products in cultured skin fibroblasts from patients with complex I deficiency. J. Clin. Invest. 
99:2877-2882. 
 
Maack, T., Park, C. H., Camargo, M. J. F. (1985) Renal filtration, transport, and metabolism of proteins. In: The Kidney: Physiology 
and Pathophysiology. (Seldin, D. W., Giebisch, G., eds). Raven Press, New York, p. 1773-1803. 
 
Madden, S. L., Cook, D. M., Morris, J. F., Gashler, A., Sukhatme, V. P., Rauscher III, F. J. (1991) Transcriptional repression 
mediated by the WT1 Wilms tumor gene product. Science 253:1550-1553. 
 
Mahan, J. D., Sisson-Ross, S., Vernier, R. L. (1986) Glomerular basement membrane anionic charge site changes early in 
aminonucleoside nehrosis. Am. J. Pathol. 125:393-401. 
 
Main, I. W., Nikolic-Paterson, D. J., Atkins, R. C. (1992) T cells and macrophages and their role in renal injury. Semin. Nephrol. 
12:393-407. 
 
Makino, H., Gibbons, J. T., Reddy, K. M., Kanwar, Y. S. (1986) Nephritogenicity of antibodies to proteoglycan of the glomerular 
basement membrane. J. Clin. Invest. 77:142-156. 
 
Mandel, I. J., Bacallao, R., Zampighi, G. (1993) Uncoupling of the molecular fence and paracellular gate functions in epithelial tight 
junctions.Nature 361:552-555. 
 
Marklund, S. L. (1984) Extracellular superoxide dismutase and other superoxide dismutase isoenzymes in tissues from nine 
mammalian species. Biochem. J. 222:649-655. 
 
Martinez-Hernandez, A., Amenta, P. S. (1983) The basement membrane in pathology. Lab. Invest. 48:656-677. 
 
Mathews, L. S., Norstedt, G., Palmiter, R. D. (1986) Regulation of insulin-like growth factor I gene expression by growth hormone. 
Proc. Natl. Acad. Sci. USA 83:9343-9347. 
 
Mathis, B. J., Kim, S. H., Calbrese, K., Haas, M., Seidman, J. G., Seidman, C. E., Pollak, M. R. (1998) A locus for inherited focal 
segmental glomerulosclerosis maps to chromosome 19q13. Kidney Int. 53:282-286. 
 
Matsell, D. G., Delhanty, P. J. D., Stepaniuk, O., Goodyer, C., Han, V. K. M. (1994) Expression of insulin-like growth factor and 
binding protein genes during nephrogenesis. Kidney Int. 46:1031-1042. 
 
Maulbecker, C. C., Gruss, P. (1993) The oncogenic potential of Pax genes. The EMBO Journal 12:2361-2367. 
 
Meakin, S. O., Shooter, E. M. (1992) The nerve growth factor family of receptors. Trends in Neurosciences 15:323-331. 
 
Mendrick, D. L., Rennke, H. G. (1988a) Epitope specific induction of proteinuria by monoclonal antibodies. Kidney Int. 33:831-841. 
 
Mendrick, D. L., Rennke, H. G. (1988b) Induction of proteinuria in the rat by a monoclonal antibody against SGP-115/107. Kidney 
Int. 33:818-830. 
 
Merenmies J., Rauvala, H. (1990) Molecular cloning nof the 18-kDa growth-associated protein of developing brain. J. Biol. Chem. 
265:16721-16724. 
 
Messina, A., Davies, D. J., Dillane, P. C., Ryan, G. B. (1987) Glomerular epithelial abnormalities associated with the onset of 
proteinuria in aminonucleoside nephrosis. Am. J. Pathol. 126:220-229. 
 
Michael, A. F., Keane, W. F., Raij, L., Vernier, L. R., Mauer, S. M. (1980) The glomerular mesangium. Kidney Int 17:141-154. 
 
Miettinen, A., Törnroth, T., Tikkanen, I., Virtanen, I., Linder, E. (1980) Heymann nephritis induced by kidney brush border 
glycoproteins. Lab. Invest. 43:547-555. 
 
Miettinen, A., Stow, J. L., Mentone, S., Farquhar, M. G. (1986) Antibodies to basement membrane heparan sulphate proteoglycans 
bind to the laminae rarae of the glomerular basement membrane (GBM) and induce subepithelial GBM thickening. J. Exp. Med. 
163:1064-1084. 
 
Miettinen, A., Dekan, G., Farquhar, M. G. (1990) Monoclonal antibodies against membrane  proteins of rat glomerulus. Am. J. 
Pathol. 137:929-944. 
 
 
 
   
 
 82 
  
 
Miner, J. H. (1999) Renal basement membrane components. Kidney Int. 56:2016-2024. 
 
Mita, S., Schmidt, B., Schon, E. A., DiMauro, S., Bonilla, E. (1989) Detection of "deleted" mitochondrial genomes in cytochrome-c 
oxidase-deficient muscle fibers of a patient with Kearns-Sayre syndrome. Proc. Natl. Acad. Sci. USA 86:9509-9513. 
 
Mitsiadis, T. A., Salmivirta, M., Muramatsu, T., Muramatsu, H., Rauvala, H., Lehtonen, E., Jalkanen, M., Thesleff, I. (1995) 
Expression of the heparin-binding cytokines, midkine (MK) and HB-GAM (pleiotrophin) is associated with epithelial-mesenchymal 
interactions during fetal development and organogenesis. Development 121:37-51. 
 
Moggio, M., Bresolin, N., Scarpini, E., Addobati, L., Prelle, A., Gallanti, A., Bet, L., Fortunato, F., Pellegrini, G., Scarlato, G. 
(1989) Cytochrome c oxidase during human fetal development. Int. J. Dev. Neurosci. 7:5-14. 
 
Montine, T. J., Amarnath, V., Martin, M. E., Strittmatter, M. J., Graham, D. G. (1996) E-4-hydroxy-2-nonenal is cytotoxic and cross-
links cytoskeletal proteins in P19 neuroglial cultures. Am. J. Pathol. 48:89-93. 
 
Moraes, C. T., Shanske, S., Tritschler, H.-J., Aprille, J. R., Andreetta, F., Bonilla, E., Schon, E. A., DiMauro, S. (1991) mtDNA 
depletion with variable tissue expression: a novel genetic abnormality in mitochondrial diseases. Am. J. Hum. Genet. 48:492-501. 
 
Mou, L., Miller, H., Li, J., Wang, E., Chalifour, L. (1994) Improvements to the differential display method for gene analysis. 
Biochem. Biophys. Res. Commun. 199:564-569. 
 
Mrowka, C., Schedl, A. (2000) Wilms' tumor suppressor gene WT1: from structure to renal pathophysiologic features. J. Am. Soc. 
Nephrol. 11 (Suppl. 16):S106-S115. 
 
Müller, U., Wang, D., Denda, S., Meneses, J. J., Pedersen, R. A., Reichardt, L. F. (1997) Integrin α8β1 is critically important for 
epithelial-mesenchymal interactions during kidney morphogenesis. Cell 88:603-613. 
 
Müller, U., Brändli, A. W. (1999) Cell adhesion molecules and extracellular-matrix constituents in kidney development and disease. 
J. Cell Science 112:3855-3867. 
 
Muramatsu, H., Muramatsu, T. (1991) Purification of recombinant midkine and examination of its biological activities: functional 
comparison of new heparin binding factors. Biochem. Biophys. Res. Commun. 177:652-658. 
 
Muramatsu, T. (1993) Midkine, the product of a retinoic acid responsive gene, and pleiotrophin constitute a new protein family 
ofregulating growth and differentiation. Int. J. Dev. Biol. 37:183-188. 
 
Murphy, L. J., Bell, G. I., Friesen, H. G. (1987) Growth hormone stimulates sequential induction of c-myc and insulin-like growth 
factor I expression in vivo. Endocrinology 120:1806-1812. 
 
Mustonen, T., Alitalo, K. (1995) Endothelial receptor tyrosine kinases involved in angiogenesis. J. Cell Biol. 129:895-898. 
 
Männikkö, M., Kestilä, M., Holmberg, C., Norio, R., Ryynänen, M., Olsen, A., Peltonen, L., Tryggvason, K. (1995) Fine mapping 
and haplotype analysis of the locus for congenital nephrotic syndrome on chromosome 19q13.1. Am. J. Hum. Gen. 57:1377-1383. 
 
Männikkö, M., Kestilä, M., Lenkkeri, U., Alakurtti, H., Holmberg, C., Leisti, J., Salonen, R., Aula, P., Mustonen, A., Peltonen, L., 
Tryggvason, K. (1997) Improved prenatal diagnosis of the congenital nephrotic syndrome of the Finnish type based on DNA 
analysis. Kidney Int. 51:868-872. 
 
Nagley, P. (1991) Coordination of gene expression in the formation of mammalian mitochondria. Trends. Genet. 7:1-4. 
 
Nagy, J. A., Brown, L. F., Senger, D. R., Lanir, N., Van De Water L., Dvorak, A. M., Dvorak, H. F. (1988) Pathogenesis of tumor 
stroma generation: a critical role for leaky blood vessels and fibrin deposition. Biochim. Biophys. Acta 948:305-326. 
 
Nakamoto, M., Matsubara, S., Miyauchi, T., Obama, H., Ozawa, M., Muramatsu, T. (1992) A new family of heparin binding 
growth/differentiation factors: differential expression of the midkine (MK) and HB-GAM genes during mouse development. J. 
Biochem. 112:346-349. 
 
Nakamura, T., Ebihara, I., Shirato, I., Tomino, Y., Koide, H (1991) Modulation of basement membrane component gene expression 
in glomeruli of aminonucleoside nephrosis. Lab. Invest. 64:640-647. 
 
Neale, T. J., Ojha, P. P., Exnar, M., Poczewski, H., Ruger, B., Wiztum, J. L., Davis, P., Kerjaschki, D. (1994) Proteinuria in passive 
Heymann nephritis is associated with lipid peroxidation and formation of adducts on type IV collagen. J. Clin. Invest. 94:1577-1584. 
 
Niaudet, P., Rötig, A. (1997) The kidney in mitochondrial cytopathies. Kidney Int. 51:1000-1007. 
 
   
 
 83 
  
Nishio, Y., Aiello, L. P., King, G. L. (1994) Glucose induced genes in bovine aortic smooth muscle cells identified by mRNA 
differential display. FASEB J. 8:103-106. 
 
Nishio, Y., Warren, C. E., Buczek-Thomas, J. A., Rulfs, J., Koya, D., Aiello, L. P., Feener, E. P., Miller, T. B., Dennis, J. W., King, 
G. L. (1995) Identification and characterization of a gene regulating enzymatic glycosylation which is induced by diabetes and 
hyperglycemia specifically in rat cardiac tissue. J. Clin. Invest. 96:1759-1767. 
 
Noakes, P. G., Miner, J. H., Gautam, M., Cunningham, J. M., Sanes, J. R., Merlie, J. P. (1995) The renal glomerulus of mice lacking 
s-laminin/laminin beta 2: nephrosis despite molecular compensation by laminin beta 1. Nat. Genet. 10:400-406. 
 
Nolin, L., Courteau, M. (1999) Management of IgA nephropathy: evidence-based recommendations. Kidney Int. (suppl) 70:56-62. 
 
Norio, R. (1966) Heredity in the congenital nephrotic syndrome. Ann. Pediatr. Fenn. 12 (suppl. 27):1-94. 
 
Oberley, T. D., Gilbert, E. F., Viseskul, C., Arya, S. (1981) Culture of human glomeruli from patients with metabolic or genetic 
diseases. Arch. Pathol. Lab. Med. 105:256-258. 
 
Orikasa, M., Matsui, K., Oite, T., Shimizu, F. (1988) Massive proteinuria induced in rats by a single intravenous injection of a 
monoclonal antibody. J. Immunol. 141:807-814. 
 
Orth, S. R., Ritz, E. (1998) The nephrotic syndrome. N. Engl. J. Med. 338:1202-1211. 
 
Pabst, R. Sterzel, R. B. (1983) Cell renewal of glomerular cell types in normal rats. An autoradiographic analysis. Kidney Int. 
24:626-631. 
 
Pagtalunan, M. E., Miller, P. L., Jumping-Eagle, S., Nelson, R. G., Myers, B. D., Rennke, H. G., Coplon, N. S., Sun, L., Meyer, T. 
W. (1997) Podocyte loss and progressive glomerular injury in type II diabetes. J. Clin. Invest. 99:342-348. 
 
Patrakka, J., Kestilä, M., Wartiovaara, J., Ruotsalainen, V., Tissari, P., Lenkkeri, U., Männikkö, M., Visapää, I., Holmberg, C., 
Rapola, J., Tryggvason, K., Jalanko, H. (2000) Congenital nephrotic syndrome (NPHS1): features resulting from different mutations 
in Finnish patients. Kidney Int. 58:972-980. 
 
Patrakka, J., Ruotsalainen, V., Ketola, I., Holmberg, C., Heikinheimo, M., Tryggvason, K., Jalanko, H. (2001) Expression of nephrin 
in pediatric kidney diseases. J. Am. Soc. Nephrol. 12:289-296. 
 
Patrakka, J., Ruotsalainen, V., Martin, P., Qvist, E., Laine, J., Holmberg, C., Tryggvason, K., Jalanko, H. (2002) Recurrence of 
nephrotic syndrome in kidney grafts of NPHS1 patients: Role of nephrin. Transplant. (in press) 
 
Pelletier, J., Bruening, W., Kashtan, C. E., Mauer, S. M., Manivel, J. C., Striegel, J. E., Houghton, D. C., Junien, C., Habib, R., 
Fouser, L., Fine, R. N., Silverman, B. L., Haber, D. A., Housman, D. (1991) Germline mutations  in the Wilms´tumessor gene are 
associated with abnormal urogenital development in Denys-Drash syndrome. Cell 67:437-447. 
 
Peten, E. P., Striker, L. J. (1994) Progression of glomerular disease. J. Intern. Med. 236:241-249. 
 
Pichel, J. G., Shen, L., Sheng, H. Z., Granholm, A.-C., Drago, J., Grinberg, A., Lee, E. J., Huang, S. P., Saarma, M., Hoffer, B. J., 
Sariola, H., Westphal, H (1996) Defects in enteric innervation and kidney development in mice lacking GDNF. Nature 382:73-76. 
 
Pitkänen, S., Robinson, B. H. (1996) Mitochondrial complex I deficiency leads to increased production of superoxide radicals and 
induction of superoxide dismutase. J. Clin. Invest. 98:345-351. 
 
Poleev, A., Fickenscher, H., Mundlos, S., Winterpacht, A., Zabel, B., Fidler, A., Gruss, P., Plachov, D. (1992) PAX8, a human 
paired box gene: isolation and expression in developing thyroid, kidney and Wilms´tumors. Development 116:611-623. 
 
Pritchard-Jones, K., Fleming, S., Davidson, D, Bickmore, W., Porteous, D., Gosden, C., Bard, J., Buckler, A., Pelletier, J., Housman, 
D., van Heyningen, V., Hastie, N. (1990) The candidate Wilms’ tumour gene is involved in genitourinary development. Nature 
346:194-197. 
 
Putaala, H., Soininen, R., Kilpeläinen, P., Wartiovaara, J., Tryggvason, K. (2001) The murine nephrin gene is specifically expressed 
in kidney, brain and pancreas. Inactivation of the gene leads to massive proteinuria and neonatal death. Hum. Mol. Genet.  10:1-8. 
 
Quatacker, J., Praet, M., Matthys, E. (1987) Ultrastructural alterations in the sialic acid distribution in minimal change disease and 
membranous glomerulonephritis. Pathol. Res. Pract. 182:188-194. 
 
 
 
 
   
 
 84 
  
Rackley, R. R., Kessler, P. M., Campbell, C., Williams, B. R. G. (1995) In situ expression of the early growth response gene-1 
during murine nephrogenesis. The Journal of Urology 154:700-705. 
 
Rapola, J., Sariola, H., Ekblom, P. (1984) Pathology of fetal congenital nephrosis: immunohistochemical and ultrastructural studies. 
Kidney Int. 25:701-707. 
 
Rapola, J. (1987) Congenital nephrotic syndrome. Pediatr. Nephrol. 1:441-446. 
 
Rapola, J., Huttunen, N.-P., Hallman, N. (1992) Congenital and infantile nephrotic syndrome. In: Pediatric kidney disease, 
(Edelmann, C.M., ed.), 2nd ed. Little & Brown company, Boston p. 1291-1305. 
 
Raulo, E., Julkunen, I., Merenmies, J., Pihlaskari, R., Rauvala, H. (1992) Secretion and biological activities of heparin-binding 
growth-associated molecule. J. Biol. Chem. 267:11408-11416. 
 
Rauscher, F. J., Morris, J. F., Tournay, O. E., Cook, D. M., Curran, T. (1990) Binding of the Wilms´tumor locus zinc finger protein 
to the EGR1 consensus sequence. Science 250:1259-1262. 
 
Rauvala, H. (1989) An 18-kd heparin-binding protein of developing brain that is distinct from fibroblast growth factors. EMBO J. 
8:2933-2941. 
 
Reeve, A. E., Eccles, M. R., Wilkins, R. J., Bell, G. I., Millow, L. J. (1985) Expression of insulin-like growth factor-II transcripts in 
Wilms' tumor. Nature 317:258-260. 
 
Reiser, J., Kriz, W., Kretzler, M., Mundel, P. (2000) The glomerular slit diaphgram is a modified adherens junction. J. Am. Soc. 
Nephrol. 11:1-8. 
 
Remuzzi, A., Remuzzi, G. (1994) Glomerular permselective function. Kidney Int. 45:398-402. 
 
Rennke, H. G. (1994) How does glomerular epithelial cell injury contribute to progressive glomerular damage. Kidney Int. 45 
(Suppl. 45):S58-S63. 
 
Risau, W. (1998) Development and differentiation of endothelium. Kidney Int. 54 (Suppl. 67): S3-S6. 
 
Ritvos, O., Tuuri, T., Erämaa, M., Sainio, K., Hildén, K., Saxén, L., Gilbert, S. (1995) Activin disrupts epithelial branching 
morphogenesis in developing glandular organs of the mouse. Mech. Dev. 50:229-245. 
 
Ritz, E., Stefanski, A. (1996) Diabetic nephropathy in type II diabetes. Am. J. Kidney Dis. 27:167-194. 
 
Rodewald, R., Karnovsky, M. J. (1974) Porous substructure of the glomerular slit diaphragm in the rat and mouse. J. Cell Biol. 
60:423-433. 
 
Roelink, H., Nusse, R. (1991) Expression of two members of the Wnt family during mouse development - restricted temporal and 
spatial patterns in the developing neural tube. Genes Dev. 5:381-388. 
 
Romppanen, E. L., Mononen, I (2000) Detection of the Finnish-type congenital nephrotic syndrome by restriction fragment lenght 
polymorphism and dual-color oligonucleotide ligation assays. Clin. Chem. 46:811-816. 
 
Rosenzweig, L. J., Kanwar, Y. S. (1982) Removal of sulfated (heparan sulfate) or nonsulfated (hyaluronic acid) glycosaminoglycans 
results in increased permeability of the glomerular basement membrane to 125I-bovine serum albumin. Lab. Invest. 47:177-184. 
 
Rothenpieler, U. W., Dressler, G. R. (1993) Pax2 is required for mesenchyme-to-epithelium conversion during kidney development. 
Development 119:711-720. 
 
Ruotsalainen, V., Ljungberg, P., Wartiovaara, J., Lenkkeri, U., Kestilä, M., Jalanko, H., Holmberg, C., Tryggvason, K. (1999) 
Nephrin is specifically located at the slit diaphragm of glomerular podocytes. Proc. Natl. Acad. Sci. USA 96:7962-7967. 
 
Ruotsalainen, V., Patrakka, J., Tissari, P., Reponen, P., Hess, M., Kestilä, M., Holmberg, C., Salonen, R., Heikinheimo, M., 
Wartiovaara, J., Tryggvason, K., Jalanko, H. (2000) Role of nephrin in cell jucntion formation in human nephrogenesis. Am. J. 
Pathol. 157:1905-1916. 
 
Russo, P. A., Bendayn, M. (1990) Distribution of endogenous albumin in the glomerular wall of proteinuric patients. Am. J. Pathol. 
137:1481-1490. 
 
Safirstein, R. (1994) Gene expression in nephrotoxic and ischemic acute renal failure. J. Am. Soc. Nephrol. 4:1387-1395. 
 
   
 
 85 
  
Sainio, K., Suvanto, P., Davies, J., Wartiovaara, J., Wartiovaara, K., Saarma. M., Arumäe, U., Meng, X., Lindahl, M., Pachnis, V., 
Sariola, H. (1997) Glial-cell-line-derived neurotrophic factor is required for bud initiation from ureteric epithelium. Development 
124:4077-4087. 
 
Salant, D. J. (1987) Immunopathogenesis of crescentic glomerulonephritis and lung purpura. Kidney Int. 32:408-425. 
 
Salesiotis, A. N., Wang, C. K., Wang, C. D., Burger, A., Li, H., Seth, A. (1995) Identification of novel genes from stomach cancer 
cell lines by differential display. Cancer Lett 91:47-54. 
 
Sambrook, J., Fritch, E. F., Maniatis, T. (1989) Molecular cloning: A laboratory manual. Cold Spring Harbor Laboratory, Cold 
Spring Harbor, New York. 
 
Sánchez, M. P., Silos-Santiago, I., Frisén, J., He, B., Lira, S. A., Barbacid, M. (1996) Renal agenesis and the absence of enteric 
neurons in mice lacking GDNF. Nature 382:70-73. 
 
Santos, O. F. P., Nigam, S. K. (1993) HGF-induced tubulogenesis and branching of epithelial cells is modulated by extracellular 
matrix and TGF-ß. Dev. Biol. 160:293-302. 
 
Sariola, H., Kuusela, P., Ekblom, P. (1984a) Cellular origin of fibronectin in interspecies hybrid kidneys. J. Cell Biol. 99:2099-2107. 
 
Sariola, H., Timpl, R., von der Mark, K., Mayne, R., Fitch, J. M., Linsenmayer, T. F., Ekblom, P. (1984b) Dual origin of glomerular 
basement membrane. Dev. Biol. 101:86-96. 
 
Sariola, H., Saarma, M., Sainio, K., Arumäe, U., Palgi, J., Vaahtokari, A., Thesleff, I., Karavanov, A. (1991) Dependence of kidney 
morphogenesis on the expression of nerve growth factor receptor. Science 254:571-573. 
 
Savage, C. (1994) The biology of the glomerulus: endothelial cells. Kidney Int. 45:314-319. 
 
Savage, J. M., Jefferson, J. A., Maxwell, A. P., Hughes, A. E., Shanks, J. H., Gill, D. (1999) Improved prognosis for congenital 
nephrotic syndrome of the Finnish type in Irish families. Arch. Dis. Child. 80:466-469. 
 
Savin, V. J. (1993) Mechanisms of proteinuria in noninflammatory glomerular diseases. Am. J. Kidney Dis. 21:347-362. 
 
Saxén, L. (1987) Organogenesis of the kidney. Cambridge University Press, Cambridge. 
 
Scarpulla, R. C. (1997) Nuclear control of respiratory chain expression in mammalian cells. J. Bioenerg. Biomembr. 29:109-119. 
 
Schon, E. A., Hirano, M., DiMauro, S. (1994) Mitochondrial encephalomyopathies: clinical and molecular analysis. J. Bioenerg. 
Biomembr. 26:291-299. 
 
Schuchardt, A., D’Agati, V., Pachnis, V., Costantini, F. (1996) Renal agenesis and hypodysplasia in ret-k-mutant mice result from 
defects in ureteric bud development. Development 122:1919-1929. 
 
Schägger, H., von Jagov, G. (1991) Blue native electrophoresis for isolation of membrane protein complexes in enzymatically active 
form. Anal. Biochem. 199:223-231. 
 
Schägger, H. (1995) Quantification of oxidative phosphorylation enzymes after blue native electrophoresis and two-dimensional 
resolution: normalcomplex I protein amounts in Parkinsos´s disease conflict with reduced catalytic activities. Electrophoresis 
16:763-770. 
 
Scott, J., Cowell, J., Robertson, M. E., Priestley, L. M., Wadey, R., Hopkins, B., Pritchard, J., Bell, G. I., Rall, L. B., Graham, C. F., 
Knott, T. J. (1985) Insulin-like growth factor-II gene expression in Wilms´tumour and embryonic tissues. Nature 317:260-262. 
 
Scott, M. P. (1993) A rational nomenclature for vertebrate homeobox (hox) genes. Nucleic Acids Res. 21:1687-1688. 
 
Seaquist, E. R., Goetz, F. C., Rich, S., Barbosa, J (1989) Familial clustering of diabetic kidney disease. Evidence for genetic 
susceptibility to diabetic nephropathy. N. Engl. J. Med. 320:1161-1165. 
 
Seligman, A. M., Karnovsky, M. J., Wasserkrug, H. L., Hanker, J. S. (1968) Nondroplet ultrastructural demonstration of cytochrome 
oxidase activity with a polymerizing osmiophilic reagent, diaminobenzidine (DAB). J. Cell Biol. 38:1-13. 
 
Sell, S., Pierce, G. B. (1994) Maturation arrest of stem cell differentiation is a common pathway for the cellular origin of 
teratocarcinomas and epithelial cell cancers. Lab. Invest 70:6-22. 
 
 
 
   
 
 86 
  
Senger, D. R., Galli, S. J., Dvorak, A. M., Peruzzi, C. A., Harvey, V. S., Dvorak, H. F. (1983) Tumor cells secrete a vascular 
permeability factor that promotes accumulation of ascites fluid. Science 219:983-985. 
 
Seppälä, M., Rapola, J., Huttunen, N.-P., Aula, P., Karjalainen, O., Ruoslahti, E. (1976) Congenital nephrotic syndrome: prenatal 
diagnosis and genetic counselling by estimation of amniotic-fluid and maternal serum alpha-fetoprotein. Lancet 7977:123-125. 
 
Shalaby, F., Rossant, J., Yamaguchi, T. P., Gertsenstein, M., Wu, X. F., Breitman, M. L., Schuh, A. C. (1995) Failure in blood-
island formation and vasculogenesis in Flk-1-deficient mice. Nature 376:62-66. 
 
Shankland, S. J. (2000) New insights into the pathogenesis of membranous nephropathy. Kidney Int. 57:1204-1205. 
 
Sharif, K., Goyal, M., Kershaw, D., Kunkel, R., Wiggins, R. (1998) Podocyte phenotypes as defined by expression and distribution 
of GLEPP1 in the developing glomerulus and in nephrotic glomeruli from MCD, CNF, and FSGS. A dedifferentiation hypothesis for 
the nephrotic syndrome. Exp. Nephrol. 6:234-244. 
 
Shih, N. Y., Li, J., Karpitskii, V., Nguyen, A., Dustin, M. L., Kanagawa, O., Miner, J. H., Shaw, A. S. (1999) Congenital nephrotic 
syndrome in mice lacking CD2-associated protein. Science 286:312-315. 
 
Shirato, I., Sakai, T., Kimura, K., Tomiko, Y., Kriz, W. (1996) Cytoskeletal changes in podocytes associated with foot process 
effacement in Masugi nephritis. Am. J. Pathol. 148:1283-1289. 
 
Shull, M. M., Ormsby, I., Kier, A. B., Pawlowski, S., Diebold, R. J., Yin, M., Allen, R., Sidman, C., Proetzel, G., Calvin, D., 
Annunziata, N., Doetschman, T. (1992) Targeted disruption of the mouse transforming growth factor-ß 1 gene results in multifocal 
inflammatory disease. Nature 359:693-699. 
 
Shulman, K., Rosen, S., Tognazzi, K., Manseau, E. J., Brown, L. (1996) Expression of vascular permeability factor (VPF/VEGF) is 
altered in many glomerular diseases. J. Am. Soc. Nephrol. 7:661-666. 
 
Siimes, M. A., Rönnholm, K. A. R., Antikainen, M., Holmberg, C. (1992) Factors limiting the erythropoietin response in rapidly 
growing infants with congenital nephrosis on peritoneal dialyses regimen after nephrectomy. J. Pediatr. 120:44-48. 
 
Simon, M., Gröne, H.-J., Jöhren, O., Kullmer, J., Plate, K. H., Risau, W., Fuchs, E. (1995) Expression of vascular endothelial growth 
factor and its receptors in human renal ontogenesis and in adult kidney. Am. J. Physiol. 268:F240-F250. 
 
Singh, P. J., Santella, R. N., Zawada, E. T. (1996) Mitochondrial genome mutations and kidney disease. Am. J. Kidney Dis. 28:140-
146. 
 
Solin, M.-L., Pitkänen, S., Taanman, J.-W., Holthöfer, H. (2000) Mitochondrial dysfunction in congenital nephrotic syndrome. Lab. 
Invest. 80:1227-1232. 
 
Solin, M.-L., Ahola, H., Haltia, A., Ursini, F., Montine, T., Roveri, A., Kerjaschki, D., Holthöfer, H. (2001) Lipid peroxidation in 
human proteinuric disease. Kidney Int. 59:481-487. 
 
Sompayrac, L., Jane, S., Burn, T. C., Tene, D. G., Danna, K. J. (1995) Overcoming limitations of teh mRNA differential display 
technique. Nucleic Acids Res. 23:4738-4739. 
 
Song, I, Yamada, T., Trent, J. M. (1992) Mapping of the gene encoding the alpha-subunit of the human H(+), K(+)-ATPase to 
chromosome 19q13.1 by fluorescent in situ hybridization. Genomics 14:547-548. 
 
Sorokin, L., Sonnenberg, A., Aumailley, M., Timpl, R., Ekblom, P. (1990) Recognition of the laminin E8 cell-binding site by an 
integrin possessing the ?6 integrin subunit is essential for eoithelial polarization in developing kidney tubules. J. Cell Biol. 111: 
1265-1273. 
 
Sorokin, L., Ekblom, P. (1992) Development of tubular and glomerular cells of the kidney. Kidney Int. 41:657-664. 
 
Spitzer, A. (1985) The developing kidney and the process of growth. In: The Kidney: Physiology and Pathophysiology. 
( Seldin, D. W., Giebisch, G., eds). Raven Press, New York, p. 1979-2015. 
 
Stark, K., Vainio, S., Vassileva, G., McMahon, A. P. (1994) Epithelial transformatio n of metanephric mesenchyme in the developing 
kidney regulated by Wnt-4. Nature 372:679-683. 
 
St John, P. L., Wang, R., Yin, Y., Miner, J. H., Robert, B., Abrahamson, D. R. (2001) Glomerular laminin isoform transitions: errors 
in metanephric culture are corrected by grafting. Am. J. Physiol. Renal Physiol. 280:F695-F705. 
 
   
 
 87 
  
 
 
Striker, G. E., Striker, L. J. (1985) Glomerular cell culture. Lab. Invest. 53:122-131. 
 
Striker, G. E., Peten, E. P., Yang, C.-W., Striker, L. J. (1994) Glomerulosclerosis: Studies of its pathogenesis in human and animals. 
In: Extracellular matrix in the kidney (Koide, H., Hayashi, T., eds) Karger, Basel. Contrib. Nephrol. 107:124-131. 
 
Subramaniam, M., Harris, S. A., Oursler, M. J., Rasmussen, K., Riggs, B. L., Spelsberg, T. C. (1995) Identification of a novel TGF-
?-regulated gene encoding a putative zinc finger protein in human osteoblasts. Nucleic Acids Res. 23:4907-4912. 
 
Suikkari, A.-M., Leivo, I., Kämäräinen, M., Holthöfer, H., Seppälä, M., Julkunen, M., Koistinen, R. (1992) Expression of insulin-
like growth factor binding protein-1 mRNA in human fetal kidney. Kidney Int. 42:749-754. 
 
Sukhatme, V. P., Cao, X., Chang, L. C., Tsai-Morris, C.-H., Stamenkovich, D., Ferreira, P. C. P., Cohen,  D. R., Edwards, S. A., 
Shows, T. B., Curran, T., Le Beau, M. M., Adamson, E. D. (1988) A zinc finger-encoding gene coregulated with c-fos during growth 
and differentiation, and after cellular depolarization. Cell 53:37-43. 
 
Sukhatme, V. P. (1992) The Egr transcription factor family: From signal transduction to kidney differentiation. Kidney Int. 41:550-
553. 
 
Suomalainen, A. (1997) Mitochondrial DNA and disease. Ann. Med. 29:235-246. 
 
Szabolcs, M. J., Seigle, R., Shanske, S., Bonilla, E., DiMauro, S., D´Agati, V. (1994) Mitochondrial DNA depletion: a cause of 
chronic tubulointerstitial nephropathy. Kidney Int. 45:1388-1396. 
 
Taanman, J.-W., van der Veen, A. Y., Schrage, C., de Vries, H., Buys, C. H. (1991) Assignment of the gene coding for human 
cytochrome c oxidase subunit VIb to chromosome 19, band q13.1, by fluorescence in situ hybridization. Hum Genet. 87:325-327. 
 
Taanman, J.-W., Hall, C. E., Tang, C., Marusich, M. F., Kennaway, N. G., Capaldi, R. A. (1993) Tissue distribution of cytochrome -c 
oxidase isoforms in mammals characterized with monoclonal and polyclonal antibodies. Biochim. Biophys. Acta 1225:95-100. 
 
Taanman, J.-W., Burton, M. D., Marusich, M. F., Kennaway, N. G., Capaldi, R. A. (1996) Subunit specific monoclonal antibodies 
show different steady-state levels of various cytochrome-c oxidase subunits in chronic progressive external ophthalmoplegia. 
Biochim. Biophys. Acta 315:199-207. 
 
Taanman, J.-W., Bodnar, A. G., Cooper, J. M., Morris, A. A. M., Clayton, P. T., Leonard, J. V., Schapira, A. H. V. (1997) Molecular 
mechanisms in mitochondrial depletion syndrome. Hum. Mol. Genet. 6:935-942. 
 
Tagge, E. P., Hanson, P., Re, G. G., Othersen, H. B., Smith, C. D., Garvin, A. J. (1994) Paired box gene expression in Wilms´tumor. 
J. Pediatr. Surgery 29:134-141. 
 
Tassabehji, M., Read, A. P., Newton, V. E., Harris, R., Balling, R., Gruss, P., Strachan, T. (1992) Waardenburg´s syndrome patients 
have mutation in the human homologue of the Pax-3 paired box gene. Nature 355:635-636. 
 
Terman, B. I., Dougher-Vermazen, M., Carrion, M. E., Dimitrov, D., Armellino, D. C., Gospodarowicz, D., Bohlen, P. (1992) 
Identification of the KDR tyrosine kinase receptor as a receptor for vascular endothelial cell growth factor. Biochem. Biophys. Res. 
Commun. 187:1579-1586. 
 
Thakur, V., Walker, P. D., Shah, S. V. (1988) Evidence suggesting a role for hydroxyl radical in puromycin aminonucleoside-
induced proteinuria. Kidney Int. 34:494-499. 
 
Thompson, R. B., Igarashi, P., Biemesderfer, D., Kim, R., Abu-Alfa, A., Soleimani, M., Aronson, P. S. (1995) Isolation and cDNA 
cloning of KSP-cadherin, a novel kidney-specific member of the cadherin multigene family. J. Biol. Chem. 250:17594-17601. 
 
Tisher, C. C., Madsen, K. M. (1991) Anatomy of the kidney. In: The Kidney. (Brenner, B. M., Rector, F. C., eds) W.B. Saunders 
Company, Philadelphia p. 3-75.  
 
Ton, C. C. T., Hirvonen, H., Miwa, H., Well, M. M., Monagghan, P., Jordan, T., van Heyningen, V., Hastie, N. D., Meijers-Heijboer, 
H., Drechsler, M., Royer-Pokora, B., Collins, F., Swaroop, A., Strong, L. C., Saunders, G. F. (1991) Positional cloning and 
characterization of a paired box and homeobox-containing gene from the aniridia region. Cell 67:1059-1074. 
 
Topham, P. S., Kawachi, H., Haydar, S. A., Chugh, S., Addona, T. A., Charron, K. B., Holzman, L. B., Shia, M., Shimizu, F., Salant, 
D. J (1999) Nephritogenic mAb 5-1-6 is directed at the extracellular domain of rat nephrin. J. Clin. Invest. 104:1559-1566. 
 
 
 
   
 
 88 
  
Tricoli, J. V., Rall, L. B., Scott, J., Bell, G. I., Shows, T. B. (1984) Localization of insulin-like growth factor genes to human 
chromosomes 11 and 12. Nature 310:784-786. 
 
Tryggvason, K., Kouvalainen, K. (1975) Number of nephrons in normal human kidneys and kidneys of patients with congenital 
nephrotic syndrome. A study using a sieving method for counting glomeruli. Nephron 15:62-68. 
 
Tryggvason, K. (1977) Composition of the glomerular basement membrane in the congenital nephrotic syndrome of the Finnish type. 
Eur. J. Clin. Invest. 7:177-180. 
 
Tryggvason, K. (1978) Morphometric studies on glomeruli in the congenital nephrotic syndrome. Nephron 22:544-550. 
 
Tryggvason, K., Zhou, J., Hostikka, S. L., Shows, T. B. (1993) Molecular genetics of Alport syndrome. Kidney Int. 43:38-44. 
 
Tryggvason, K. (1999) Unraveling the mechanisms of glomerular ultrafiltration: nephrin, a key component of the slit diaphragm. J. 
Am. Soc. Nephrol. 10:2440-2445. 
 
Tsutsui, J.-I., Uehara, K., Kadomatsu, K., Matsubara, S., Muramatsu, T. (1991) A new family of heparin binding factors: Strong 
conservation of midkine (MK) sequences between the human and the mouse. Biochem. Biophys. Res. Commun. 176:792-797. 
 
Vainio, S., Lehtonen, E., Jalkanen, M., Bernfield, M., Saxén, L. (1989) Epithelial-mesenchymal interactions regulate the stage-
specific expression of a cell surface proteoglycan, syndecan in developing kidney. Dev. Biol. 134:382-391. 
 
Vainio, S., Jalkanen, M., Bernfield, M., Saxén, L. (1992) Transient expression of syndecan in mesenchymal cell aggregates of the 
embryonic kidney. Dev. Biol. 152:221-232. 
 
Vermylen, C., Levin, M., Mossman, J., Barrat, T. M. (1989) Glomerular and urinary heparan sulfate in congenital nephrotic 
syndrome. Pediatr. Nephrol. 3:122-129. 
 
Vestweber, D., Kemler, R., Ekblom, P. (1985) Cell-adhesion molecule uvomorulin during kidney development. Dev. Biol. 112:213-
221. 
 
Vogeli-Lange, R., Burckert, N., Boller, T., Wiemken, A. (1996) Rapid selection and classification of positive clones generated by 
mRNA differential display. Nucleic Acids Res. 24:1385-1386. 
 
Voos, W., Moczko, M., Pfanner, N. (1994) Targetting, translocation and folding of mitochondrial preproteins. In:Mitochondria: 
DNA, proteins and diseases. (Darley-Usmar, V., Schapira, A. H. V., eds), Portland Press, London p. 221-239. 
 
Wang, S. X., Ahola, H., Palmén, T., Solin, M.-L., Luimula, P., Holthöfer, H. (2001) Recurrence after transplantation in CNF is due 
to autoantibodies to nephrin. Exp. Nephrol. 9:327-331. 
 
Wang, Z.-Y., Qiu, Q.-Q., Deuel, T. F. (1993) The Wilms’ tumor gene product WT1 activates or suppresses transcription through 
separate functional domains. J. Biol. Chem. 268:9172-9175. 
 
Watanabe, Y., Kahihara, N., Makino, H., Kanwar, Y. S. (1992) Modulation of glomerularproteoglycans by insulin-like growth 
factor-1. Kidney Int. 41:1262-1273. 
 
Weiher, H., Noda, T., Gray, D. A., Sharpe, A. H., Jaenisch, R. (1990) Transgenic mouse model of kidney disease: Insertional 
inactivation of ubiquitously expressed gene leads to nephrotic syndrome. Cell 62:425-434. 
 
Whiteside, C., Prutis, K., Cameron, R., Thompson, J. (1989) Glomerular epithelial detachment, not reduced charge density, 
correlates with proteinuria in adriamycin and puromycin nephrosis. Lab. Invest. 61:650-660. 
 
Wilcox, J. N. (1993) Fundamental principles of in situ hybridization. J. Histochem. Cytochem. 41:1725-1733. 
 
Wilkinson, A., Williams, D. G., Gillespie, C., Hartley, B. (1986)  Nephrotic plasma increases proteinuria and reduced anionic sites on 
the glomerular basement membrane  in vivo in NZW rabbits. Kidney Int. 29:295. 
 
Wilkinson, D. G., Bailes, J. A., McMahon, A. P. (1987) Expression of the proto-oncogene int-1 is restricted to specific neural cells 
in the developing mouse embryo. Cell 50:79-88. 
 
Winetz, J. A., Robertson, C. R., Colbetz, H. V., Carrie, B. J., Salyer, N. R., Myers, B. D. (1981) The nature of the glomerular injury 
in minimal change and focal sclerosing glomerulopathies. Am. J. Kidney Dis. 1:91-98. 
 
 
 
 
   
 
 89 
  
Winn, M. P., Conlon, P. J., Lynn, K. L., Howell, D. N., Slotterbeck, B. D., Smith, A. H., Graham, F. L., Bembe, M., Quarles, L. D., 
Pericak-Vance, M. A. (1999) Linkage of the gene causing familial focal segmental glomerulosclerosis to chromosome 11 and further 
evidence of genetic heterogeneity. Genomics 58:113-120. 
 
Yaffe, M. P. (1999) The machinery of mitochondrial inheritance and behavior. Science 283:1493-1497. 
 
Yasui, M., Tanaka, H., Seino, Y. (1997) The role of tissue-fixed macrophages in apoptosis in the developing kidney. Nephron 77: 
325-332. 
 
Yoshika, K., Takemura, T., Murakami, K., Okada, M., Hino, S., Miyamoto, H., Maki, S. (1993) Transforming growth factor-β 
protein and mRNA in glomeruli in normal and diseased human kidneys. Lab. Invest. 68:154-163. 
 
Yun, K. (1993) Clear cell sarcoma of the kidney expresses insulin-like growth factor-II but not WT1 transcripts. Am. J. Pathol. 
142:39-47. 
 
Xiang, Y. Y., Tanaka, M., Suzuki, M., Igarashi, H., Kiyokawa, E., Naito, Y., Ohtawara, Y., Shen, Q., Sugimura, H., Kino, I. (1994) 
Isolation of complementary DNA encoding K-cadherin, a novel rat cadherin preferentially expressed in fetal kidney and kidney 
carcinoma. Cancer Res. 54:3034-3041. 
 
Zhang, Q., Berggren, P. O., Tally, M. (1997) Glucose increases both the plasma membrane number and phosphorylationof insulin-
like growth factor II/mannose 6-phosphate receptors. J. Biol. Chem. 272:23703-23706. 
 
Zhao, S., Ooi, S. L., Pardee, A. B. (1995) New primer strategy improves precision of differential display. Biotechniques 18:842-846. 
 
Zimmerman, K. A., Yancopoulos, G. D., Collum, R. G., Smith, R. K., Kohl, N. E., Denis, K. A., Nau, M. M., Witte, O. N., Toran-
Allerand, D., Gee, C. E., Minna, J. D., Alt, F. W. (1986) Differential expression of myc family genes during murine development. 
Nature 319:780-783. 
 
Zimmerman, S. W. (1984) Increased urinary protein excertion in the rat produced by serum from a patient with recurrent focal 
glomerular sclerosis after renal transplantation.Clin. Nephrol. 22:32-38. 
 
Zimmermann J. W., Schultz, R. M. (1994) Analysis of gene expression in the preimplantation mouse embryo: Use of mRNA 
differential display. Proc. Natl. Acad. Sci. USA 91:5456-5460. 
 
Zwacka, R. M., Reuter, A., Pfaff, E., Moll, J., Gorgas, K., Karasawa, M., Weiher, H. (1994) The glomerulosclerosis gene Mpv 17 
encodes a peroxisomal protein producing reactive oxygen species. EMBO J. 13:5129-5134. 
 
 
 
 
